
<!DOCTYPE html>
<html lang="en" >
    <head >

        <meta charset="UTF-8" />
        <meta http-equiv="X-UA-Compatible" content="IE=edge" />
        <meta name="HandheldFriendly" content="True" />
        <meta name="MobileOptimized" content="320" />
        <meta name="viewport" content="width=device-width, initial-scale=1.0" />

        
        

        
        
  <link rel="stylesheet" href="/static/assets/style-8258669d.css" />
<script type="module" crossorigin="" src="/static/assets/base_style-f4a99799.js"></script>

  <link rel="stylesheet" href="/static/assets/style-ef962842.css" />
<link rel="stylesheet" href="/static/assets/style-3ade8b5c.css" />
<script type="module" crossorigin="" src="/static/assets/article_style-d757a0dd.js"></script>

  
  
    <style>
  
  
  @media screen and (min-width: 64em) {
    div.pmc-wm {
      background: repeat-y;
      background-image: url("data:image/svg+xml,%3Csvg xmlns='http://www.w3.org/2000/svg' width='20' height='350' xmlns:xlink='http://www.w3.org/1999/xlink'%3E%3Cdefs%3E%3Cfilter x='-.02' y='0' width='1.05' height='1' id='c'%3E%3CfeFlood flood-color='%23FFF'/%3E%3CfeComposite in='SourceGraphic'/%3E%3C/filter%3E%3Ctext id='b' font-family='Helvetica' font-size='11pt' style='opacity:1;fill:%23005ea2;stroke:none;text-anchor:middle' x='175' y='14'%3E%3C/text%3E%3Cpath id='a' style='fill:%23005ea2' d='M0 8h350v3H0z'/%3E%3C/defs%3E%3Cuse xlink:href='%23a' transform='rotate(90 10 10)'/%3E%3Cuse xlink:href='%23b' transform='rotate(90 10 10)' filter='url(%23c)'/%3E%3C/svg%3E");
      padding-left: 3rem;
    }
  }
</style>

  



        
            <link rel="apple-touch-icon"
                  sizes="180x180"
                  href="/static/img/favicons/apple-touch-icon.png" />
            <link rel="icon"
                  type="image/png"
                  sizes="48x48"
                  href="/static/img/favicons/favicon-48x48.png" />
            <link rel="icon"
                  type="image/png"
                  sizes="32x32"
                  href="/static/img/favicons/favicon-32x32.png" />
            <link rel="icon"
                  type="image/png"
                  sizes="16x16"
                  href="/static/img/favicons/favicon-16x16.png" />
            <link rel="manifest" href="/static/img/favicons/site.webmanifest" />
            <link rel="mask-icon"
                  href="/static/img/favicons/safari-pinned-tab.svg"
                  color="#0071bc" />
            <meta name="msapplication-config"
                  content="/static/img/favicons/browserconfig.xml" />
            <meta name="theme-color" content="#ffffff" />
        

        <title>
            The effect of travoprost on primary human limbal epithelial cells and the siRNA-based aniridia limbal epithelial cell model, in vitro - PMC
        </title>

        
        
  
  <!-- Logging params: Pinger defaults -->
<meta name="ncbi_app" content="cloudpmc-viewer" />
<meta name="ncbi_db" content="pmc" />
<meta name="ncbi_phid" content="D2E4B8888AF3F45305B888002E0F8A04.m_1" />
<meta name="ncbi_pinger_stat_url" content="https://pmc.ncbi.nlm.nih.gov/stat" />
<!-- Logging params: Pinger custom -->
<meta name="ncbi_pdid" content="article" />
  
    <link rel="preconnect" href="https://www.google-analytics.com" />

    
        <link rel="preconnect" href="https://cdn.ncbi.nlm.nih.gov" />
    

    <!-- Include USWDS Init Script -->
    <script src="/static/assets/uswds-init.js"></script>


    <meta name="ncbi_domain" content="plosone">
<meta name="ncbi_type" content="fulltext">
<meta name="ncbi_pcid" content="journal">
<meta name="ncbi_feature" content="associated_data">
<link rel="canonical" href="https://pmc.ncbi.nlm.nih.gov/articles/PMC12364336/">
<meta name="robots" content="INDEX,NOFOLLOW,NOARCHIVE">
<meta name="citation_journal_title" content="PLOS One">
<meta name="citation_title" content="The effect of travoprost on primary human limbal epithelial cells and the siRNA-based aniridia limbal epithelial cell model, in vitro">
<meta name="citation_author" content="Shuailin Li">
<meta name="citation_author_institution" content="Dr. Rolf M. Schwiete Center for Limbal Stem Cell and Congenital Aniridia Research, Saarland University, Homburg/Saar, Germany">
<meta name="citation_author_institution" content="Department of Experimental Ophthalmology, Saarland University, Homburg/Saar, Germany">
<meta name="citation_author" content="Tanja Stachon">
<meta name="citation_author_institution" content="Dr. Rolf M. Schwiete Center for Limbal Stem Cell and Congenital Aniridia Research, Saarland University, Homburg/Saar, Germany">
<meta name="citation_author_institution" content="Department of Experimental Ophthalmology, Saarland University, Homburg/Saar, Germany">
<meta name="citation_author" content="Shanhe Liu">
<meta name="citation_author_institution" content="Dr. Rolf M. Schwiete Center for Limbal Stem Cell and Congenital Aniridia Research, Saarland University, Homburg/Saar, Germany">
<meta name="citation_author_institution" content="Department of Experimental Ophthalmology, Saarland University, Homburg/Saar, Germany">
<meta name="citation_author" content="Zhen Li">
<meta name="citation_author_institution" content="Dr. Rolf M. Schwiete Center for Limbal Stem Cell and Congenital Aniridia Research, Saarland University, Homburg/Saar, Germany">
<meta name="citation_author" content="Shao-Lun Hsu">
<meta name="citation_author_institution" content="Dr. Rolf M. Schwiete Center for Limbal Stem Cell and Congenital Aniridia Research, Saarland University, Homburg/Saar, Germany">
<meta name="citation_author_institution" content="Department of Experimental Ophthalmology, Saarland University, Homburg/Saar, Germany">
<meta name="citation_author" content="Swarnali Kundu">
<meta name="citation_author_institution" content="Dr. Rolf M. Schwiete Center for Limbal Stem Cell and Congenital Aniridia Research, Saarland University, Homburg/Saar, Germany">
<meta name="citation_author" content="Fabian N Fries">
<meta name="citation_author_institution" content="Dr. Rolf M. Schwiete Center for Limbal Stem Cell and Congenital Aniridia Research, Saarland University, Homburg/Saar, Germany">
<meta name="citation_author_institution" content="Department of Ophthalmology, Saarland University Medical Center, Homburg/Saar, Germany">
<meta name="citation_author" content="Berthold Seitz">
<meta name="citation_author_institution" content="Department of Ophthalmology, Saarland University Medical Center, Homburg/Saar, Germany">
<meta name="citation_author" content="Maryam Amini">
<meta name="citation_author_institution" content="Dr. Rolf M. Schwiete Center for Limbal Stem Cell and Congenital Aniridia Research, Saarland University, Homburg/Saar, Germany">
<meta name="citation_author" content="Shweta Suiwal">
<meta name="citation_author_institution" content="Dr. Rolf M. Schwiete Center for Limbal Stem Cell and Congenital Aniridia Research, Saarland University, Homburg/Saar, Germany">
<meta name="citation_author_institution" content="Department of Experimental Ophthalmology, Saarland University, Homburg/Saar, Germany">
<meta name="citation_author" content="Nóra Szentmáry">
<meta name="citation_author_institution" content="Dr. Rolf M. Schwiete Center for Limbal Stem Cell and Congenital Aniridia Research, Saarland University, Homburg/Saar, Germany">
<meta name="citation_author_institution" content="Department of Experimental Ophthalmology, Saarland University, Homburg/Saar, Germany">
<meta name="citation_publication_date" content="2025 Aug 19">
<meta name="citation_volume" content="20">
<meta name="citation_issue" content="8">
<meta name="citation_firstpage" content="e0330492">
<meta name="citation_doi" content="10.1371/journal.pone.0330492">
<meta name="citation_pmid" content="40828815">
<meta name="citation_abstract_html_url" content="https://pmc.ncbi.nlm.nih.gov/articles/PMC12364336/">
<meta name="citation_fulltext_html_url" content="https://pmc.ncbi.nlm.nih.gov/articles/PMC12364336/">
<meta name="citation_pdf_url" content="https://pmc.ncbi.nlm.nih.gov/articles/PMC12364336/pdf/pone.0330492.pdf">
<meta name="description" content="Haploinsufficiency of the PAX6 gene is the primary pathogenic mechanism underlying classical congenital aniridia. Notably, at least 50% of patients with this condition develop glaucoma. Prostaglandin analogues, such as travoprost, are widely used to ...">
<meta name="og:title" content="The effect of travoprost on primary human limbal epithelial cells and the siRNA-based aniridia limbal epithelial cell model, in vitro">
<meta name="og:type" content="article">
<meta name="og:site_name" content="PubMed Central (PMC)">
<meta name="og:description" content="Haploinsufficiency of the PAX6 gene is the primary pathogenic mechanism underlying classical congenital aniridia. Notably, at least 50% of patients with this condition develop glaucoma. Prostaglandin analogues, such as travoprost, are widely used to ...">
<meta name="og:url" content="https://pmc.ncbi.nlm.nih.gov/articles/PMC12364336/">
<meta name="og:image" content="https://cdn.ncbi.nlm.nih.gov/pmc/cms/images/pmc-card-share.jpg?_=0">
<meta name="twitter:card" content="summary_large_image">
<meta name="twitter:site" content="@ncbi">
    
    

    </head>
    <body >
        
    <a class="usa-skipnav " href="#main-content">
      Skip to main content
    </a>


        
            

<section class="usa-banner " aria-label="Official website of the United States government" >
    <div class="usa-accordion">
        <header class="usa-banner__header">
            <div class="usa-banner__inner">
                <div class="grid-col-auto">
                    <img aria-hidden="true"
                         class="usa-banner__header-flag"
                         src="/static/img/us_flag.svg"
                         alt="" />
                </div>

                <div class="grid-col-fill tablet:grid-col-auto" aria-hidden="true">
                    <p class="usa-banner__header-text">
                        An official website of the United States government
                    </p>
                    <span class="usa-banner__header-action">Here's how you know</span>
                </div>

                



















    
        <button
            type="button"
        
    
    class="usa-accordion__button usa-banner__button
           

           
               
               
               
               
            

           
           
           
           "
    aria-expanded="false"
    aria-controls="gov-banner-default"
    
    data-testid="storybook-django-banner"
    
    >
    
        

        
                    <span class="usa-banner__button-text">Here's how you know</span>
                

        
    
        
            </button>
        


            </div>
        </header>

        <div class="usa-banner__content usa-accordion__content"
             id="gov-banner-default"
             hidden>
            <div class="grid-row grid-gap-lg">
                <div class="usa-banner__guidance tablet:grid-col-6">
                    <img class="usa-banner__icon usa-media-block__img"
                         src="/static/img/icon-dot-gov.svg"
                         alt=""
                         aria-hidden="true" />
                    <div class="usa-media-block__body">
                        <p>
                            <strong>Official websites use .gov</strong>
                            <br />
                            A
                            <strong>.gov</strong> website belongs to an official
                            government organization in the United States.
                        </p>
                    </div>
                </div>

                <div class="usa-banner__guidance tablet:grid-col-6">
                    <img class="usa-banner__icon usa-media-block__img"
                         src="/static/img/icon-https.svg"
                         alt=""
                         aria-hidden="true" />

                    <div class="usa-media-block__body">
                        <p>
                            <strong>Secure .gov websites use HTTPS</strong>
                            <br />
                            A <strong>lock</strong> (
                            <span class="icon-lock">
                                <svg xmlns="http://www.w3.org/2000/svg"
                                     width="52"
                                     height="64"
                                     viewBox="0 0 52 64"
                                     class="usa-banner__lock-image"
                                     role="graphics-symbol"
                                     aria-labelledby="banner-lock-description"
                                     focusable="false">
                                    <title id="banner-lock-title">Lock</title>
                                    <desc id="banner-lock-description">
                                    Locked padlock icon
                                    </desc>
                                    <path fill="#000000"
                                          fill-rule="evenodd"
                                          d="M26 0c10.493 0 19 8.507 19 19v9h3a4 4 0 0 1 4 4v28a4 4 0 0 1-4 4H4a4 4 0 0 1-4-4V32a4 4 0 0 1 4-4h3v-9C7 8.507 15.507 0 26 0zm0 8c-5.979 0-10.843 4.77-10.996 10.712L15 19v9h22v-9c0-6.075-4.925-11-11-11z" />
                                </svg>
</span>) or <strong>https://</strong> means you've safely
                                connected to the .gov website. Share sensitive
                                information only on official, secure websites.
                            </p>
                        </div>
                    </div>
                </div>
            </div>
        </div>
    </section>

        

        
    
    
    

<div class="usa-overlay">
</div>



<header class="usa-header usa-header--extended usa-header--wide" data-header data-testid="header"    >
    <div class="ncbi-header">
        <div class="ncbi-header__container">
            <a class="ncbi-header__logo-container"
               href="https://www.ncbi.nlm.nih.gov/">
                <img alt="NCBI home page"
                     class="ncbi-header__logo-image"
                     src="/static/img/ncbi-logos/nih-nlm-ncbi--white.svg"
                     width="410"
                     height="100" />
            </a>

            <!-- Mobile menu hamburger button -->
            



















    
        <button
            type="button"
        
    
    class="usa-menu-btn ncbi-header__hamburger-button
           

           
               
               
               
               
            

           
           
           
           "
    
    
    aria-label="Show menu"
    data-testid="navMenuButton"
    
    >
    
        

        
                <svg aria-hidden="true"
                     class="ncbi-hamburger-icon"
                     fill="none"
                     focusable="false"
                     height="21"
                     viewBox="0 0 31 21"
                     width="31"
                     xmlns="http://www.w3.org/2000/svg">
                    <path clip-rule="evenodd"
                          d="M0.125 20.75H30.875V17.3333H0.125V20.75ZM0.125 12.2083H30.875V8.79167H0.125V12.2083ZM0.125 0.25V3.66667H30.875V0.25H0.125Z"
                          fill="#F1F1F1"
                          fill-rule="evenodd" />
                </svg>
            

        
    
        
            </button>
        



            
                <!-- Desktop buttons-->
                <div class="ncbi-header__desktop-buttons">
                    
                        <!-- Desktop search button -->
                        



















    
        <button
            type="button"
        
    
    class="usa-button
           

           
               
               
               
               
            

           
           
           usa-button--unstyled ncbi-header__desktop-button
           "
    aria-expanded="false"
    aria-controls="search-field-desktop-navigation"
    aria-label="Show search overlay"
    data-testid="toggleSearchPanelButton"
    data-toggle-search-panel-button
    >
    
        

        
                            



    <svg class="usa-icon " role="graphics-symbol" aria-hidden="true" >
        
        <use xlink:href="/static/img/sprite.svg#search" />
    </svg>


                            Search
                        

        
    
        
            </button>
        


                    

                    <!-- Desktop login dropdown -->
                    
                        <div class="ncbi-header__login-dropdown">
                            



















    
        <button
            type="button"
        
    
    class="usa-button
           

           
               
               
               
               
            

           
           
           usa-button--unstyled ncbi-header__desktop-button ncbi-header__login-dropdown-button
           "
    aria-expanded="false"
    aria-controls="login-dropdown-menu"
    aria-label="Show login menu"
    data-testid="toggleLoginMenuDropdown"
    data-desktop-login-button
    >
    
        

        
                                



    <svg class="usa-icon " role="graphics-symbol" aria-hidden="true" >
        
        <use xlink:href="/static/img/sprite.svg#person" />
    </svg>



                                <span data-login-dropdown-text>Log in</span>

                                <!-- Dropdown icon pointing up -->
                                



    <svg class="usa-icon ncbi-header__login-dropdown-icon ncbi-header__login-dropdown-icon--expand-less ncbi-header__login-dropdown-icon--hidden" role="graphics-symbol" aria-hidden="true" data-login-dropdown-up-arrow>
        
        <use xlink:href="/static/img/sprite.svg#expand_less" />
    </svg>



                                <!-- Dropdown icon pointing down -->
                                



    <svg class="usa-icon ncbi-header__login-dropdown-icon ncbi-header__login-dropdown-icon--expand-more ncbi-header__login-dropdown-icon--hidden" role="graphics-symbol" aria-hidden="true" data-login-dropdown-down-arrow>
        
        <use xlink:href="/static/img/sprite.svg#expand_more" />
    </svg>


                            

        
    
        
            </button>
        



                            <!-- Login dropdown menu -->
                            <ul class="usa-nav__submenu ncbi-header__login-dropdown-menu"
                                id="login-dropdown-menu"
                                data-desktop-login-menu-dropdown
                                hidden>
                                
                                    <li class="usa-nav__submenu-item">
                                        <!-- Uses custom style overrides to render external and document links. -->
                                        









    <a href="https://www.ncbi.nlm.nih.gov/myncbi/" class="usa-link  "  >
        

        
            Dashboard
        

        
    </a>


                                    </li>
                                
                                    <li class="usa-nav__submenu-item">
                                        <!-- Uses custom style overrides to render external and document links. -->
                                        









    <a href="https://www.ncbi.nlm.nih.gov/myncbi/collections/bibliography/" class="usa-link  "  >
        

        
            Publications
        

        
    </a>


                                    </li>
                                
                                    <li class="usa-nav__submenu-item">
                                        <!-- Uses custom style overrides to render external and document links. -->
                                        









    <a href="https://www.ncbi.nlm.nih.gov/account/settings/" class="usa-link  "  >
        

        
            Account settings
        

        
    </a>


                                    </li>
                                
                                <li class="usa-nav__submenu-item">
                                    



















    
        <button
            type="button"
        
    
    class="usa-button
           

           
               
               
               
               
            

           
           
           usa-button--outline ncbi-header__login-dropdown-logout-button
           "
    
    
    
    data-testid="desktopLogoutButton"
    data-desktop-logout-button
    >
    
        

        Log out

        
    
        
            </button>
        


                                </li>
                            </ul>
                        </div>
                    
                </div>
            
        </div>
    </div>

    <!-- Search panel -->
    
        <div class="ncbi-search-panel ncbi--show-only-at-desktop"
             data-header-search-panel
             hidden>
            <div class="ncbi-search-panel__container">
                <form action="https://www.ncbi.nlm.nih.gov/search/all/"
                      
                      autocomplete="off"
                      class="usa-search usa-search--big ncbi-search-panel__form"
                      data-testid="desktop-navigation-search-form"
                      method="GET"
                      role="search">
                    <label class="usa-sr-only" for="search-field-desktop-navigation">
                        Search…
                    </label>
                    <input class="usa-input"
                           id="search-field-desktop-navigation"
                           name="term"
                           
                               placeholder="Search NCBI"
                           
                           type="search"
                           value="" />
                    



















    
        <button
            type="submit"
        
    
    class="usa-button
           

           
               
               
               
               
            

           
           
           
           "
    
    
    
    
    
    >
    
        

        
                        <span class="usa-search__submit-text">
                            Search NCBI
                        </span>
                    

        
    
        
            </button>
        


                </form>

                
            </div>
        </div>
    

    <nav aria-label="Primary navigation" class="usa-nav">
        <p class="usa-sr-only" id="primary-navigation-sr-only-title">
            Primary site navigation
        </p>

        <!-- Mobile menu close button -->
        



















    
        <button
            type="button"
        
    
    class="usa-nav__close ncbi-nav__close-button
           

           
               
               
               
               
            

           
           
           
           "
    
    
    aria-label="Close navigation menu"
    data-testid="navCloseButton"
    
    >
    
        

        
            <img src="/static/img/usa-icons/close.svg" alt="Close" />
        

        
    
        
            </button>
        



        
            <!-- Mobile search component -->
            <form class="usa-search usa-search--small ncbi--hide-at-desktop margin-top-6"
                  action="https://www.ncbi.nlm.nih.gov/search/all/"
                  
                  autocomplete="off"
                  data-testid="mobile-navigation-search-form"
                  method="GET"
                  role="search">
                <label class="usa-sr-only" for="search-field-mobile-navigation">
                    Search
                </label>

                <input class="usa-input"
                       id="search-field-mobile-navigation"
                       type="search"
                       
                           placeholder="Search NCBI"
                       
                       name="term" />

                



















    
        <button
            type="submit"
        
    
    class="usa-button
           

           
               
               
               
               
            

           
           
           
           "
    
    
    
    
    
    >
    
        

        
                    <!-- This SVG should be kept inline and not replaced with a link to the icon as otherwise it will render in the wrong color -->
                    <img src="data:image/svg+xml;base64,PHN2ZyB4bWxucz0iaHR0cDovL3d3dy53My5vcmcvMjAwMC9zdmciIGhlaWdodD0iMjQiIHZpZXdCb3g9IjAgMCAyNCAyNCIgd2lkdGg9IjI0Ij48cGF0aCBkPSJNMCAwaDI0djI0SDB6IiBmaWxsPSJub25lIi8+PHBhdGggZmlsbD0iI2ZmZiIgZD0iTTE1LjUgMTRoLS43OWwtLjI4LS4yN0E2LjQ3MSA2LjQ3MSAwIDAgMCAxNiA5LjUgNi41IDYuNSAwIDEgMCA5LjUgMTZjMS42MSAwIDMuMDktLjU5IDQuMjMtMS41N2wuMjcuMjh2Ljc5bDUgNC45OUwyMC40OSAxOWwtNC45OS01em0tNiAwQzcuMDEgMTQgNSAxMS45OSA1IDkuNVM3LjAxIDUgOS41IDUgMTQgNy4wMSAxNCA5LjUgMTEuOTkgMTQgOS41IDE0eiIvPjwvc3ZnPg=="
                         class="usa-search__submit-icon"
                         alt="Search" />
                

        
    
        
            </button>
        


            </form>

            
        

        <!-- Primary navigation menu items -->
        <!-- This usa-nav__inner wrapper is required to correctly style the navigation items on Desktop -->
        

        
            <div class="ncbi-nav__mobile-login-menu ncbi--hide-at-desktop"
                 data-mobile-login-menu
                 hidden>
                <p class="ncbi-nav__mobile-login-menu-status">
                    Logged in as:
                    <strong class="ncbi-nav__mobile-login-menu-email"
                            data-mobile-login-email-text></strong>
                </p>
                <ul class="usa-nav__primary usa-accordion">
                    
                        <li class="usa-nav__primary-item">
                            









    <a href="https://www.ncbi.nlm.nih.gov/myncbi/" class="usa-link  "  >
        

        
            Dashboard
        

        
    </a>


                        </li>
                    
                        <li class="usa-nav__primary-item">
                            









    <a href="https://www.ncbi.nlm.nih.gov/myncbi/collections/bibliography/" class="usa-link  "  >
        

        
            Publications
        

        
    </a>


                        </li>
                    
                        <li class="usa-nav__primary-item">
                            









    <a href="https://www.ncbi.nlm.nih.gov/account/settings/" class="usa-link  "  >
        

        
            Account settings
        

        
    </a>


                        </li>
                    
                </ul>
            </div>
        

        



















    
        <button
            type="button"
        
    
    class="usa-button
           

           
               
               
               
               
            

           
           
           ncbi-nav__mobile-login-button ncbi--hide-at-desktop
           "
    
    
    
    data-testid="mobileLoginButton"
    data-mobile-login-button
    >
    
        

        Log in

        
    
        
            </button>
        


    </nav>
</header>

    
    
        

<section class="pmc-header pmc-header--basic" aria-label="PMC Header with search box">
    <div class="pmc-nav-container">
        <div class="pmc-header__bar">
           <div class="pmc-header__logo">
               <a href="/" title="Home" aria-label="PMC Home"></a>
           </div>
            <button
                    type="button"
                    class="usa-button usa-button--unstyled pmc-header__search__button"
                    aria-label="Open search"
                    data-ga-category="search"
                    data-ga-action="PMC"
                    data-ga-label="pmc_search_panel_mobile"
            >
                <svg class="usa-icon width-4 height-4 pmc-icon__open" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#search"></use>
                </svg>
                <svg class="usa-icon width-4 height-4 pmc-icon__close" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#close"></use>
                </svg>
            </button>
        </div>
        <div class="pmc-header__search">
            


<form class="usa-search usa-search--extra usa-search--article-right-column  pmc-header__search__form" id="pmc-search-form" autocomplete="off" role="search">
<label class="usa-sr-only" for="pmc-search">Search PMC Full-Text Archive</label>
<span class="autoComplete_wrapper flex-1">
<input class="usa-input width-full maxw-none" required="required" placeholder="Search PMC Full-Text Archive" id="pmc-search"  type="search" name="term" data-autocomplete-url="https://pmc.ncbi.nlm.nih.gov/autocomp/search/autocomp/"/>
</span>
<button
class="usa-button"
type="submit"
formaction="https://www.ncbi.nlm.nih.gov/pmc/"
data-ga-category="search"
data-ga-action="PMC"
data-ga-label="PMC_search_button"
>
<span class="usa-search__submit-text">Search in PMC</span>
<img
src="/static/img/usa-icons-bg/search--white.svg"
class="usa-search__submit-icon"
alt="Search"
/>
</button>
</form>
            <div class="display-flex flex-column tablet:flex-row tablet:flex-justify flex-justify-center flex-align-center width-full desktop:maxw-44">
                <ul class="pmc-header__search__menu">
                    <li>
                        
                            <a class="usa-link" href="/journals/" data-ga-action="featured_link" data-ga-label="journal list">
                                Journal List
                            </a>
                        
                    </li>
                    <li>
                        
                            <a class="usa-link" href="/about/userguide/" data-ga-action="featured_link"
                            data-ga-label="user guide">
                                User Guide
                            </a>
                        
                    </li>
                </ul>
                
                    <button form="pmc-search-form" formaction="https://pmc.ncbi.nlm.nih.gov/search/" type="submit" class="usa-button usa-button--unstyled hover:text-no-underline text-no-underline width-auto margin-top-1 tablet:margin-top-0">
     <span class="bg-green-label padding-05 text-white">New</span><span class="text-underline text-primary">Try this search in PMC Beta Search</span>
</button>
                
            </div>
        </div>
    </div>
</section>

    


        
        

       
  <div class="usa-section padding-top-0 desktop:padding-top-6 pmc-article-section" data-article-db="pmc" data-article-id="12364336">

    

   



<div class="grid-container pmc-actions-bar" aria-label="Actions bar" role="complementary">
    <div class="grid-row">
        <div class="grid-col-fill display-flex">
             <div class="display-flex">
                <ul class="usa-list usa-list--unstyled usa-list--horizontal">
                    <li class="margin-right-2 mobile-lg:margin-right-4 display-flex mob">
                        <button
                                type="button"
                                class="usa-button pmc-sidenav__container__open usa-button--unstyled width-auto display-flex"
                                aria-label="Open resources"
                                data-extra-class="is-visible-resources"
                                data-ga-category="resources_accordion"
                                data-ga-action="click"
                                data-ga-label="mobile_icon"
                        >
                            <svg class="usa-icon width-4 height-4" aria-hidden="true" focusable="false" role="img">
                                <use xlink:href="/static/img/sprite.svg#more_vert"></use>
                            </svg>
                        </button>
                    </li>
                    
                    <li class="margin-right-2 mobile-lg:margin-right-4 display-flex mob">
                        <a
                                href="https://doi.org/10.1371/journal.pone.0330492"
                                class="usa-link display-flex usa-tooltip"
                                role="button"
                                target="_blank"
                                rel="noreferrer noopener"
                                title="View on publisher site"
                                data-position="bottom"
                                aria-label="View on publisher site"
                                data-ga-category="actions"
                                data-ga-action="click"
                                data-ga-label="publisher_link_mobile"
                        >
                                <svg class="usa-icon width-4 height-4" aria-hidden="true" focusable="false" role="img">
                                    <use xlink:href="/static/img/sprite.svg#launch"></use>
                                </svg>
                        </a>
                    </li>
                    
                    
                        <li class="margin-right-2 mobile-lg:margin-right-4 display-flex">
                             <a
                                     href="pdf/pone.0330492.pdf"
                                     class="usa-link display-flex usa-tooltip"
                                     role="button"
                                     title="Download PDF"
                                     data-position="bottom"
                                     aria-label="Download PDF"
                                     data-ga-category="actions"
                                     data-ga-action="click"
                                     data-ga-label="pdf_download_mobile"
                             >
                                <svg class="usa-icon width-4 height-4" aria-hidden="true" focusable="false" role="img">
                                    <use xlink:href="/static/img/sprite.svg#file_download"></use>
                                </svg>
                            </a>
                        </li>
                    
                    <li class="margin-right-2 mobile-lg:margin-right-4 display-flex">
                        <button
                            class="usa-button usa-button--unstyled  usa-tooltip collections-dialog-trigger collections-button display-flex collections-button-empty"
                            title="Add to Collections"
                            data-position="bottom"
                            aria-label="Save article in MyNCBI collections."
                            data-ga-category="actions"
                            data-ga-action="click"
                            data-ga-label="collections_button_mobile"
                            data-collections-open-dialog-enabled="false"
                            data-collections-open-dialog-url="https://account.ncbi.nlm.nih.gov/?back_url=https%3A%2F%2Fpmc.ncbi.nlm.nih.gov%2Farticles%2FPMC12364336%2F%3Freport%3Dclassic%23open-collections-dialog"
                            data-in-collections="false"
                        >
                            <svg class="usa-icon width-4 height-4 usa-icon--bookmark-full" aria-hidden="true" focusable="false" role="img" hidden>
                                <use xlink:href="/static/img/action-bookmark-full.svg#icon"></use>
                            </svg>
                            <svg class="usa-icon width-4 height-4 usa-icon--bookmark-empty" aria-hidden="true" focusable="false" role="img" hidden>
                                <use xlink:href="/static/img/action-bookmark-empty.svg#icon"></use>
                            </svg>
                        </button>
                    </li>
                    
                    <li class="margin-right-2 mobile-lg:margin-right-4 display-flex">
                        <button role="button" class="usa-button usa-button--unstyled usa-tooltip citation-dialog-trigger display-flex"
                            aria-label="Open dialog with citation text in different styles"
                            title="Cite"
                            data-position="bottom"
                            data-ga-category="actions"
                            data-ga-action="open"
                            data-ga-label="cite_mobile"
                            data-all-citations-url="/resources/citations/12364336/"
                            data-citation-style="nlm"
                            data-download-format-link="/resources/citations/12364336/export/"
                        >
                            <svg class="usa-icon width-4 height-4 usa-icon--bookmark-empty" aria-hidden="true" focusable="false" role="img" hidden>
                                <use xlink:href="/static/img/sprite.svg#format_quote"></use>
                            </svg>
                        </button>
                    </li>
                    
                    <li class="pmc-permalink display-flex" >
                         <button
                                 type="button"
                                 title="Permalink"
                                 data-position="bottom"
                                 class="usa-button usa-button--unstyled display-flex usa-tooltip"
                                 aria-label="Show article permalink"
                                 aria-expanded="false"
                                 aria-haspopup="true"
                                 data-ga-category="actions"
                                 data-ga-action="open"
                                 data-ga-label="permalink_mobile"
                         >
                            <svg class="usa-icon width-4 height-4" aria-hidden="true" focusable="false" role="img">
                                <use xlink:href="/static/img/sprite.svg#share"></use>
                            </svg>
                        </button>
                        

<div class="pmc-permalink__dropdown" hidden>
    <div class="pmc-permalink__dropdown__container">
          <h2 class="usa-modal__heading margin-top-0 margin-bottom-2 text-uppercase font-sans-xs">PERMALINK</h2>
          <div class="pmc-permalink__dropdown__content">
              <input type="text" class="usa-input" value="https://pmc.ncbi.nlm.nih.gov/articles/PMC12364336/" aria-label="Article permalink">
              <button class="usa-button display-inline-flex pmc-permalink__dropdown__copy__btn margin-right-0" title="Copy article permalink" data-ga-category="save_share" data-ga-action="link" data-ga-label="copy_link">
                  <svg class="usa-icon" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#content_copy"></use>
                  </svg>
                  <span class="margin-left-1">Copy</span>
              </button>
          </div>
    </div>
</div>
                    </li>
                </ul>
            </div>
            <button
                    type="button"
                    class="usa-button pmc-sidenav__container__open usa-button--unstyled width-auto display-flex"
                    aria-label="Open article navigation"
                    data-extra-class="is-visible-in-page"
                    data-ga-category="actions"
                    data-ga-action="open"
                    data-ga-label="article_nav_mobile"
            >
                <svg class="usa-icon width-4 height-4" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#list"></use>
                </svg>
            </button>
        </div>
    </div>
</div>
    <div class="grid-container desktop:padding-left-6">
      <div id="article-container" class="grid-row grid-gap">
        <div class="grid-col-12 desktop:grid-col-8 order-2 pmc-layout__content">
            <div class="grid-container padding-left-0 padding-right-0">
                <div class="grid-row desktop:margin-left-neg-6">
                    <div class="grid-col-12">
                        <div class="pmc-layout__disclaimer" role="complementary" aria-label="Disclaimer note">
    As a library, NLM provides access to scientific literature. Inclusion in an NLM database does not imply endorsement of, or agreement with,
    the contents by NLM or the National Institutes of Health.<br/>
    Learn more:
    <a class="usa-link" data-ga-category="Link click" data-ga-action="Disclaimer" data-ga-label="New disclaimer box" href="/about/disclaimer/">PMC Disclaimer</a>
    |
    <a class="usa-link" data-ga-category="Link click" data-ga-action="PMC Copyright Notice" data-ga-label="New disclaimer box" href="/about/copyright/">
        PMC Copyright Notice
    </a>
</div>
                    </div>
                </div>
                <div class="grid-row pmc-wm desktop:margin-left-neg-6">
                    <!-- Main content -->
                    <main
                      id="main-content"
                      class="usa-layout-docs__main usa-layout-docs grid-col-12 pmc-layout pmc-prose padding-0"
                    >

                      
                        <section class="pmc-journal-banner text-center line-height-none" aria-label="Journal banner"><img src="https://cdn.ncbi.nlm.nih.gov/pmc/banners/logo-plosone.png" alt="PLOS One logo" usemap="#pmc-banner-imagemap" width="500" height="75"><map name="pmc-banner-imagemap"><area alt="Link to PLOS One" title="Link to PLOS One" shape="default" href="https://doi.org/10.1371/journal.pone.0330492" target="_blank" rel="noopener noreferrer"></map></section><article lang="en"><section aria-label="Article citation and metadata"><section class="pmc-layout__citation font-secondary font-xs"><div>
<div class="display-inline-block"><button type="button" class="cursor-pointer text-no-underline bg-transparent border-0 padding-0 text-left margin-0 text-normal text-primary" aria-controls="journal_context_menu">PLoS One</button></div>. 2025 Aug 19;20(8):e0330492. doi: <a href="https://doi.org/10.1371/journal.pone.0330492" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">10.1371/journal.pone.0330492</a>
</div>
<nav id="journal_context_menu" hidden="hidden"><ul class="menu-list font-family-ui" role="menu">
<li role="presentation"><a href="https://www.ncbi.nlm.nih.gov/pmc/?term=%22PLoS%20One%22%5Bjour%5D" class="usa-link" role="menuitem">Search in PMC</a></li>
<li role="presentation"><a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22PLoS%20One%22%5Bjour%5D" lang="en" class="usa-link" role="menuitem">Search in PubMed</a></li>
<li role="presentation"><a href="https://www.ncbi.nlm.nih.gov/nlmcatalog?term=%22PLoS%20One%22%5BTitle%20Abbreviation%5D" class="usa-link" role="menuitem">View in NLM Catalog</a></li>
<li role="presentation"><a href="?term=%22PLoS%20One%22%5Bjour%5D" class="usa-link" role="menuitem" data-add-to-search="true">Add to search</a></li>
</ul></nav></section><section class="front-matter"><div class="ameta p font-secondary font-xs">
<hgroup><h1>The effect of travoprost on primary human limbal epithelial cells and the siRNA-based aniridia limbal epithelial cell model, <em>in vitro</em>
</h1></hgroup><div class="cg p">
<a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Li%20S%22%5BAuthor%5D" class="usa-link" aria-describedby="id1"><span class="name western">Shuailin Li</span></a><div hidden="hidden" id="id1">
<h3><span class="name western">Shuailin Li</span></h3>
<div class="p">
<sup>1</sup>Dr. Rolf M. Schwiete Center for Limbal Stem Cell and Congenital Aniridia Research, Saarland University, Homburg/Saar, Germany</div>
<div class="p">
<sup>2</sup>Department of Experimental Ophthalmology, Saarland University, Homburg/Saar, Germany</div>
<div>Conceptualization, Data curation, Formal analysis, Investigation, Methodology, Project administration, Writing – original draft</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Li%20S%22%5BAuthor%5D" class="usa-link"><span class="name western">Shuailin Li</span></a>
</div>
</div>
<sup>1,</sup><sup>2,</sup><sup>*</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Stachon%20T%22%5BAuthor%5D" class="usa-link" aria-describedby="id2"><span class="name western">Tanja Stachon</span></a><div hidden="hidden" id="id2">
<h3><span class="name western">Tanja Stachon</span></h3>
<div class="p">
<sup>1</sup>Dr. Rolf M. Schwiete Center for Limbal Stem Cell and Congenital Aniridia Research, Saarland University, Homburg/Saar, Germany</div>
<div class="p">
<sup>2</sup>Department of Experimental Ophthalmology, Saarland University, Homburg/Saar, Germany</div>
<div>Methodology, Project administration, Resources, Supervision, Writing – review &amp; editing</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Stachon%20T%22%5BAuthor%5D" class="usa-link"><span class="name western">Tanja Stachon</span></a>
</div>
</div>
<sup>1,</sup><sup>2</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Liu%20S%22%5BAuthor%5D" class="usa-link" aria-describedby="id3"><span class="name western">Shanhe Liu</span></a><div hidden="hidden" id="id3">
<h3><span class="name western">Shanhe Liu</span></h3>
<div class="p">
<sup>1</sup>Dr. Rolf M. Schwiete Center for Limbal Stem Cell and Congenital Aniridia Research, Saarland University, Homburg/Saar, Germany</div>
<div class="p">
<sup>2</sup>Department of Experimental Ophthalmology, Saarland University, Homburg/Saar, Germany</div>
<div>Data curation, Investigation, Writing – review &amp; editing</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Liu%20S%22%5BAuthor%5D" class="usa-link"><span class="name western">Shanhe Liu</span></a>
</div>
</div>
<sup>1,</sup><sup>2</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Li%20Z%22%5BAuthor%5D" class="usa-link" aria-describedby="id4"><span class="name western">Zhen Li</span></a><div hidden="hidden" id="id4">
<h3><span class="name western">Zhen Li</span></h3>
<div class="p">
<sup>1</sup>Dr. Rolf M. Schwiete Center for Limbal Stem Cell and Congenital Aniridia Research, Saarland University, Homburg/Saar, Germany</div>
<div>Writing – review &amp; editing</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Li%20Z%22%5BAuthor%5D" class="usa-link"><span class="name western">Zhen Li</span></a>
</div>
</div>
<sup>1</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Hsu%20SL%22%5BAuthor%5D" class="usa-link" aria-describedby="id5"><span class="name western">Shao-Lun Hsu</span></a><div hidden="hidden" id="id5">
<h3><span class="name western">Shao-Lun Hsu</span></h3>
<div class="p">
<sup>1</sup>Dr. Rolf M. Schwiete Center for Limbal Stem Cell and Congenital Aniridia Research, Saarland University, Homburg/Saar, Germany</div>
<div class="p">
<sup>2</sup>Department of Experimental Ophthalmology, Saarland University, Homburg/Saar, Germany</div>
<div>Writing – review &amp; editing</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Hsu%20SL%22%5BAuthor%5D" class="usa-link"><span class="name western">Shao-Lun Hsu</span></a>
</div>
</div>
<sup>1,</sup><sup>2</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Kundu%20S%22%5BAuthor%5D" class="usa-link" aria-describedby="id6"><span class="name western">Swarnali Kundu</span></a><div hidden="hidden" id="id6">
<h3><span class="name western">Swarnali Kundu</span></h3>
<div class="p">
<sup>1</sup>Dr. Rolf M. Schwiete Center for Limbal Stem Cell and Congenital Aniridia Research, Saarland University, Homburg/Saar, Germany</div>
<div>Writing – review &amp; editing</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Kundu%20S%22%5BAuthor%5D" class="usa-link"><span class="name western">Swarnali Kundu</span></a>
</div>
</div>
<sup>1</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Fries%20FN%22%5BAuthor%5D" class="usa-link" aria-describedby="id7"><span class="name western">Fabian N Fries</span></a><div hidden="hidden" id="id7">
<h3><span class="name western">Fabian N Fries</span></h3>
<div class="p">
<sup>1</sup>Dr. Rolf M. Schwiete Center for Limbal Stem Cell and Congenital Aniridia Research, Saarland University, Homburg/Saar, Germany</div>
<div class="p">
<sup>3</sup>Department of Ophthalmology, Saarland University Medical Center, Homburg/Saar, Germany</div>
<div>Writing – review &amp; editing</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Fries%20FN%22%5BAuthor%5D" class="usa-link"><span class="name western">Fabian N Fries</span></a>
</div>
</div>
<sup>1,</sup><sup>3</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Seitz%20B%22%5BAuthor%5D" class="usa-link" aria-describedby="id8"><span class="name western">Berthold Seitz</span></a><div hidden="hidden" id="id8">
<h3><span class="name western">Berthold Seitz</span></h3>
<div class="p">
<sup>3</sup>Department of Ophthalmology, Saarland University Medical Center, Homburg/Saar, Germany</div>
<div>Writing – review &amp; editing</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Seitz%20B%22%5BAuthor%5D" class="usa-link"><span class="name western">Berthold Seitz</span></a>
</div>
</div>
<sup>3</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Amini%20M%22%5BAuthor%5D" class="usa-link" aria-describedby="id9"><span class="name western">Maryam Amini</span></a><div hidden="hidden" id="id9">
<h3><span class="name western">Maryam Amini</span></h3>
<div class="p">
<sup>1</sup>Dr. Rolf M. Schwiete Center for Limbal Stem Cell and Congenital Aniridia Research, Saarland University, Homburg/Saar, Germany</div>
<div>Writing – review &amp; editing</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Amini%20M%22%5BAuthor%5D" class="usa-link"><span class="name western">Maryam Amini</span></a>
</div>
</div>
<sup>1</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Suiwal%20S%22%5BAuthor%5D" class="usa-link" aria-describedby="id10"><span class="name western">Shweta Suiwal</span></a><div hidden="hidden" id="id10">
<h3><span class="name western">Shweta Suiwal</span></h3>
<div class="p">
<sup>1</sup>Dr. Rolf M. Schwiete Center for Limbal Stem Cell and Congenital Aniridia Research, Saarland University, Homburg/Saar, Germany</div>
<div class="p">
<sup>2</sup>Department of Experimental Ophthalmology, Saarland University, Homburg/Saar, Germany</div>
<div>Writing – review &amp; editing</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Suiwal%20S%22%5BAuthor%5D" class="usa-link"><span class="name western">Shweta Suiwal</span></a>
</div>
</div>
<sup>1,</sup><sup>2</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Szentm%C3%A1ry%20N%22%5BAuthor%5D" class="usa-link" aria-describedby="id11"><span class="name western">Nóra Szentmáry</span></a><div hidden="hidden" id="id11">
<h3><span class="name western">Nóra Szentmáry</span></h3>
<div class="p">
<sup>1</sup>Dr. Rolf M. Schwiete Center for Limbal Stem Cell and Congenital Aniridia Research, Saarland University, Homburg/Saar, Germany</div>
<div class="p">
<sup>2</sup>Department of Experimental Ophthalmology, Saarland University, Homburg/Saar, Germany</div>
<div>Conceptualization, Methodology, Project administration, Resources, Supervision, Writing – review &amp; editing</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Szentm%C3%A1ry%20N%22%5BAuthor%5D" class="usa-link"><span class="name western">Nóra Szentmáry</span></a>
</div>
</div>
<sup>1,</sup><sup>2</sup>
</div>
<div class="cg p">Editor: <span class="name western">Alexander V Ljubimov</span><sup>4</sup>
</div>
<ul class="d-buttons inline-list">
<li><button class="d-button" aria-controls="aip_a" aria-expanded="false">Author information</button></li>
<li><button class="d-button" aria-controls="anp_a" aria-expanded="false">Article notes</button></li>
<li><button class="d-button" aria-controls="clp_a" aria-expanded="false">Copyright and License information</button></li>
</ul>
<div class="d-panels font-secondary-light">
<div id="aip_a" class="d-panel p" style="display: none">
<div class="p" id="aff001">
<sup>1</sup>Dr. Rolf M. Schwiete Center for Limbal Stem Cell and Congenital Aniridia Research, Saarland University, Homburg/Saar, Germany</div>
<div id="aff002">
<sup>2</sup>Department of Experimental Ophthalmology, Saarland University, Homburg/Saar, Germany</div>
<div id="aff003">
<sup>3</sup>Department of Ophthalmology, Saarland University Medical Center, Homburg/Saar, Germany</div>
<div id="edit1">
<sup>4</sup>Cedars-Sinai Medical Center, UNITED STATES OF AMERICA</div>
<div class="author-notes p">
<div class="fn" id="coi001"><p><strong>Competing Interests: </strong>The authors have declared that no competing interests exist.</p></div>
<div class="fn" id="cor001">
<sup>✉</sup><p class="display-inline">* E-mail: <span>shuailinli97@gmail.com</span></p>
</div>
</div>
<h4 class="font-secondary">Roles</h4>
<div class="p">
<strong class="contrib"><span class="name western">Shuailin Li</span></strong>: <span class="role">Conceptualization, Data curation, Formal analysis, Investigation, Methodology, Project administration, Writing – original draft</span>
</div>
<div>
<strong class="contrib"><span class="name western">Tanja Stachon</span></strong>: <span class="role">Methodology, Project administration, Resources, Supervision, Writing – review &amp; editing</span>
</div>
<div>
<strong class="contrib"><span class="name western">Shanhe Liu</span></strong>: <span class="role">Data curation, Investigation, Writing – review &amp; editing</span>
</div>
<div>
<strong class="contrib"><span class="name western">Zhen Li</span></strong>: <span class="role">Writing – review &amp; editing</span>
</div>
<div>
<strong class="contrib"><span class="name western">Shao-Lun Hsu</span></strong>: <span class="role">Writing – review &amp; editing</span>
</div>
<div>
<strong class="contrib"><span class="name western">Swarnali Kundu</span></strong>: <span class="role">Writing – review &amp; editing</span>
</div>
<div>
<strong class="contrib"><span class="name western">Fabian N Fries</span></strong>: <span class="role">Writing – review &amp; editing</span>
</div>
<div>
<strong class="contrib"><span class="name western">Berthold Seitz</span></strong>: <span class="role">Writing – review &amp; editing</span>
</div>
<div>
<strong class="contrib"><span class="name western">Maryam Amini</span></strong>: <span class="role">Writing – review &amp; editing</span>
</div>
<div>
<strong class="contrib"><span class="name western">Shweta Suiwal</span></strong>: <span class="role">Writing – review &amp; editing</span>
</div>
<div>
<strong class="contrib"><span class="name western">Nóra Szentmáry</span></strong>: <span class="role">Conceptualization, Methodology, Project administration, Resources, Supervision, Writing – review &amp; editing</span>
</div>
<div class="p">
<strong class="contrib"><span class="name western">Alexander V Ljubimov</span></strong>: <span class="role">Editor</span>
</div>
</div>
<div id="anp_a" class="d-panel p" style="display: none"><div class="notes p"><section id="historyarticle-meta1" class="history"><p>Received 2025 Apr 23; Accepted 2025 Aug 3; Collection date 2025.</p></section></div></div>
<div id="clp_a" class="d-panel p" style="display: none">
<div>© 2025 Li et al</div>
<p>This is an open access article distributed under the terms of the <a href="https://creativecommons.org/licenses/by/4.0/" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Creative Commons Attribution License</a>, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.</p>
<div class="p"><a href="/about/copyright/" class="usa-link">PMC Copyright notice</a></div>
</div>
</div>
<div>PMCID: PMC12364336  PMID: <a href="https://pubmed.ncbi.nlm.nih.gov/40828815/" class="usa-link">40828815</a>
</div>
</div></section></section><section aria-label="Article content"><section class="body main-article-body"><section class="abstract" id="abstract1"><h2>Abstract</h2>
<section id="sec001"><h3 class="pmc_sec_title">Purpose</h3>
<p>Haploinsufficiency of the PAX6 gene is the primary pathogenic mechanism underlying classical congenital aniridia. Notably, at least 50% of patients with this condition develop glaucoma. Prostaglandin analogues, such as travoprost, are widely used to lower intraocular pressure in this patient population. At the same time, limbal epithelial cells (LECs) are believed to play a key role in the development and progression of aniridia-associated keratopathy (AAK). Therefore, the aim of this study was to investigate the effects of travoprost on cell viability, proliferation, migration, and the expression of key genes and proteins in both normal and PAX6-knockdown LECs.</p></section><section id="sec002"><h3 class="pmc_sec_title">Materials and Methods</h3>
<p>Primary human LECs were isolated from seven corneal donors. To simulate the haploinsufficient state characteristic of congenital aniridia, a PAX6-knockdown model, using siRNA was employed. LECs were treated with 0.039–40 μg/mL travoprost concentration for 20 minutes. Cell viability was assessed using the XTT assay, while cell proliferation was evaluated by the BrdU assay. Based on XTT results, 0.156 and 0.313 μg/mL travoprost were selected for further measurements in both LECs and PAX6-knockdown LECs. A scratch assay was conducted to measure cell migration. The expression levels of PAX6, FOSL2, MAPKs, inflammatory markers, caspase-3, and MMP9 were analyzed at both the gene and protein levels using qRT-PCR, Western blot, and ELISA.</p></section><section id="sec003"><h3 class="pmc_sec_title">Results</h3>
<p>Travoprost significantly reduced LEC viability at 0.156 μg/mL (p = 0.028), while only higher concentrations (20 and 40 μg/mL) inhibited significantly LEC proliferation (p ≤ 0.004). PAX6-knockdown LECs exhibited reduced migration compared to control cells (p ≤ 0.046); however, treatment with 0.313 μg/mL travoprost significantly enhanced their migration (p = 0.047), accompanied by upregulation of JNK1/2 protein (p = 0.039) and MMP9 mRNA and protein levels (p = 0.021, p = 0.027). PAX6 knockdown led to suppression of inflammation-related genes (p ≤ 0.031) and travoprost did not exacerbate inflammatory responses (p ≥ 0.155). Additionally, 0.313 μg/mL travoprost significantly increased caspase-3 protein levels in PAX6-knockdown LECs (p = 0.044).</p></section><section id="sec004"><h3 class="pmc_sec_title">Conclusions</h3>
<p>Travoprost, at specific concentrations, can reduce the viability and proliferation of limbal epithelial cells. At 0.313 μg/mL, it significantly upregulates JNK1/2 and MMP9 expression, thereby enhancing the migratory capacity of PAX6-knockdown LECs. These findings may offer valuable insights for the selection of antiglaucomatous medications in patients with congenital aniridia.</p></section></section><section id="sec005"><h2 class="pmc_sec_title">1 Introduction</h2>
<p>Congenital aniridia is a rare hereditary ocular developmental disorder that follows an autosomal dominant inheritance pattern. It is primarily caused by haploinsufficiency of the paired box gene 6 (PAX6) gene located on chromosome 11p13 [<a href="#pone.0330492.ref001" class="usa-link" aria-describedby="pone.0330492.ref001">1</a>,<a href="#pone.0330492.ref002" class="usa-link" aria-describedby="pone.0330492.ref002">2</a>]. PAX6 is a master regulatory transcription factor essential for ocular development, playing a pivotal role in the formation of multiple eye structures during embryogenesis [<a href="#pone.0330492.ref003" class="usa-link" aria-describedby="pone.0330492.ref003">3</a>]. In addition to the partial or complete absence of the iris, affected individuals often exhibit a spectrum of structural and functional ocular abnormalities, including lens subluxation or cataract, macular hypoplasia, optic nerve malformations, congenital or secondary glaucoma, and aniridia-associated keratopathy (AAK) [<a href="#pone.0330492.ref004" class="usa-link" aria-describedby="pone.0330492.ref004">4</a>,<a href="#pone.0330492.ref005" class="usa-link" aria-describedby="pone.0330492.ref005">5</a>]. Among these, limbal stem cell deficiency (LSCD) is recognized as a key pathological feature contributing to corneal opacification, neovascularization, and progressive vision loss in patients with AAK [<a href="#pone.0330492.ref006" class="usa-link" aria-describedby="pone.0330492.ref006">6</a>–<a href="#pone.0330492.ref008" class="usa-link" aria-describedby="pone.0330492.ref008">8</a>].</p>
<p>In patients with congenital aniridia, approximately 50% develop secondary glaucoma, which is commonly attributed to abnormalities in the development of the anterior chamber angle and Schlemm’s canal, or to angle closure resulting from anterior rotation of the rudimentary iris [<a href="#pone.0330492.ref009" class="usa-link" aria-describedby="pone.0330492.ref009">9</a>–<a href="#pone.0330492.ref011" class="usa-link" aria-describedby="pone.0330492.ref011">11</a>]. In clinical practice, effective management of aniridia-associated glaucoma often necessitates the long-term use of prostaglandin analogues, such as travoprost, along with additional antiglaucoma medications to achieve adequate intraocular pressure control [<a href="#pone.0330492.ref012" class="usa-link" aria-describedby="pone.0330492.ref012">12</a>].</p>
<p>Travoprost is a highly selective and potent prostaglandin F2α analogue commonly used in the treatment of glaucoma and ocular hypertension. It exerts its effect by selectively activating prostaglandin FP receptors, which leads to increased expression of matrix metalloproteinases (MMPs). These enzymes remodel the extracellular matrix of the ciliary muscle and sclera, thereby enhancing aqueous humor outflow through the uveoscleral pathway and effectively reducing intraocular pressure (IOP) [<a href="#pone.0330492.ref013" class="usa-link" aria-describedby="pone.0330492.ref013">13</a>–<a href="#pone.0330492.ref015" class="usa-link" aria-describedby="pone.0330492.ref015">15</a>]. Recent <em>in vivo</em> and <em>in vitro</em> studies suggest that, beyond its IOP-lowering properties, travoprost may also influence ocular surface tissues, particularly corneal epithelial cells. Reported effects include changes in cell viability, proliferation capacity, and cell–cell adhesion, along with elevated expression of inflammatory cytokines such as IL-6 and IL-8 [<a href="#pone.0330492.ref016" class="usa-link" aria-describedby="pone.0330492.ref016">16</a>–<a href="#pone.0330492.ref020" class="usa-link" aria-describedby="pone.0330492.ref020">20</a>]. However, there is a lack of systematic research on the specific mechanisms by which travoprost affects limbal epithelial cells, particularly in special populations such as patients with congenital aniridia.</p>
<p>Fos like 2 (FOSL2) is considered a target gene of PAX6 and is closely associated with corneal opacity [<a href="#pone.0330492.ref021" class="usa-link" aria-describedby="pone.0330492.ref021">21</a>]. It is also thought to play a role in regulating cell migration and proliferation [<a href="#pone.0330492.ref022" class="usa-link" aria-describedby="pone.0330492.ref022">22</a>]. Mitogen-activated protein kinases (MAPKs) are primarily categorized into three subfamilies: extracellular signal-regulated kinases (ERKs), c-Jun N-terminal kinases (JNKs), and mitogen-activated protein kinase 14 (MAPK14, also known as p38) [<a href="#pone.0330492.ref023" class="usa-link" aria-describedby="pone.0330492.ref023">23</a>]. Among these, ERKs and JNKs are particularly implicated in controlling cell proliferation, migration, and apoptosis [<a href="#pone.0330492.ref024" class="usa-link" aria-describedby="pone.0330492.ref024">24</a>–<a href="#pone.0330492.ref026" class="usa-link" aria-describedby="pone.0330492.ref026">26</a>]. As previously noted, travoprost can elevate MMP levels, thereby contributing to the reduction of IOP [<a href="#pone.0330492.ref027" class="usa-link" aria-describedby="pone.0330492.ref027">27</a>]. Related studies have also demonstrated that MMP expression is regulated through the JNK pathway [<a href="#pone.0330492.ref028" class="usa-link" aria-describedby="pone.0330492.ref028">28</a>]. In our earlier investigation of aniridia limbal stromal cells (AN-LSCs), we found that travoprost may influence MMP9 expression via the JNK signaling pathway, subsequently affecting cell migration [<a href="#pone.0330492.ref029" class="usa-link" aria-describedby="pone.0330492.ref029">29</a>]. Based on these findings, the present study focuses on evaluating the expression of these key genes and proteins.</p>
<p>Given its role as a first-line medication for glaucoma, the potential effects of travoprost on limbal epithelial cells (LECs)—particularly its mechanisms of action in special populations such as patients with congenital aniridia—warrant further investigation. Therefore, the aim of this study is to analyze changes in cell viability, proliferation, migration, as well as the expression of key genes and proteins associated with inflammation, apoptosis, and related pathways following travoprost treatment, using an siRNA-based aniridia LEC model, with PAX6 knockdown [<a href="#pone.0330492.ref030" class="usa-link" aria-describedby="pone.0330492.ref030">30</a>,<a href="#pone.0330492.ref031" class="usa-link" aria-describedby="pone.0330492.ref031">31</a>]. This work aims to evaluate the functional impact of travoprost on LECs and to provide theoretical insights and practical guidance for optimizing pharmacological treatment strategies in congenital aniridia patients with coexisting glaucoma.</p></section><section id="sec006"><h2 class="pmc_sec_title">2 Materials and Methods</h2>
<section id="sec007"><h3 class="pmc_sec_title">2.1 Ethical approval and consent to participate</h3>
<p>This study was approved by the Ethics Committee of Saarland, Germany (Approval Number: 124/23), and all procedures were conducted in accordance with the principles of the Declaration of Helsinki. Our research started on July 1st, 2023, and ended on January 31st, 2025.</p></section><section id="sec008"><h3 class="pmc_sec_title">2.2 Cell culture and PAX6 knockdown</h3>
<p>Limbal biopsies were obtained from seven healthy corneal donors (mean age 77.1 ± 10.0 years; age range 60–91 years; 57.1% male) through the LIONS Cornea Bank Saar-Lor-Lux, Trier/Westpfalz, in Homburg/Saar, Germany. A summary of the donor characteristics is provided in <strong><a href="#pone.0330492.t001" class="usa-link">Table 1</a></strong>. Using a 1.5 mm biopsy punch, tissue was collected from the limbal area of the cornea. The harvested samples were enzymatically digested in keratinocyte growth medium (KGM3; Promocell, Heidelberg, Germany) supplemented with collagenase A (Roche Diagnostic GmbH, Mannheim, Germany) at 37°C for 24 hours. Following digestion, LECs were seeded into single wells of six-well culture plates, with 2.5 mL of KGM3 per well. Upon reaching full confluence, the cells were detached using Trypsin-EDTA (Sigma-Aldrich, Saint Louis, USA) and subsequently reseeded into new six-well plates. The LECs were maintained under standard culture conditions at 37°C, with 95% humidity and 5% CO₂.</p>
<section class="tw xbox font-sm" id="pone.0330492.t001"><h4 class="obj_head">Table 1. Information on the corneal donors used.</h4>
<div class="tbl-box p" tabindex="0"><table class="content" frame="hsides" rules="groups">
<colgroup span="1">
<col align="left" valign="middle" span="1">
<col align="left" valign="middle" span="1">
<col align="left" valign="middle" span="1">
</colgroup>
<thead><tr>
<th align="left" rowspan="1" colspan="1">Donor Number</th>
<th align="left" rowspan="1" colspan="1">Age (years)</th>
<th align="left" rowspan="1" colspan="1">Gender</th>
</tr></thead>
<tbody>
<tr>
<td align="left" rowspan="1" colspan="1">1</td>
<td align="left" rowspan="1" colspan="1">76</td>
<td align="left" rowspan="1" colspan="1">Male</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">2</td>
<td align="left" rowspan="1" colspan="1">72</td>
<td align="left" rowspan="1" colspan="1">Male</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">3</td>
<td align="left" rowspan="1" colspan="1">83</td>
<td align="left" rowspan="1" colspan="1">Male</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">4</td>
<td align="left" rowspan="1" colspan="1">91</td>
<td align="left" rowspan="1" colspan="1">Female</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">5</td>
<td align="left" rowspan="1" colspan="1">84</td>
<td align="left" rowspan="1" colspan="1">Male</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">6</td>
<td align="left" rowspan="1" colspan="1">60</td>
<td align="left" rowspan="1" colspan="1">Female</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">7</td>
<td align="left" rowspan="1" colspan="1">74</td>
<td align="left" rowspan="1" colspan="1">Female</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">
<strong>Total</strong>
</td>
<td align="left" rowspan="1" colspan="1">77.1 ± 10.0 (60-91)</td>
<td align="left" rowspan="1" colspan="1">4 (57.1%) Male</td>
</tr>
</tbody>
</table></div>
<div class="p text-right font-secondary"><a href="table/pone.0330492.t001/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div></section><p>When LECs reached approximately 80% confluence, they were subjected to PAX6 gene silencing. For each well of a six-well plate, 2 mL of KGM3 medium was used in combination with a transfection mixture consisting of 500 μL of Opti-MEM™ I Reduced Serum Medium, GlutaMAX™ Supplement (Gibco, Thermo Fisher Scientific, Grand Island, USA), 5 μL of Lipofectamine™ 2000 (Thermo Fisher Scientific, Carlsbad, USA), and 1 μL of either Silencer™ Select PAX6 siRNA or Negative Control No.1 siRNA (Thermo Fisher Scientific, Waltham, USA).</p>
<p>Prior to application, Lipofectamine™ 2000 and siRNA were mixed and incubated for 20 minutes at room temperature in Opti-MEM™ to allow formation of the transfection complex. The experimental group received PAX6-targeting siRNA, while the control group was treated with non-targeting control siRNA. After 24 hours of transfection, the medium was replaced with 2.5 mL of fresh KGM3 medium to facilitate cellular recovery over the following 24 hours.</p></section><section id="sec009"><h3 class="pmc_sec_title">2.3 Travoprost treatment</h3>
<p>Travoprost (Sigma-Aldrich, St. Louis, USA) was initially prepared in KGM3 medium at a concentration of 40 μg/mL (0.004%). This stock solution was subsequently twofold serially diluted to generate a concentration gradient ranging from 40 μg/mL to 0.039 μg/mL, specifically: 40, 20, 10, 5, 2.5, 1.25, 0.625, 0.313, 0.156, 0.078, and 0.039 μg/mL.</p>
<p>To assess cell viability and proliferation, experiments were conducted using 96-well plates. LECs were seeded in KGM3 medium, and upon reaching 80–90% confluence, the medium was replaced with the various concentrations of travoprost solutions, or with KGM3 alone as a negative control. After 20 minutes of exposure, the treatment solutions were removed, cells were rinsed with phosphate-buffered saline (PBS) (Merck, Sigma-Aldrich, Taufkirchen, Germany), and fresh KGM3 medium was added to each well.</p>
<p>For evaluation of cell migration and for RNA and protein extraction, the medium of both LECs and PAX6-knockdown LECs was replaced with KGM3 medium containing 0.156 μg/mL or 0.313 μg/mL of travoprost, or drug-free medium as a control. After a 20-minute incubation, the supernatant was collected, cells were rinsed with PBS, and fresh KGM3 medium was added to each well.</p></section><section id="sec010"><h3 class="pmc_sec_title">2.4 Cell viability assay</h3>
<p>Cell viability was assessed using the Cell Proliferation Kit II (XTT) (Roche, Sigma-Aldrich, Mannheim, Germany) according to the manufacturer’s instructions. Prior to use, 5 mL of XTT labeling solution was mixed with 0.1 mL of the electron coupling reagent, both of which were thawed and freshly prepared. A 50 μL aliquot of this working solution was added to each well of the 96-well plate. The cells were then incubated at 37 °C for 2 hours. Absorbance was measured at 450 nm, with a reference wavelength of 690 nm, using an Infinite F50 Absorbance Microplate Reader (TECAN Deutschland GmbH, Crailsheim, Germany).</p></section><section id="sec011"><h3 class="pmc_sec_title">2.5 Cell proliferation assay</h3>
<p>Cell proliferation was assessed using the ELISA-BrdU (colorimetric) assay kit (Roche, Sigma-Aldrich, Mannheim, Germany). Briefly, cells were incubated with 10 μL of BrdU labeling reagent at 37 °C for 3 hours. Following incubation, the labeling reagent was removed, and each well was treated with 200 μL of FixDenat solution for 30 minutes to fix and denature the DNA. Thereafter, a mixture of anti-BrdU-POD antibody and dilution buffer was added, followed by three washes with 200 μL of PBS to remove unbound antibodies. Upon the addition of the stop solution to the substrate, a colorimetric change was observed. Absorbance was measured using the Tecan Infinite F50 Absorbance Microplate Reader, as previously described.</p></section><section id="sec012"><h3 class="pmc_sec_title">2.6 Cell migration assay</h3>
<p>To begin, three parallel reference lines were marked on the underside of each well in the six-well culture plates, spaced 5 mm apart. LECs were seeded into these wells with 2.5 mL of KGM3 medium. Following the previously described PAX6 knockdown protocol, a linear scratch was made perpendicular to the reference lines using 100 μL pipette tips (Eppendorf AG, Hamburg, Germany).</p>
<p>Cells were then treated for 20 minutes with either 0.156 μg/mL or 0.313 μg/mL of travoprost, or with travoprost-free medium as a control, as outlined earlier. Phase-contrast microscopy was used to capture images at baseline (0 hours) and at 6, 12, and 24 hours post-treatment. In each well, four separate wound areas aligned with the reference lines were imaged for subsequent analysis.</p>
<p>ImageJ software (<a href="https://imagej.nih.gov/ij/" class="usa-link" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">https://imagej.nih.gov/ij/</a>) was used to quantify wound closure. The migration rate (MR) was calculated using the following formula:</p>
<table class="disp-formula p" id="pone.0330492.e001"><tr><td class="formula"><math id="M1" display="block" overflow="linebreak"><mrow><mi mathvariant="normal">M</mi><mi mathvariant="normal">R</mi><mo>=</mo><mo stretchy="false">[</mo><mi mathvariant="normal">W</mi><mi mathvariant="normal">o</mi><mi mathvariant="normal">u</mi><mi mathvariant="normal">n</mi><mi mathvariant="normal">d</mi><mtext> </mtext><mi mathvariant="normal">a</mi><mi mathvariant="normal">r</mi><mi mathvariant="normal">e</mi><mi mathvariant="normal">a</mi><mtext> </mtext><mo stretchy="false">(</mo><mn>0</mn><mtext> </mtext><mi mathvariant="normal">h</mi><mo stretchy="false">)</mo><mtext> </mtext><mi mathvariant="normal">–</mi><mtext> </mtext><mi mathvariant="normal">W</mi><mi mathvariant="normal">o</mi><mi mathvariant="normal">u</mi><mi mathvariant="normal">n</mi><mi mathvariant="normal">d</mi><mtext> </mtext><mi mathvariant="normal">a</mi><mi mathvariant="normal">r</mi><mi mathvariant="normal">e</mi><mi mathvariant="normal">a</mi><mtext> </mtext><mo stretchy="false">(</mo><mn>6</mn><mo>/</mo><mn>12</mn><mo>/</mo><mn>24</mn><mi mathvariant="normal">h</mi><mo stretchy="false">)</mo><mo stretchy="false">]</mo><mo>/</mo><mtext> </mtext><mi mathvariant="normal">W</mi><mi mathvariant="normal">o</mi><mi mathvariant="normal">u</mi><mi mathvariant="normal">n</mi><mi mathvariant="normal">d</mi><mtext> </mtext><mi mathvariant="normal">a</mi><mi mathvariant="normal">r</mi><mi mathvariant="normal">e</mi><mi mathvariant="normal">a</mi><mtext> </mtext><mo stretchy="false">(</mo><mn>0</mn><mtext> </mtext><mi mathvariant="normal">h</mi><mo stretchy="false">)</mo><mo>.</mo><mi mathvariant="normal">\]</mi></mrow></math></td></tr></table></section><section id="sec013"><h3 class="pmc_sec_title">2.7 RNA/protein isolation and cDNA synthesis</h3>
<p>Total RNA and protein were simultaneously isolated using the RNA/DNA/Protein Purification Plus Kit (Norgen Biotek, Ontario, Canada), following the manufacturer’s instructions. The concentration of the extracted RNA was determined using a UV/VIS spectrophotometer (Analytik Jena AG, Jena, Germany), and samples were stored at –80 °C until further processing.</p>
<p>cDNA synthesis was carried out using the One Taq® RT-PCR Kit (New England Biolabs INC, Frankfurt, Germany), with 500 ng of total RNA used per reaction. The resulting cDNA was stored at –20 °C for subsequent applications.</p></section><section id="sec014"><h3 class="pmc_sec_title">2.8 Quantitative Real Time PCR</h3>
<p>Primers used for quantitative real time Polymerase Chain Reaction (qRT-PCR) are listed in <strong><a href="#pone.0330492.t002" class="usa-link">Table 2</a></strong>. Each qRT-PCR reaction was performed in a final volume of 9 μL, containing 1 μL of gene-specific primer mix, 5 μL of SYBR Green Master Mix (Vazyme, Nanjing, China), and 3 μL of nuclease-free water. In addition, 1 μL of synthesized cDNA was added, in accordance with the manufacturer’s protocol. Reactions were carried out on a QuantStudio 5 Real-Time PCR System (Thermo Fisher Scientific, Waltham, USA) using the following thermal cycling conditions: initial denaturation at 95 °C for 10 seconds, followed by annealing/extension at 60 °C for 30 seconds, and a final denaturation step at 95 °C for 15 seconds, repeated for a total of 40 cycles.</p>
<section class="tw xbox font-sm" id="pone.0330492.t002"><h4 class="obj_head">Table 2. Primers used for quantitative real time PCR (qRT-PCR).</h4>
<div class="tbl-box p" tabindex="0"><table class="content" frame="hsides" rules="groups">
<colgroup span="1">
<col align="left" valign="middle" span="1">
<col align="left" valign="middle" span="1">
<col align="left" valign="middle" span="1">
<col align="left" valign="middle" span="1">
</colgroup>
<thead><tr>
<th align="left" rowspan="1" colspan="1">Primer</th>
<th align="left" rowspan="1" colspan="1">Gene Symbol</th>
<th align="left" rowspan="1" colspan="1">QIAGEN catalog number</th>
<th align="left" rowspan="1" colspan="1">Manufacturer<br>(company, city, country)</th>
</tr></thead>
<tbody>
<tr>
<td align="left" rowspan="1" colspan="1">Caspase-3</td>
<td align="left" rowspan="1" colspan="1">CASP3</td>
<td align="left" rowspan="1" colspan="1">QT00023947</td>
<td align="left" rowspan="1" colspan="1">Qiagen N.V., Venlo, Netherlands</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">FOSL2</td>
<td align="left" rowspan="1" colspan="1">FOSL2</td>
<td align="left" rowspan="1" colspan="1">QT01000881</td>
<td align="left" rowspan="1" colspan="1">Qiagen N.V., Venlo, Netherlands</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">GUSB</td>
<td align="left" rowspan="1" colspan="1">GUSB</td>
<td align="left" rowspan="1" colspan="1">QT00046046</td>
<td align="left" rowspan="1" colspan="1">Qiagen N.V., Venlo, Netherlands</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">IL-1α</td>
<td align="left" rowspan="1" colspan="1">IL1A</td>
<td align="left" rowspan="1" colspan="1">QT00001127</td>
<td align="left" rowspan="1" colspan="1">Qiagen N.V., Venlo, Netherlands</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">IL-1β</td>
<td align="left" rowspan="1" colspan="1">IL1B</td>
<td align="left" rowspan="1" colspan="1">QT00021385</td>
<td align="left" rowspan="1" colspan="1">Qiagen N.V., Venlo, Netherlands</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">IL-6</td>
<td align="left" rowspan="1" colspan="1">IL6</td>
<td align="left" rowspan="1" colspan="1">QT00083720</td>
<td align="left" rowspan="1" colspan="1">Qiagen N.V., Venlo, Netherlands</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">IL-8</td>
<td align="left" rowspan="1" colspan="1">CXCL8</td>
<td align="left" rowspan="1" colspan="1">QT00000322</td>
<td align="left" rowspan="1" colspan="1">Qiagen N.V., Venlo, Netherlands</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">MAPK1</td>
<td align="left" rowspan="1" colspan="1">MAPK1</td>
<td align="left" rowspan="1" colspan="1">QT00065933</td>
<td align="left" rowspan="1" colspan="1">Qiagen N.V., Venlo, Netherlands</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">MAPK3</td>
<td align="left" rowspan="1" colspan="1">MAPK3</td>
<td align="left" rowspan="1" colspan="1">QT02589314</td>
<td align="left" rowspan="1" colspan="1">Qiagen N.V., Venlo, Netherlands</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">MAPK8</td>
<td align="left" rowspan="1" colspan="1">MAPK8</td>
<td align="left" rowspan="1" colspan="1">QT00091056</td>
<td align="left" rowspan="1" colspan="1">Qiagen N.V., Venlo, Netherlands</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">MMP9</td>
<td align="left" rowspan="1" colspan="1">MMP9</td>
<td align="left" rowspan="1" colspan="1">QT00040040</td>
<td align="left" rowspan="1" colspan="1">Qiagen N.V., Venlo, Netherlands</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">NF-κB</td>
<td align="left" rowspan="1" colspan="1">RELA</td>
<td align="left" rowspan="1" colspan="1">QT02324308</td>
<td align="left" rowspan="1" colspan="1">Qiagen N.V., Venlo, Netherlands</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">PAX6</td>
<td align="left" rowspan="1" colspan="1">PAX6</td>
<td align="left" rowspan="1" colspan="1">QT00071169</td>
<td align="left" rowspan="1" colspan="1">Qiagen N.V., Venlo, Netherlands</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">PTGES2</td>
<td align="left" rowspan="1" colspan="1">PTGES2</td>
<td align="left" rowspan="1" colspan="1">QT00082068</td>
<td align="left" rowspan="1" colspan="1">Qiagen N.V., Venlo, Netherlands</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">TBP</td>
<td align="left" rowspan="1" colspan="1">TBP</td>
<td align="left" rowspan="1" colspan="1">QT00000721</td>
<td align="left" rowspan="1" colspan="1">Qiagen N.V., Venlo, Netherlands</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">TNFα</td>
<td align="left" rowspan="1" colspan="1">TNF</td>
<td align="left" rowspan="1" colspan="1">QT00029162</td>
<td align="left" rowspan="1" colspan="1">Qiagen N.V., Venlo, Netherlands</td>
</tr>
</tbody>
</table></div>
<div class="p text-right font-secondary"><a href="table/pone.0330492.t002/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div></section><p>All reactions were performed in duplicate. Gene expression levels were normalized against two housekeeping genes, TATA-binding protein (TBP) and β-glucuronidase (GUSB), using the comparative ΔΔCT method. Relative expression levels were calculated as fold changes (2^ΔΔCT), with untreated LECs serving as the baseline (fold change = 1).</p></section><section id="sec015"><h3 class="pmc_sec_title">2.9 Western blot analysis</h3>
<p>For Western blot analysis, 20 μg of total protein per sample was mixed with 5 μL of Laemmli buffer, heated at 95 °C for 5 minutes, and loaded onto a 4–12% NuPAGE™ Bis-Tris SDS precast gel (Invitrogen, Waltham, MA, USA). To estimate molecular weight, 2.5 μL of Precision Plus Protein™ All Blue Prestained Protein Standards (Bio-Rad Laboratories, Hercules, USA) was loaded into the first lane. Electrophoresis was performed using NuPAGE™ MOPS SDS Running Buffer (20×) (Thermo Fisher Scientific, Waltham, USA).</p>
<p>Following electrophoretic separation, proteins were transferred to a nitrocellulose membrane using the Trans-Blot Turbo Transfer System (Bio-Rad Laboratories) according to the manufacturer’s pre-set protocol optimized for high molecular weight proteins via semi-dry transfer. Total protein normalization was performed using No-Stain™ Protein Labeling Reagent (Thermo Fisher Scientific, Dreieich, Germany). Membranes were washed three times with 10 mL of Western Froxx washing buffer (BioFroxx GmbH, Einhausen, Germany) for 5 minutes each.</p>
<p>Membranes were then incubated overnight at 4 °C with primary antibodies listed in <strong><a href="#pone.0330492.t003" class="usa-link">Table 3</a></strong>, diluted in a combined blocking and secondary antibody solution containing WesternFroxx anti-Rabbit or anti-Mouse HRP (BioFroxx GmbH). Following incubation, three additional washes were conducted to remove unbound antibodies. Protein detection was carried out using Western Lightning Plus ECL substrate (PerkinElmer Inc., Waltham, USA), and chemiluminescent signals were captured using the iBright™ CL1500 Imaging System (Thermo Fisher Scientific, Waltham, USA). After detection, membranes were treated with Western Froxx stripping solution (BioFroxx GmbH) to allow reprobing with alternative antibodies.</p>
<section class="tw xbox font-sm" id="pone.0330492.t003"><h4 class="obj_head">Table 3. Antibodies used for Western blot analysis.</h4>
<div class="tbl-box p" tabindex="0"><table class="content" frame="hsides" rules="groups">
<colgroup span="1">
<col align="left" valign="middle" span="1">
<col align="left" valign="middle" span="1">
<col align="left" valign="middle" span="1">
<col align="left" valign="middle" span="1">
</colgroup>
<thead><tr>
<th align="left" rowspan="1" colspan="1">Antibody</th>
<th align="left" rowspan="1" colspan="1">Dilution</th>
<th align="left" rowspan="1" colspan="1">Catalog number</th>
<th align="left" rowspan="1" colspan="1">Manufacturer</th>
</tr></thead>
<tbody>
<tr>
<td align="left" rowspan="1" colspan="1">Caspase3/p17/p19 Polyclonal antibody</td>
<td align="left" rowspan="1" colspan="1">1:1000</td>
<td align="left" rowspan="1" colspan="1">19677-1-AP</td>
<td align="left" rowspan="1" colspan="1">Proteintech Group, Rosemont, USA</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">FRA2 (FOSL2) Mouse Monoclonal Antibody</td>
<td align="left" rowspan="1" colspan="1">1:2000</td>
<td align="left" rowspan="1" colspan="1">TA809660</td>
<td align="left" rowspan="1" colspan="1">OriGene Technologies, lnc., Rockville, USA</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">p44/42 MAPK (Erk1/2) (137F5) Rabbit mAb</td>
<td align="left" rowspan="1" colspan="1">1:1000</td>
<td align="left" rowspan="1" colspan="1">4695</td>
<td align="left" rowspan="1" colspan="1">Cell Signaling Technology, Danvers, USA</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">JNK Polyclonal antibody</td>
<td align="left" rowspan="1" colspan="1">1:5000</td>
<td align="left" rowspan="1" colspan="1">24164-1-AP</td>
<td align="left" rowspan="1" colspan="1">Proteintech Group, Rosemont, USA</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">NF-κB p65 (D14E12) XP Rabbit mAb</td>
<td align="left" rowspan="1" colspan="1">1:1000</td>
<td align="left" rowspan="1" colspan="1">8242</td>
<td align="left" rowspan="1" colspan="1">Cell Signaling Technology, Danvers, USA</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">PAX6 Rabbit Polyclonal antibody</td>
<td align="left" rowspan="1" colspan="1">1:500</td>
<td align="left" rowspan="1" colspan="1">12323-1-AP</td>
<td align="left" rowspan="1" colspan="1">Proteintech Group, Rosemont, USA</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">PTGES2 Polyclonal antibody</td>
<td align="left" rowspan="1" colspan="1">1:500</td>
<td align="left" rowspan="1" colspan="1">10881-1-AP</td>
<td align="left" rowspan="1" colspan="1">Proteintech Group, Rosemont, USA</td>
</tr>
</tbody>
</table></div>
<div class="p text-right font-secondary"><a href="table/pone.0330492.t003/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div></section></section><section id="sec016"><h3 class="pmc_sec_title">2.10 Enzyme linked immunosorbent assay (ELISA)</h3>
<p>Quantification of IL-1α, IL-1β, IL-6, IL-8, TNFα, and MMP9 protein levels was performed using DuoSet® ELISA Kits (R&amp;D Systems, Bio-Techne, Minneapolis, USA), as detailed in <strong><a href="#pone.0330492.t004" class="usa-link">Table 4</a></strong> and in accordance with the manufacturer’s instructions. Each sample was analyzed in duplicate, and absorbance was measured at 450 nm using the Tecan Infinite F50 Absorbance Microplate Reader. The resulting cytokine concentrations were normalized to total protein content of the supernatant to obtain final values.</p>
<section class="tw xbox font-sm" id="pone.0330492.t004"><h4 class="obj_head">Table 4. ELISA kits used in the study.</h4>
<div class="tbl-box p" tabindex="0"><table class="content" frame="hsides" rules="groups">
<colgroup span="1">
<col align="left" valign="middle" span="1">
<col align="left" valign="middle" span="1">
<col align="left" valign="middle" span="1">
</colgroup>
<thead><tr>
<th align="left" rowspan="1" colspan="1">ELISA kit</th>
<th align="left" rowspan="1" colspan="1">Catalog number</th>
<th align="left" rowspan="1" colspan="1">Manufacturer</th>
</tr></thead>
<tbody>
<tr>
<td align="left" rowspan="1" colspan="1">Human IL-1 alpha/IL-1F1 DuoSet ELISA</td>
<td align="left" rowspan="1" colspan="1">DY-200–05</td>
<td align="left" rowspan="1" colspan="1">R&amp;D Systems, Bio-Techne, Minneapolis, USA</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">Human IL-1 beta/IL-1F2 DuoSet ELISA</td>
<td align="left" rowspan="1" colspan="1">DY-201–05</td>
<td align="left" rowspan="1" colspan="1">R&amp;D Systems, Bio-Techne, Minneapolis, USA</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">Human IL-6 DuoSet ELISA</td>
<td align="left" rowspan="1" colspan="1">DY206</td>
<td align="left" rowspan="1" colspan="1">R&amp;D Systems, Bio-Techne, Minneapolis, USA</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">Human IL-8/CXCL8 DuoSet ELISA</td>
<td align="left" rowspan="1" colspan="1">DY208</td>
<td align="left" rowspan="1" colspan="1">R&amp;D Systems, Bio-Techne, Minneapolis, USA</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">Human MMP-9 DuoSet ELISA</td>
<td align="left" rowspan="1" colspan="1">DY911</td>
<td align="left" rowspan="1" colspan="1">R&amp;D Systems, Bio-Techne, Minneapolis, USA</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">Human TNF-alpha DuoSet ELISA</td>
<td align="left" rowspan="1" colspan="1">DY210−05</td>
<td align="left" rowspan="1" colspan="1">R&amp;D Systems, Bio-Techne, Minneapolis, USA</td>
</tr>
</tbody>
</table></div>
<div class="p text-right font-secondary"><a href="table/pone.0330492.t004/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div></section></section><section id="sec017"><h3 class="pmc_sec_title">2.11 Statistical analysis</h3>
<p>Statistical analysis and graph generation were conducted using GraphPad Prism software (version 9.2.0). Results from cell viability, proliferation, and migration experiments are presented as mean±standard deviation (SD), while qRT-PCR data are expressed as geometric mean±geometric SD. Western blot results are also reported as mean±SD. One-way ANOVA was used to assess differences in cell viability and proliferation. For comparisons involving cell migration, gene expression (2^ΔΔCt), and protein quantification across varying concentrations of travoprost, two-way ANOVA followed by Tukey’s post hoc test was applied. A p-value &lt;0.05 was considered statistically significant.</p></section></section><section id="sec018"><h2 class="pmc_sec_title">3 Results</h2>
<section id="sec019"><h3 class="pmc_sec_title">3.1 Cell viability and proliferation</h3>
<p>The XTT assay and BrdU assay were employed to assess LECs viability and proliferation, respectively. Changes in LECs viability and proliferation following 20-minute treatments with varying concentrations of travoprost are summarized in <strong><a href="#pone.0330492.g001" class="usa-link">Fig 1</a> and <a href="#pone.0330492.g002" class="usa-link">Fig 2</a></strong>. Regarding cell viability, a significant decrease was observed starting at a travoprost concentration of 0.156 μg/mL compared to the control group (p = 0.028).</p>
<figure class="fig xbox font-sm" id="pone.0330492.g001"><h4 class="obj_head">Fig 1. Cell viability of primary human limbal epithelial cells (LECs) after 20-minute treatment with travoprost at concentrations ranging from 0.039 μg/mL to 40 μg/mL (n = 7).</h4>
<p class="img-box line-height-none margin-x-neg-2 tablet:margin-x-0 text-center"><img class="graphic" src="https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fb05/12364336/120e8269769c/pone.0330492.g001.jpg" loading="lazy" height="872" width="722" alt="Fig 1"></p>
<div class="p text-right font-secondary"><a href="figure/pone.0330492.g001/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div>
<figcaption><p>A significant reduction in LEC viability was observed starting at a travoprost concentration of 0.156 μg/mL (p ≤ 0.028).</p></figcaption></figure><figure class="fig xbox font-sm" id="pone.0330492.g002"><h4 class="obj_head">Fig 2. Cell proliferation of limbal epithelial cells (LECs) after 20-minute treatment with travoprost at concentrations ranging from 0.039 μg/mL to 40 μg/mL, using the ELISA-BrdU (colorimetric) kit (n = 7).</h4>
<p class="img-box line-height-none margin-x-neg-2 tablet:margin-x-0 text-center"><img class="graphic" src="https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fb05/12364336/def1f2fda07b/pone.0330492.g002.jpg" loading="lazy" height="659" width="722" alt="Fig 2"></p>
<div class="p text-right font-secondary"><a href="figure/pone.0330492.g002/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div>
<figcaption><p>LEC proliferation decreased significantly following treatment with 20 μg/mL and 40 μg/mL concentrations of travoprost (p = 0.029 and p = 0.006, respectively).</p></figcaption></figure><p>For cell proliferation, a significant reduction was noted in LECs treated with 20 μg/mL and 40 μg/mL of travoprost for 20 minutes (p = 0.029 and p = 0.004, respectively). No significant changes in proliferation were observed at lower concentrations (p ≥ 0.128).</p>
<p>Based on these results, travoprost concentrations of 0.156 µg/mL and 0.313 µg/mL were used for the following experiments.</p></section><section id="sec020"><h3 class="pmc_sec_title">3.2 Cell migration</h3>
<p>The scratch assay was used to evaluate cell migration ability. <strong><a href="#pone.0330492.g003" class="usa-link">Fig 3</a></strong> presents representative scratch assay images at 0, 6, 12, and 24 hours after travoprost treatment, along with the corresponding migration rates of LECs and PAX6-knockdown LECs at 6, 12, and 24 hours. At all three time points—6, 12, and 24 hours post-treatment—PAX6-knockdown LECs demonstrated significantly lower migration rates compared to LECs (p = 0.001, p = 0.046, and p &lt; 0.001, respectively). At 6 hours, the migration rate of untreated PAX6-knockdown LECs was significantly reduced compared to that of untreated LECs (p = 0.002). Furthermore, in PAX6-knockdown LECs, treatment with 0.313 μg/mL travoprost led to a significantly higher migration rate than in the untreated group (p = 0.047). At 24 hours, this trend persisted, with untreated PAX6-knockdown LECs continuing to show significantly lower migration than untreated LECs (p = 0.012).</p>
<figure class="fig xbox font-sm" id="pone.0330492.g003"><h4 class="obj_head">Fig 3. Images of scratch assays (A, B) and quantification of migration rates (C, D, E) for limbal epithelial cells (LECs) and PAX6-knockdown LECs at 0, 6, 12, and 24 hours following a 20-minute treatment with travoprost at concentrations of 0.156 μg/mL and 0.313 μg/mL (n = 5).</h4>
<p class="img-box line-height-none margin-x-neg-2 tablet:margin-x-0 text-center"><a class="tileshop" target="_blank" href="https://www.ncbi.nlm.nih.gov/core/lw/2.0/html/tileshop_pmc/tileshop_pmc_inline.html?title=Click%20on%20image%20to%20zoom&amp;p=PMC3&amp;id=12364336_pone.0330492.g003.jpg"><img class="graphic zoom-in" src="https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fb05/12364336/399f143de40c/pone.0330492.g003.jpg" loading="lazy" height="796" width="700" alt="Fig 3"></a></p>
<div class="p text-right font-secondary"><a href="figure/pone.0330492.g003/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div>
<figcaption><p>At 6, 12, and 24 hours, the migration rate in LECs was significantly higher than in PAX6-knockdown LECs (p ≤ 0.046). At 6 hours, untreated LECs demonstrated a significantly higher migration rate compared to untreated PAX6-knockdown LECs (p = 0.002) <strong>(C)</strong>. Additionally, PAX6-knockdown LECs treated with 0.313 μg/mL travoprost showed a significantly higher migration rate than untreated PAX6-knockdown cells (p = 0.047). At 24 hours, untreated LECs continued to exhibit a significantly higher migration rate than their PAX6-knockdown counterparts (p = 0.012) <strong>(E)</strong>. <strong>Scale bar: 50 μm.</strong></p></figcaption></figure></section><section id="sec021"><h3 class="pmc_sec_title">3.3 PAX6 mRNA and protein levels</h3>
<p>We compared the mRNA and protein levels of PAX6 in LECs and PAX6-knockdown LECs to verify the success of the PAX6 knockdown. Compared to LECs, PAX6-knockdown LECs showed a significant reduction in <em>PAX6</em> mRNA levels (p &lt; 0.001). Similarly, PAX6 protein levels were also significantly lower in the knockdown group (p = 0.004). However, travoprost treatment had no significant effect on PAX6 mRNA or protein level in either cell type (p ≥ 0.773) (<strong><a href="#pone.0330492.g004" class="usa-link">Fig 4</a></strong>).</p>
<figure class="fig xbox font-sm" id="pone.0330492.g004"><h4 class="obj_head">Fig 4. PAX6 mRNA levels, protein levels, and representative Western blot in limbal epithelial cells (LECs) and PAX6-knockdown LECs following a 20-minute treatment with travoprost at concentrations of 0.156 μg/mL and 0.313 μg/mL (n = 7) (A-C).</h4>
<p class="img-box line-height-none margin-x-neg-2 tablet:margin-x-0 text-center"><a class="tileshop" target="_blank" href="https://www.ncbi.nlm.nih.gov/core/lw/2.0/html/tileshop_pmc/tileshop_pmc_inline.html?title=Click%20on%20image%20to%20zoom&amp;p=PMC3&amp;id=12364336_pone.0330492.g004.jpg"><img class="graphic zoom-in" src="https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fb05/12364336/f4af84e35981/pone.0330492.g004.jpg" loading="lazy" height="593" width="700" alt="Fig 4"></a></p>
<div class="p text-right font-secondary"><a href="figure/pone.0330492.g004/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div>
<figcaption><p>mRNA values are presented on a logarithmic scale (Log₂) and expressed as the geometric mean±geometric standard deviation (SD). Protein levels are shown on a logarithmic scale (Log₁₀) as mean±SD. Two-way ANOVA was used for statistical analysis, and significant p-values (p &lt; 0.05) are indicated in the diagrams. TPN LB Corr. Vol. refers to the total lane protein-normalized, local background-corrected volume on the Y-axis. <em>PAX6</em> mRNA levels were significantly lower in PAX6-knockdown LECs compared to LECs (p &lt; 0.001) <strong>(A)</strong>. Similarly, PAX6 protein levels were significantly reduced in PAX6-knockdown LECs relative to LECs (p = 0.004) <strong>(B)</strong>.</p></figcaption></figure></section><section id="sec022"><h3 class="pmc_sec_title">3.4 <em>Ki67</em> mRNA levels</h3>
<p>Ki67 is widely regarded as a marker of cell proliferation [<a href="#pone.0330492.ref032" class="usa-link" aria-describedby="pone.0330492.ref032">32</a>]. The mRNA levels of <em>Ki67</em> did not differ significantly between LECs and PAX6-knockdown LECs (p = 0.321). Moreover, treatment with travoprost did not affect <em>Ki67</em> mRNA expression in either the LEC or PAX6-knockdown subgroups (p ≥ 0.867) (<a href="#pone.0330492.g005" class="usa-link">Fig 5</a>).</p>
<figure class="fig xbox font-sm" id="pone.0330492.g005"><h4 class="obj_head">Fig 5. <em>Ki67</em> mRNA levels in limbal epithelial cells (LECs) and PAX6-knockdown LECs following a 20-minute treatment with travoprost at concentrations of 0.156 μg/mL and 0.313 μg/mL (n = 7).</h4>
<p class="img-box line-height-none margin-x-neg-2 tablet:margin-x-0 text-center"><img class="graphic" src="https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fb05/12364336/454bdff927d9/pone.0330492.g005.jpg" loading="lazy" height="368" width="600" alt="Fig 5"></p>
<div class="p text-right font-secondary"><a href="figure/pone.0330492.g005/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div>
<figcaption><p>mRNA values are presented on a logarithmic scale (Log₂) and expressed as the geometric mean±geometric standard deviation (SD). Two-way ANOVA was used for statistical analysis, and significant p-values (p &lt; 0.05) are indicated in the diagrams. No significant differences were observed between any of the analyzed groups or subgroups (p ≥ 0.321).</p></figcaption></figure></section><section id="sec023"><h3 class="pmc_sec_title">3.5 FOSL2 and mitogen-activated protein kinases (MAPKs)</h3>
<p>FOSL2 is regarded as a downstream gene regulated by PAX6 and has been closely linked to corneal opacity. It is also thought to contribute to the control of cell migration and proliferation [<a href="#pone.0330492.ref021" class="usa-link" aria-describedby="pone.0330492.ref021">21</a>,<a href="#pone.0330492.ref022" class="usa-link" aria-describedby="pone.0330492.ref022">22</a>]. MAPKs are similarly recognized for their roles in governing key cellular processes, including proliferation, migration, and apoptosis [<a href="#pone.0330492.ref024" class="usa-link" aria-describedby="pone.0330492.ref024">24</a>–<a href="#pone.0330492.ref026" class="usa-link" aria-describedby="pone.0330492.ref026">26</a>]. In PAX6-knockdown LECs, the mRNA levels of <em>FOSL2</em>, <em>ERK1 (MAPK3)</em>, <em>ERK2 (MAPK1)</em>, and <em>JNK (MAPK8)</em> were significantly lower than those observed in LECs (p = 0.007, p &lt; 0.001, p = 0.016, p = 0.043). In addition, the protein levels of JNK1/2 were significantly reduced in untreated PAX6-knockdown LECs compared to untreated LECs (p = 0.046). Treatment with 0.313 μg/mL travoprost significantly increased JNK1/2 protein expression in PAX6-knockdown LECs (p = 0.039) (<strong><a href="#pone.0330492.g006" class="usa-link">Fig 6</a></strong>).</p>
<figure class="fig xbox font-sm" id="pone.0330492.g006"><h4 class="obj_head">Fig 6. FOSL2, ERK1 (MAPK3), ERK2 (MAPK1), and JNK (MAPK8) mRNA and protein levels, and representative Western blots for FOSL2, ERK1/2, and JNK1/2 in limbal epithelial cells (LECs) and PAX6-knockdown LECs following a 20-minute treatment with travoprost at concentrations of 0.156 μg/mL and 0.313 μg/mL (n = 7) (A–I).</h4>
<p class="img-box line-height-none margin-x-neg-2 tablet:margin-x-0 text-center"><a class="tileshop" target="_blank" href="https://www.ncbi.nlm.nih.gov/core/lw/2.0/html/tileshop_pmc/tileshop_pmc_inline.html?title=Click%20on%20image%20to%20zoom&amp;p=PMC3&amp;id=12364336_pone.0330492.g006.jpg"><img class="graphic zoom-in" src="https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fb05/12364336/5235e7f4b99a/pone.0330492.g006.jpg" loading="lazy" height="688" width="700" alt="Fig 6"></a></p>
<div class="p text-right font-secondary"><a href="figure/pone.0330492.g006/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div>
<figcaption><p>mRNA values are presented on a logarithmic scale (Log₂) and expressed as the geometric mean±geometric standard deviation (SD). Protein levels are shown on a logarithmic scale (Log₁₀) as mean±SD. Two-way ANOVA was used for statistical analysis, and significant p-values (p &lt; 0.05) are indicated in the diagrams. TPN LB Corr. Vol. refers to the total lane protein-normalized, local background-corrected volume on the Y-axis. <strong>mRNA levels of <em>FOSL2, ERK1, ERK2</em>, and <em>JNK</em> were significantly lower in PAX6-knockdown LECs compared to LECs (p ≤ 0.043) (A, C, E, G).</strong> JNK1/2 protein levels were significantly reduced in untreated PAX6-knockdown LECs compared to LECs (p = 0.046), while treatment with 0.313 μg/mL travoprost significantly increased JNK1/2 protein levels in PAX6-knockdown LECs compared to untreated PAX6-knockdown cells (p = 0.039) (<strong>H</strong>).</p></figcaption></figure></section><section id="sec024"><h3 class="pmc_sec_title">3.6 Inflammation-related genes and proteins</h3>
<p>In PAX6-knockdown LECs, the mRNA levels of inflammation-related genes <em>IL-1α</em>, <em>IL-1β</em>, <em>IL-6</em>, <em>IL-8</em>, <em>TNFα</em>, and <em>NF-κB</em> were significantly lower than those in LECs (p = 0.019, p = 0.015, p &lt; 0.001, p = 0.031, p &lt; 0.001, p = 0.017, respectively). There were no significant differences in <em>PTGES2</em> mRNA levels between LECs and PAX6-knockdown LECs, nor among different concentrations of travoprost (p ≥ 0.175). At the protein level, IL-6 was significantly reduced in PAX6-knockdown LECs compared to LECs (p = 0.025), while travoprost treatment had no significant effect on IL-6 expression (p ≥ 0.589). Additionally, no significant differences were found in the protein levels of IL-1α, IL-1β, IL-8, TNFα, NF-κB, and PTGES2 between LECs and PAX6-knockdown LECs, or across the different travoprost concentrations (p ≥ 0.155) (<strong><a href="#pone.0330492.g007" class="usa-link">Fig 7</a></strong>).</p>
<figure class="fig xbox font-sm" id="pone.0330492.g007"><h4 class="obj_head">Fig 7. mRNA and protein levels of inflammation-related markers including IL-1α, IL-1β, IL-6, IL-8, TNFα, NF-κB, and PTGES2, as well as representative Western blots for each marker, in limbal epithelial cells (LECs) and PAX6-knockdown LECs following a 20-minute treatment with travoprost at concentrations of 0.156 μg/mL and 0.313 μg/mL (n = 7) (A-O).</h4>
<p class="img-box line-height-none margin-x-neg-2 tablet:margin-x-0 text-center"><a class="tileshop" target="_blank" href="https://www.ncbi.nlm.nih.gov/core/lw/2.0/html/tileshop_pmc/tileshop_pmc_inline.html?title=Click%20on%20image%20to%20zoom&amp;p=PMC3&amp;id=12364336_pone.0330492.g007.jpg"><img class="graphic zoom-in" src="https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fb05/12364336/10e62d7c46bd/pone.0330492.g007.jpg" loading="lazy" height="960" width="785" alt="Fig 7"></a></p>
<div class="p text-right font-secondary"><a href="figure/pone.0330492.g007/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div>
<figcaption><p>mRNA expression values are presented on a logarithmic scale (Log₂) as geometric mean±geometric standard deviation (SD). Protein levels of IL-1α, IL-1β, IL-6, IL-8, and TNFα were determined by Western blot and are shown on a logarithmic scale (Log₁₀) as mean±SD. NF-κB and PTGES2 protein levels were measured using ELISA, also presented on a Log₁₀ scale as mean±SD. Statistical analysis was performed using two-way ANOVA, and p-values &lt;0.05 are indicated in the figures. TPN LB Corr. Vol. refers to the total lane protein-normalized, local background-corrected volume plotted on the Y-axis. <em>IL-1α, IL-1β, IL-6, IL-8, TNFα</em>, and <em>NF-κB</em> mRNA levels were significantly lower in PAX6-knockdown LECs compared to LECs (p ≤ 0.031) <strong>(A, C, E, G, I, K)</strong>. The IL-6 protein level was also significantly reduced in PAX6-knockdown LECs relative to LECs (p = 0.025) <strong>(F)</strong>. No significant differences were observed between any of the other analyzed groups or subgroups.</p></figcaption></figure></section><section id="sec025"><h3 class="pmc_sec_title">3.7 Caspase-3 mRNA and protein levels</h3>
<p>Caspase-3 is a crucial enzyme involved in the apoptotic process and is commonly used as a marker of apoptosis [<a href="#pone.0330492.ref033" class="usa-link" aria-describedby="pone.0330492.ref033">33</a>]. In PAX6-knockdown LECs, the mRNA level of <em>caspase-3</em> was significantly lower compared to that in LECs (p = 0.017). However, when treated with 0.313 μg/mL travoprost, PAX6-knockdown LECs exhibited significantly higher caspase-3 protein levels than LECs treated with the same concentration (p = 0.019). Furthermore, in PAX6-knockdown LECs, 0.313 μg/mL travoprost significantly increased caspase-3 protein level compared to the untreated group (p = 0.044) (<strong><a href="#pone.0330492.g008" class="usa-link">Fig 8</a></strong>).</p>
<figure class="fig xbox font-sm" id="pone.0330492.g008"><h4 class="obj_head">Fig 8. Caspase-3 mRNA and protein levels, and representative Western blot in limbal epithelial cells (LECs) and PAX6-knockdown LECs following a 20-minute treatment with travoprost at concentrations of 0.156 μg/mL and 0.313 μg/mL (n = 7) (A-C).</h4>
<p class="img-box line-height-none margin-x-neg-2 tablet:margin-x-0 text-center"><a class="tileshop" target="_blank" href="https://www.ncbi.nlm.nih.gov/core/lw/2.0/html/tileshop_pmc/tileshop_pmc_inline.html?title=Click%20on%20image%20to%20zoom&amp;p=PMC3&amp;id=12364336_pone.0330492.g008.jpg"><img class="graphic zoom-in" src="https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fb05/12364336/3e21f65ba24d/pone.0330492.g008.jpg" loading="lazy" height="549" width="700" alt="Fig 8"></a></p>
<div class="p text-right font-secondary"><a href="figure/pone.0330492.g008/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div>
<figcaption><p>mRNA values are presented on a logarithmic scale (Log₂) as geometric mean±geometric standard deviation (SD). Protein values are shown on a logarithmic scale (Log₁₀) as mean±SD. Two-way ANOVA was used for statistical analysis, and significant p-values (p &lt; 0.05) are indicated in the diagrams. TPN LB Corr. Vol. refers to the total lane protein–normalized, local background–corrected volume displayed on the Y-axis. <strong><em>Caspase-3</em></strong> mRNA levels were significantly lower in PAX6-knockdown LECs than in LECs (<strong>p</strong> = 0.017) <strong>(A)</strong>. Caspase-3 protein levels were significantly higher in PAX6-knockdown LECs treated with 0.313 μg/mL travoprost compared to both LECs treated with the same concentration (p = 0.019) and untreated PAX6-knockdown LECs (p = 0.044). <strong>(B)</strong>.</p></figcaption></figure></section><section id="sec026"><h3 class="pmc_sec_title">3.8 MMP9 mRNA and protein levels</h3>
<p>An increase in MMP9 expression is one of the mechanisms through which travoprost reduces IOP and is also linked to the regulation of cell migration [<a href="#pone.0330492.ref027" class="usa-link" aria-describedby="pone.0330492.ref027">27</a>,<a href="#pone.0330492.ref034" class="usa-link" aria-describedby="pone.0330492.ref034">34</a>]. In PAX6-knockdown LECs, <em>MMP9</em> mRNA levels were significantly higher than in LECs (p = 0.003). Furthermore, in PAX6-knockdown LECs treated with 0.313 μg/mL travoprost, <em>MMP9</em> mRNA levels were significantly higher than those in LECs treated with the same concentration (p = 0.010). Travoprost treatment at 0.313 μg/mL also significantly upregulated <em>MMP9</em> mRNA level in PAX6-knockdown LECs compared to their untreated counterparts (p = 0.021).</p>
<p>Similarly, MMP9 protein levels were significantly elevated in PAX6-knockdown LECs compared to LECs (p &lt; 0.001). In addition, treatment with 0.156 μg/mL and 0.313 μg/mL travoprost further increased MMP9 protein level in PAX6-knockdown LECs (p = 0.044 and p = 0.027, respectively) (<strong><a href="#pone.0330492.g009" class="usa-link">Fig 9</a></strong>).</p>
<figure class="fig xbox font-sm" id="pone.0330492.g009"><h4 class="obj_head">Fig 9. MMP9 mRNA and protein levels in limbal epithelial cells (LECs) and PAX6-knockdown LECs following a 20-minute treatment with travoprost at concentrations of 0.156 μg/mL and 0.313 μg/mL (n = 7) (A, B).</h4>
<p class="img-box line-height-none margin-x-neg-2 tablet:margin-x-0 text-center"><a class="tileshop" target="_blank" href="https://www.ncbi.nlm.nih.gov/core/lw/2.0/html/tileshop_pmc/tileshop_pmc_inline.html?title=Click%20on%20image%20to%20zoom&amp;p=PMC3&amp;id=12364336_pone.0330492.g009.jpg"><img class="graphic zoom-in" src="https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fb05/12364336/fdd4b8945e7c/pone.0330492.g009.jpg" loading="lazy" height="313" width="660" alt="Fig 9"></a></p>
<div class="p text-right font-secondary"><a href="figure/pone.0330492.g009/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div>
<figcaption><p>mRNA values are presented on a logarithmic scale (Log₂) as geometric mean±geometric standard deviation (SD). Protein values are also shown on a logarithmic scale (Log₂) as mean±SD. Statistical analysis was performed using two-way ANOVA, and significant p-values (p &lt; 0.05) are indicated in the diagrams. <strong><em>MMP9</em></strong> mRNA levels were significantly higher in PAX6-knockdown LECs than in LECs (<strong>p</strong> = 0.003). Additionally, <em>MMP9</em> mRNA levels were significantly elevated in PAX6-knockdown LECs treated with 0.313 μg/mL travoprost compared to both travoprost-treated LECs (p = 0.010) and untreated PAX6-knockdown LECs (p = 0.021) <strong>(A)</strong>. <strong>MMP9 protein levels were significantly higher in PAX6-knockdown LECs compared to LECs (p &lt; 0.001). Treatment with 0.156 μg/mL and 0.313 μg/mL travoprost significantly increased MMP9 protein levels in PAX6-knockdown LECs compared to untreated controls (p = 0.044 and p = 0.027, respectively) (B)</strong>.</p></figcaption></figure></section></section><section id="sec027"><h2 class="pmc_sec_title">4 Discussion</h2>
<p>Congenital aniridia is a complex hereditary ocular developmental disorder, primarily caused by mutations in the PAX6 gene, resulting in reduced PAX6 gene and protein expression. This deficiency leads to widespread abnormalities of the ocular surface, particularly the development of AAK [<a href="#pone.0330492.ref035" class="usa-link" aria-describedby="pone.0330492.ref035">35</a>,<a href="#pone.0330492.ref036" class="usa-link" aria-describedby="pone.0330492.ref036">36</a>]. In this study, we used an siRNA-mediated PAX6 knockdown model in limbal epithelial cells and, for the first time, systematically investigated the effects of varying concentrations of the prostaglandin analogue travoprost on both normal LECs and PAX6-knockdown LECs. Our evaluations included analyses of cell viability, proliferation, and migration, along with the expression of key genes and proteins such as FOSL2, MAPKs, inflammatory markers, caspase-3, and MMP9. The findings demonstrated that PAX6-knockdown LECs were more sensitive to travoprost than normal LECs, and offer important experimental evidence to develop pharmacological strategies for treating patients with congenital aniridia complicated by glaucoma.</p>
<p>Our experimental data demonstrated that travoprost significantly reduced the viability of LECs at concentrations as low as 0.156 μg/mL, with a clear dose-dependent effect as the concentration increased. At lower concentrations, the reduction in LEC viability induced by travoprost may not result from overt cytotoxicity but rather from the early activation of stress- and apoptosis-related signaling pathways. In PAX6-knockdown LECs, we observed an increase in caspase-3 protein levels following treatment with 0.313 μg/mL travoprost, supporting the hypothesis that travoprost can trigger apoptotic processes even at relatively low concentrations. This early response appears to be more pronounced in PAX6-deficient cells, which exhibit impaired regulatory capacity and heightened sensitivity to external stimuli. Similarly, we found that low-concentration travoprost treatment elevated JNK protein levels in PAX6-knockdown LECs, suggesting that travoprost may also induce mild oxidative stress under these conditions [<a href="#pone.0330492.ref037" class="usa-link" aria-describedby="pone.0330492.ref037">37</a>]. This finding aligns with previous studies on corneal epithelial cell lines [<a href="#pone.0330492.ref017" class="usa-link" aria-describedby="pone.0330492.ref017">17</a>,<a href="#pone.0330492.ref019" class="usa-link" aria-describedby="pone.0330492.ref019">19</a>], where exposure to 40 μg/mL travoprost for 5, 15, or 30 minutes resulted in significantly decreased cell viability. Notably, our study examined a broader range of travoprost concentrations, allowing for a more detailed assessment of its impact on LEC viability. Interestingly, while LEC viability was reduced even at low concentrations (0.156 μg/mL), proliferation was only suppressed at higher concentrations (20 μg/mL and 40 μg/mL). This is consistent with findings by Liang et al. [<a href="#pone.0330492.ref038" class="usa-link" aria-describedby="pone.0330492.ref038">38</a>], who reported that the proliferation of immortalized human corneal epithelial cells was significantly reduced after a 30-minute exposure to 40 μg/mL travoprost. Importantly, our study excluded the effects of preservatives commonly found in antiglaucomatous eye drops, allowing us to assess the direct effects of travoprost itself. We also examined the effects of 0.156 and 0.313 μg/mL travoprost on Ki67 mRNA levels, a marker of cell proliferation [<a href="#pone.0330492.ref032" class="usa-link" aria-describedby="pone.0330492.ref032">32</a>], in both LECs and PAX6-knockdown LECs. These travoprost concentrations did not affect proliferation in either group, consistent with our BrdU assay results.</p>
<p>In the cell migration assay, PAX6-knockdown LECs exhibited a significantly lower migration rate compared to normal LECs. However, treatment with 0.313 μg/mL travoprost notably enhanced migration in the knockdown cells, suggesting a potential “restorative” effect that may be mediated through multiple mechanisms.</p>
<p>First, FOSL2, a known transcriptional target of PAX6, has been implicated in maintaining corneal transparency [<a href="#pone.0330492.ref021" class="usa-link" aria-describedby="pone.0330492.ref021">21</a>]. In our study, <em>FOSL2</em> mRNA levels were significantly reduced following PAX6 knockdown. As a member of the activator protein-1 (AP-1) transcription factor family, FOSL2 is involved in the regulation of cell proliferation and migration [<a href="#pone.0330492.ref039" class="usa-link" aria-describedby="pone.0330492.ref039">39</a>–<a href="#pone.0330492.ref041" class="usa-link" aria-describedby="pone.0330492.ref041">41</a>]. Therefore, the impaired migration observed in PAX6-deficient LECs may, in part, be attributed to the downregulation of <em>FOSL2</em>.</p>
<p>Second, our MAPK pathway analysis showed that PAX6 knockdown resulted in downregulation of <em>ERK1/2</em> and <em>JNK</em> mRNA levels. Interestingly, travoprost treatment led to an upregulation of JNK1/2 protein levels in PAX6-knockdown LECs. Given that JNK signaling plays a critical role in regulating cell migration [<a href="#pone.0330492.ref042" class="usa-link" aria-describedby="pone.0330492.ref042">42</a>,<a href="#pone.0330492.ref043" class="usa-link" aria-describedby="pone.0330492.ref043">43</a>], this suggests that travoprost may partially restore migratory capacity in PAX6-deficient cells through JNK activation.</p>
<p>Furthermore, our results demonstrated that travoprost upregulated both the gene and protein expression of MMP9 in PAX6-knockdown LECs. The upregulation of matrix metalloproteinases (MMPs) and the resulting extracellular matrix (ECM) remodeling is a well-established mechanism by which prostaglandin analogues, including travoprost, facilitate intraocular pressure reduction [<a href="#pone.0330492.ref027" class="usa-link" aria-describedby="pone.0330492.ref027">27</a>,<a href="#pone.0330492.ref044" class="usa-link" aria-describedby="pone.0330492.ref044">44</a>]. MMP9, in particular, has been shown to promote epithelial cell migration [<a href="#pone.0330492.ref034" class="usa-link" aria-describedby="pone.0330492.ref034">34</a>], and its expression is known to be regulated by the JNK signaling pathway [<a href="#pone.0330492.ref045" class="usa-link" aria-describedby="pone.0330492.ref045">45</a>,<a href="#pone.0330492.ref046" class="usa-link" aria-describedby="pone.0330492.ref046">46</a>]. Taken together, these findings suggest that travoprost may enhance the migratory capacity of PAX6-knockdown LECs via the JNK–MMP9 axis. However, it is important to consider that excessive MMP expression could potentially disrupt ECM homeostasis in corneal tissue, and its role in the progression of aniridia-associated keratopathy remains an open question that warrants further investigation.</p>
<p>Regarding the expression of inflammation-related genes and proteins, PAX6 knockdown led to a reduction in mRNA levels for most inflammatory markers. This effect may be attributed to the suppression of the JNK/ERK signaling pathways, thereby attenuating the inflammatory response [<a href="#pone.0330492.ref047" class="usa-link" aria-describedby="pone.0330492.ref047">47</a>]. Additionally, treatment with 0.156 μg/mL and 0.313 μg/mL travoprost did not elicit any significant changes in inflammatory marker expression in either normal LECs or PAX6-knockdown LECs. Unlike several previous <em>in vivo</em> and <em>in vitro</em> studies on travoprost [<a href="#pone.0330492.ref019" class="usa-link" aria-describedby="pone.0330492.ref019">19</a>,<a href="#pone.0330492.ref048" class="usa-link" aria-describedby="pone.0330492.ref048">48</a>], our study was specifically designed to assess the inflammatory effects of the active compound alone, intentionally excluding potential confounding effects from preservatives. In those earlier studies, travoprost was reported to increase the expression of inflammatory cytokines such as IL-6, IL-8, and TNF-α in corneal cells. However, it seems that these pro-inflammatory effects were at least partially driven by the presence of preservatives, whose detrimental effects on corneal cells have been well documented [<a href="#pone.0330492.ref019" class="usa-link" aria-describedby="pone.0330492.ref019">19</a>,<a href="#pone.0330492.ref049" class="usa-link" aria-describedby="pone.0330492.ref049">49</a>,<a href="#pone.0330492.ref050" class="usa-link" aria-describedby="pone.0330492.ref050">50</a>].</p>
<p>Caspase-3 is recognized as a key executioner enzyme in the apoptotic process, exhibiting proteolytic activity and regulating the expression of downstream effectors in both the intrinsic and extrinsic apoptotic pathways, ultimately leading to programmed cell death [<a href="#pone.0330492.ref051" class="usa-link" aria-describedby="pone.0330492.ref051">51</a>]. In our study, treatment with 0.313 μg/mL travoprost led to a significant increase in caspase-3 protein expression in PAX6-knockdown LECs. This observation is consistent with findings by Paimela et al. [<a href="#pone.0330492.ref019" class="usa-link" aria-describedby="pone.0330492.ref019">19</a>], where treatment of corneal epithelial cell lines with 40 μg/mL travoprost for 5, 15, and 30 minutes also resulted in an upward trend in caspase-3 expression. However, it should be emphasized that the potential pro-apoptotic effects of preservatives in those studies cannot be ruled out. Moreover, the JNK signaling pathway, which is known to be involved in apoptotic regulation, may also play a role in modulating caspase-3 expression. The travoprost-induced activation of JNK, as observed in our study, could contribute to the upregulation of caspase-3 and provide a possible mechanistic link between PAX6 deficiency, JNK activation, and apoptotic susceptibility in limbal epithelial cells. <strong><a href="#pone.0330492.g010" class="usa-link">Fig 10</a></strong> summarizes the effects of PAX6 knockdown and travoprost on the expression of the analyzed genes and proteins in limbal epithelial cells.</p>
<figure class="fig xbox font-sm" id="pone.0330492.g010"><h3 class="obj_head">Fig 10. Effects of PAX6 knockdown and travoprost on the analyzed genes and proteins in limbal epithelial cells (LECs).</h3>
<p class="img-box line-height-none margin-x-neg-2 tablet:margin-x-0 text-center"><a class="tileshop" target="_blank" href="https://www.ncbi.nlm.nih.gov/core/lw/2.0/html/tileshop_pmc/tileshop_pmc_inline.html?title=Click%20on%20image%20to%20zoom&amp;p=PMC3&amp;id=12364336_pone.0330492.g010.jpg"><img class="graphic zoom-in" src="https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fb05/12364336/cd3aa15b6e2a/pone.0330492.g010.jpg" loading="lazy" height="379" width="672" alt="Fig 10"></a></p>
<div class="p text-right font-secondary"><a href="figure/pone.0330492.g010/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div>
<figcaption><p>PAX6 knockdown inhibits the expression of inflammation-related genes—IL-1α, IL-1β, IL-6, IL-8, TNFα, NF-κB—as well as FOSL2, ERK1/2, and JNK in LECs, while it promotes the expression of MMP9. Travoprost treatment increases the expression of MMP9 and caspase-3 by upregulating JNK levels, thereby enhancing both cell migration and apoptosis. The red solid line indicates an upregulating effect, while the blue dashed line indicates a downregulating effect.</p></figcaption></figure><p>Our study has several limitations. The siRNA-mediated knockdown model only partially replicates PAX6 haploinsufficiency and does not account for the genetic heterogeneity observed in patients with congenital aniridia. Additionally, the 20-minute short-term exposure to travoprost may not accurately reflect the long-term effects of chronic medication use in clinical settings. In the present study, the limited amount of available material prevented us from measuring the active, phosphorylated forms of ERK and NF-κB, highlighting the need for further investigation. For the same reason, we were also unable to analyze the Akt and Wnt pathways, which we propose to investigate in future studies. To address these limitations, future studies involving <em>in vivo</em> animal models are warranted to further validate and extend our findings.</p></section><section id="sec028"><h2 class="pmc_sec_title">5 Conclusions</h2>
<p>In this study, a PAX6-knockdown LEC model was established to systematically evaluate the effects of travoprost on cell viability, proliferation, and migration, as well as the expression of FOSL2, MAPKs, inflammation-related markers, caspase-3, and MMP9 in both normal and PAX6-deficient LECs. The findings revealed that travoprost at specific concentrations inhibits primary human LEC viability and proliferation. Moreover, travoprost may enhance the migratory capacity of PAX6-knockdown LECs through activation of the JNK signaling pathway and upregulation of MMP9. Additionally, it may promote apoptosis via the caspase-3 pathway. Further studies are required to fully elucidate the roles of these signaling mechanisms.</p></section><section id="ack1" class="ack"><h2 class="pmc_sec_title">Acknowledgments</h2>
<p>The work of Shuailin Li, Tanja Stachon, Shanhe Liu, Zhen Li, Shao-Lun Hsu, Swarnali Kundu, Fabian N. Fries, Maryam Amini, Shweta Suiwal and Nóra Szentmáry at the Rolf M. Schwiete Center for Limbal Stem Cell and Aniridia Research was supported by the Rolf M. Schwiete Foundation. The work of Shuailin Li, Zhen Li and Shanhe Liu has been supported by the China Scholarship Council. We would like to thank Mrs. Sabrina Häcker for her excellent technical assistance.</p></section><section id="notes1"><h2 class="pmc_sec_title">Data Availability</h2>
<p>All relevant data are within the manuscript and its Supporting information files.</p></section><section id="funding-statement1" lang="en"><h2 class="pmc_sec_title">Funding Statement</h2>
<p>The author(s) received no specific funding for this work.</p></section><section id="ref-list1" class="ref-list"><h2 class="pmc_sec_title">References</h2>
<section id="ref-list1_sec2"><ul class="ref-list font-sm" style="list-style-type:none">
<li id="pone.0330492.ref001">
<span class="label">1.</span><cite>Lim HT, Kim DH, Kim H. PAX6 aniridia syndrome: clinics, genetics, and therapeutics. Curr Opin Ophthalmol. 2017;28(5):436–47. doi: 10.1097/ICU.0000000000000405

</cite> [<a href="https://doi.org/10.1097/ICU.0000000000000405" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/28598868/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Curr%20Opin%20Ophthalmol&amp;title=PAX6%20aniridia%20syndrome:%20clinics,%20genetics,%20and%20therapeutics&amp;author=HT%20Lim&amp;author=DH%20Kim&amp;author=H%20Kim&amp;volume=28&amp;issue=5&amp;publication_year=2017&amp;pages=436-47&amp;pmid=28598868&amp;doi=10.1097/ICU.0000000000000405&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="pone.0330492.ref002">
<span class="label">2.</span><cite>Hingorani M, Hanson I, van Heyningen V. Aniridia. Eur J Hum Genet. 2012;20(10):1011–7. doi: 10.1038/ejhg.2012.100

</cite> [<a href="https://doi.org/10.1038/ejhg.2012.100" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC3449076/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/22692063/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Eur%20J%20Hum%20Genet&amp;title=Aniridia&amp;author=M%20Hingorani&amp;author=I%20Hanson&amp;author=V%20van%20Heyningen&amp;volume=20&amp;issue=10&amp;publication_year=2012&amp;pages=1011-7&amp;pmid=22692063&amp;doi=10.1038/ejhg.2012.100&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="pone.0330492.ref003">
<span class="label">3.</span><cite>Lima Cunha D, Arno G, Corton M, Moosajee M. The Spectrum of PAX6 Mutations and Genotype-Phenotype Correlations in the Eye. Genes (Basel). 2019;10(12):1050. doi: 10.3390/genes10121050

</cite> [<a href="https://doi.org/10.3390/genes10121050" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC6947179/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/31861090/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Genes%20(Basel)&amp;title=The%20Spectrum%20of%20PAX6%20Mutations%20and%20Genotype-Phenotype%20Correlations%20in%20the%20Eye&amp;author=D%20Lima%20Cunha&amp;author=G%20Arno&amp;author=M%20Corton&amp;author=M%20Moosajee&amp;volume=10&amp;issue=12&amp;publication_year=2019&amp;pages=1050&amp;pmid=31861090&amp;doi=10.3390/genes10121050&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="pone.0330492.ref004">
<span class="label">4.</span><cite>Gour A, Tibrewal S, Garg A, Vohra M, Ratna R, Sangwan VS. New horizons in aniridia management: Clinical insights and therapeutic advances. Taiwan J Ophthalmol. 2023;13(4):467–78. doi: 10.4103/tjo.TJO-D-23-00140

</cite> [<a href="https://doi.org/10.4103/tjo.TJO-D-23-00140" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC10798387/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/38249501/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Taiwan%20J%20Ophthalmol&amp;title=New%20horizons%20in%20aniridia%20management:%20Clinical%20insights%20and%20therapeutic%20advances&amp;author=A%20Gour&amp;author=S%20Tibrewal&amp;author=A%20Garg&amp;author=M%20Vohra&amp;author=R%20Ratna&amp;volume=13&amp;issue=4&amp;publication_year=2023&amp;pages=467-78&amp;pmid=38249501&amp;doi=10.4103/tjo.TJO-D-23-00140&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="pone.0330492.ref005">
<span class="label">5.</span><cite>Casas-Llera P, Ruiz-Casas D, Alió JL. Macular involvement in congenital aniridia. Arch Soc Esp Oftalmol (Engl Ed). 2021;96 Suppl 1:60–7. doi: 10.1016/j.oftale.2020.11.006

</cite> [<a href="https://doi.org/10.1016/j.oftale.2020.11.006" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/34836590/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Arch%20Soc%20Esp%20Oftalmol%20(Engl%20Ed)&amp;title=Macular%20involvement%20in%20congenital%20aniridia&amp;author=P%20Casas-Llera&amp;author=D%20Ruiz-Casas&amp;author=JL%20Ali%C3%B3&amp;publication_year=2021&amp;pages=60-7&amp;pmid=34836590&amp;doi=10.1016/j.oftale.2020.11.006&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="pone.0330492.ref006">
<span class="label">6.</span><cite>Latta L, Figueiredo FC, Ashery-Padan R, Collinson JM, Daniels J, Ferrari S, et al. Pathophysiology of aniridia-associated keratopathy: Developmental aspects and unanswered questions. Ocul Surf. 2021;22:245–66. doi: 10.1016/j.jtos.2021.09.001

</cite> [<a href="https://doi.org/10.1016/j.jtos.2021.09.001" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/34520870/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Ocul%20Surf&amp;title=Pathophysiology%20of%20aniridia-associated%20keratopathy:%20Developmental%20aspects%20and%20unanswered%20questions&amp;author=L%20Latta&amp;author=FC%20Figueiredo&amp;author=R%20Ashery-Padan&amp;author=JM%20Collinson&amp;author=J%20Daniels&amp;volume=22&amp;publication_year=2021&amp;pages=245-66&amp;pmid=34520870&amp;doi=10.1016/j.jtos.2021.09.001&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="pone.0330492.ref007">
<span class="label">7.</span><cite>Lagali N, Wowra B, Fries FN, Latta L, Moslemani K, Utheim TP, et al. PAX6 Mutational Status Determines Aniridia-Associated Keratopathy Phenotype. Ophthalmology. 2020;127(2):273–5. doi: 10.1016/j.ophtha.2019.09.034

</cite> [<a href="https://doi.org/10.1016/j.ophtha.2019.09.034" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/31708273/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Ophthalmology&amp;title=PAX6%20Mutational%20Status%20Determines%20Aniridia-Associated%20Keratopathy%20Phenotype&amp;author=N%20Lagali&amp;author=B%20Wowra&amp;author=FN%20Fries&amp;author=L%20Latta&amp;author=K%20Moslemani&amp;volume=127&amp;issue=2&amp;publication_year=2020&amp;pages=273-5&amp;pmid=31708273&amp;doi=10.1016/j.ophtha.2019.09.034&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="pone.0330492.ref008">
<span class="label">8.</span><cite>van Velthoven AJH, Utheim TP, Notara M, Bremond-Gignac D, Figueiredo FC, Skottman H, et al. Future directions in managing aniridia-associated keratopathy. Surv Ophthalmol. 2023;68(5):940–56. doi: 10.1016/j.survophthal.2023.04.003

</cite> [<a href="https://doi.org/10.1016/j.survophthal.2023.04.003" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/37146692/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Surv%20Ophthalmol&amp;title=Future%20directions%20in%20managing%20aniridia-associated%20keratopathy&amp;author=AJH%20van%20Velthoven&amp;author=TP%20Utheim&amp;author=M%20Notara&amp;author=D%20Bremond-Gignac&amp;author=FC%20Figueiredo&amp;volume=68&amp;issue=5&amp;publication_year=2023&amp;pages=940-56&amp;pmid=37146692&amp;doi=10.1016/j.survophthal.2023.04.003&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="pone.0330492.ref009">
<span class="label">9.</span><cite>Bajwa A, Burstein E, Grainger RM, Netland PA. Anterior chamber angle in aniridia with and without glaucoma. Clin Ophthalmol. 2019;13:1469–73. doi: 10.2147/OPTH.S217930

</cite> [<a href="https://doi.org/10.2147/OPTH.S217930" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC6689658/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/31496636/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Clin%20Ophthalmol&amp;title=Anterior%20chamber%20angle%20in%20aniridia%20with%20and%20without%20glaucoma&amp;author=A%20Bajwa&amp;author=E%20Burstein&amp;author=RM%20Grainger&amp;author=PA%20Netland&amp;volume=13&amp;publication_year=2019&amp;pages=1469-73&amp;pmid=31496636&amp;doi=10.2147/OPTH.S217930&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="pone.0330492.ref010">
<span class="label">10.</span><cite>Soyugelen Demirok G, Ekşioğlu Ü, Yakın M, Kaderli A, Kaderli ST, Örnek F. Short- and Long-term Results of Glaucoma Valve Implantation for Aniridia-related Glaucoma: A Case Series and Literature Review. Turk J Ophthalmol. 2019;49(4):183–7. doi: 10.4274/tjo.galenos.2019.07348

</cite> [<a href="https://doi.org/10.4274/tjo.galenos.2019.07348" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC6761385/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/31486604/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Turk%20J%20Ophthalmol&amp;title=Short-%20and%20Long-term%20Results%20of%20Glaucoma%20Valve%20Implantation%20for%20Aniridia-related%20Glaucoma:%20A%20Case%20Series%20and%20Literature%20Review&amp;author=G%20Soyugelen%20Demirok&amp;author=%C3%9C%20Ek%C5%9Fio%C4%9Flu&amp;author=M%20Yak%C4%B1n&amp;author=A%20Kaderli&amp;author=ST%20Kaderli&amp;volume=49&amp;issue=4&amp;publication_year=2019&amp;pages=183-7&amp;pmid=31486604&amp;doi=10.4274/tjo.galenos.2019.07348&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="pone.0330492.ref011">
<span class="label">11.</span><cite>Calvão-Pires P, Santos-Silva R, Falcão-Reis F, Rocha-Sousa A. Congenital Aniridia: Clinic, Genetics, Therapeutics, and Prognosis. Int Sch Res Notices. 2014;2014:305350. doi: 10.1155/2014/305350

</cite> [<a href="https://doi.org/10.1155/2014/305350" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC4897488/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/27355034/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Int%20Sch%20Res%20Notices&amp;title=Congenital%20Aniridia:%20Clinic,%20Genetics,%20Therapeutics,%20and%20Prognosis&amp;author=P%20Calv%C3%A3o-Pires&amp;author=R%20Santos-Silva&amp;author=F%20Falc%C3%A3o-Reis&amp;author=A%20Rocha-Sousa&amp;volume=2014&amp;publication_year=2014&amp;pages=305350&amp;pmid=27355034&amp;doi=10.1155/2014/305350&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="pone.0330492.ref012">
<span class="label">12.</span><cite>Fries FN, Náray A, Munteanu C, Stachon T, Lagali N, Seitz B, et al. The Effect of Glaucoma Treatment on Aniridia-Associated Keratopathy (AAK) - A Report from the Homburg Register for Congenital Aniridia. Klin Monbl Augenheilkd. 2025;242(5):578–83. doi: 10.1055/a-2194-1580

</cite> [<a href="https://doi.org/10.1055/a-2194-1580" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC12094848/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/37852284/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Klin%20Monbl%20Augenheilkd&amp;title=The%20Effect%20of%20Glaucoma%20Treatment%20on%20Aniridia-Associated%20Keratopathy%20(AAK)%20-%20A%20Report%20from%20the%20Homburg%20Register%20for%20Congenital%20Aniridia&amp;author=FN%20Fries&amp;author=A%20N%C3%A1ray&amp;author=C%20Munteanu&amp;author=T%20Stachon&amp;author=N%20Lagali&amp;volume=242&amp;issue=5&amp;publication_year=2025&amp;pages=578-83&amp;pmid=37852284&amp;doi=10.1055/a-2194-1580&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="pone.0330492.ref013">
<span class="label">13.</span><cite>Whitson JT. Travoprost--a new prostaglandin analogue for the treatment of glaucoma. Expert Opin Pharmacother. 2002;3(7):965–77. doi: 10.1517/14656566.3.7.965

</cite> [<a href="https://doi.org/10.1517/14656566.3.7.965" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/12083996/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Expert%20Opin%20Pharmacother&amp;title=Travoprost--a%20new%20prostaglandin%20analogue%20for%20the%20treatment%20of%20glaucoma&amp;author=JT%20Whitson&amp;volume=3&amp;issue=7&amp;publication_year=2002&amp;pages=965-77&amp;pmid=12083996&amp;doi=10.1517/14656566.3.7.965&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="pone.0330492.ref014">
<span class="label">14.</span><cite>Arranz-Marquez E, Teus MA. Prostanoids for the management of glaucoma. Expert Opin Drug Saf. 2008;7(6):801–8. doi: 10.1517/14740330802465474

</cite> [<a href="https://doi.org/10.1517/14740330802465474" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/18983226/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Expert%20Opin%20Drug%20Saf&amp;title=Prostanoids%20for%20the%20management%20of%20glaucoma&amp;author=E%20Arranz-Marquez&amp;author=MA%20Teus&amp;volume=7&amp;issue=6&amp;publication_year=2008&amp;pages=801-8&amp;pmid=18983226&amp;doi=10.1517/14740330802465474&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="pone.0330492.ref015">
<span class="label">15.</span><cite>Subbulakshmi S, Kavitha S, Venkatesh R. Prostaglandin analogs in ophthalmology. Indian J Ophthalmol. 2023;71(5):1768–76. doi: 10.4103/IJO.IJO_2706_22

</cite> [<a href="https://doi.org/10.4103/IJO.IJO_2706_22" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC10391402/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/37203029/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Indian%20J%20Ophthalmol&amp;title=Prostaglandin%20analogs%20in%20ophthalmology&amp;author=S%20Subbulakshmi&amp;author=S%20Kavitha&amp;author=R%20Venkatesh&amp;volume=71&amp;issue=5&amp;publication_year=2023&amp;pages=1768-76&amp;pmid=37203029&amp;doi=10.4103/IJO.IJO_2706_22&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="pone.0330492.ref016">
<span class="label">16.</span><cite>Takada Y, Yamanaka O, Okada Y, Sumioka T, Reinach PS, Saika S. Effects of a prostaglandin F2alpha derivative glaucoma drug on EGF expression and E-cadherin expression in a corneal epithelial cell line. Cutan Ocul Toxicol. 2020;39(2):75–82. doi: 10.1080/15569527.2020.1722152

</cite> [<a href="https://doi.org/10.1080/15569527.2020.1722152" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/31986917/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Cutan%20Ocul%20Toxicol&amp;title=Effects%20of%20a%20prostaglandin%20F2alpha%20derivative%20glaucoma%20drug%20on%20EGF%20expression%20and%20E-cadherin%20expression%20in%20a%20corneal%20epithelial%20cell%20line&amp;author=Y%20Takada&amp;author=O%20Yamanaka&amp;author=Y%20Okada&amp;author=T%20Sumioka&amp;author=PS%20Reinach&amp;volume=39&amp;issue=2&amp;publication_year=2020&amp;pages=75-82&amp;pmid=31986917&amp;doi=10.1080/15569527.2020.1722152&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="pone.0330492.ref017">
<span class="label">17.</span><cite>Tong L, Matsuura E, Takahashi M, Nagano T, Kawazu K. Effects of Anti-Glaucoma Prostaglandin Ophthalmic Solutions on Cultured Human Corneal Epithelial Cells. Curr Eye Res. 2019;44(8):856–62. doi: 10.1080/02713683.2019.1597127

</cite> [<a href="https://doi.org/10.1080/02713683.2019.1597127" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/30884982/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Curr%20Eye%20Res&amp;title=Effects%20of%20Anti-Glaucoma%20Prostaglandin%20Ophthalmic%20Solutions%20on%20Cultured%20Human%20Corneal%20Epithelial%20Cells&amp;author=L%20Tong&amp;author=E%20Matsuura&amp;author=M%20Takahashi&amp;author=T%20Nagano&amp;author=K%20Kawazu&amp;volume=44&amp;issue=8&amp;publication_year=2019&amp;pages=856-62&amp;pmid=30884982&amp;doi=10.1080/02713683.2019.1597127&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="pone.0330492.ref018">
<span class="label">18.</span><cite>Nakagawa S, Usui T, Yokoo S, Omichi S, Kimakura M, Mori Y, et al. Toxicity evaluation of antiglaucoma drugs using stratified human cultivated corneal epithelial sheets. Invest Ophthalmol Vis Sci. 2012;53(9):5154–60. doi: 10.1167/iovs.12-9685

</cite> [<a href="https://doi.org/10.1167/iovs.12-9685" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/22695966/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Invest%20Ophthalmol%20Vis%20Sci&amp;title=Toxicity%20evaluation%20of%20antiglaucoma%20drugs%20using%20stratified%20human%20cultivated%20corneal%20epithelial%20sheets&amp;author=S%20Nakagawa&amp;author=T%20Usui&amp;author=S%20Yokoo&amp;author=S%20Omichi&amp;author=M%20Kimakura&amp;volume=53&amp;issue=9&amp;publication_year=2012&amp;pages=5154-60&amp;pmid=22695966&amp;doi=10.1167/iovs.12-9685&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="pone.0330492.ref019">
<span class="label">19.</span><cite>Paimela T, Ryhänen T, Kauppinen A, Marttila L, Salminen A, Kaarniranta K. The preservative polyquaternium-1 increases cytoxicity and NF-kappaB linked inflammation in human corneal epithelial cells. Mol Vis. 2012;18:1189–96. 
</cite> [<a href="/articles/PMC3351434/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/22605930/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Mol%20Vis&amp;title=The%20preservative%20polyquaternium-1%20increases%20cytoxicity%20and%20NF-kappaB%20linked%20inflammation%20in%20human%20corneal%20epithelial%20cells&amp;author=T%20Paimela&amp;author=T%20Ryh%C3%A4nen&amp;author=A%20Kauppinen&amp;author=L%20Marttila&amp;author=A%20Salminen&amp;volume=18&amp;publication_year=2012&amp;pages=1189-96&amp;pmid=22605930&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="pone.0330492.ref020">
<span class="label">20.</span><cite>Pellinen P, Huhtala A, Tolonen A, Lokkila J, Mäenpää J, Uusitalo H. The cytotoxic effects of preserved and preservative-free prostaglandin analogs on human corneal and conjunctival epithelium in vitro and the distribution of benzalkonium chloride homologs in ocular surface tissues in vivo. Curr Eye Res. 2012;37(2):145–54. doi: 10.3109/02713683.2011.626909

</cite> [<a href="https://doi.org/10.3109/02713683.2011.626909" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/22049909/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Curr%20Eye%20Res&amp;title=The%20cytotoxic%20effects%20of%20preserved%20and%20preservative-free%20prostaglandin%20analogs%20on%20human%20corneal%20and%20conjunctival%20epithelium%20in%20vitro%20and%20the%20distribution%20of%20benzalkonium%20chloride%20homologs%20in%20ocular%20surface%20tissues%20in%20vivo&amp;author=P%20Pellinen&amp;author=A%20Huhtala&amp;author=A%20Tolonen&amp;author=J%20Lokkila&amp;author=J%20M%C3%A4enp%C3%A4%C3%A4&amp;volume=37&amp;issue=2&amp;publication_year=2012&amp;pages=145-54&amp;pmid=22049909&amp;doi=10.3109/02713683.2011.626909&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="pone.0330492.ref021">
<span class="label">21.</span><cite>Smits JGA, Cunha DL, Amini M, Bertolin M, Laberthonnière C, Qu J, et al. Identification of the regulatory circuit governing corneal epithelial fate determination and disease. PLoS Biol. 2023;21(10):e3002336. doi: 10.1371/journal.pbio.3002336

</cite> [<a href="https://doi.org/10.1371/journal.pbio.3002336" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC10586658/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/37856539/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=PLoS%20Biol&amp;title=Identification%20of%20the%20regulatory%20circuit%20governing%20corneal%20epithelial%20fate%20determination%20and%20disease&amp;author=JGA%20Smits&amp;author=DL%20Cunha&amp;author=M%20Amini&amp;author=M%20Bertolin&amp;author=C%20Laberthonni%C3%A8re&amp;volume=21&amp;issue=10&amp;publication_year=2023&amp;pmid=37856539&amp;doi=10.1371/journal.pbio.3002336&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="pone.0330492.ref022">
<span class="label">22.</span><cite>Zhang S, Li P, Li J, Gao J, Qi Q, Dong G, et al. Chromatin accessibility uncovers KRAS-driven FOSL2 promoting pancreatic ductal adenocarcinoma progression through up-regulation of CCL28. Br J Cancer. 2023;129(3):426–43. doi: 10.1038/s41416-023-02313-y

</cite> [<a href="https://doi.org/10.1038/s41416-023-02313-y" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC10403592/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/37380804/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Br%20J%20Cancer&amp;title=Chromatin%20accessibility%20uncovers%20KRAS-driven%20FOSL2%20promoting%20pancreatic%20ductal%20adenocarcinoma%20progression%20through%20up-regulation%20of%20CCL28&amp;author=S%20Zhang&amp;author=P%20Li&amp;author=J%20Li&amp;author=J%20Gao&amp;author=Q%20Qi&amp;volume=129&amp;issue=3&amp;publication_year=2023&amp;pages=426-43&amp;pmid=37380804&amp;doi=10.1038/s41416-023-02313-y&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="pone.0330492.ref023">
<span class="label">23.</span><cite>Fang JY, Richardson BC. The MAPK signalling pathways and colorectal cancer. Lancet Oncol. 2005;6(5):322–7. doi: 10.1016/S1470-2045(05)70168-6

</cite> [<a href="https://doi.org/10.1016/S1470-2045(05)70168-6" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/15863380/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Lancet%20Oncol&amp;title=The%20MAPK%20signalling%20pathways%20and%20colorectal%20cancer&amp;author=JY%20Fang&amp;author=BC%20Richardson&amp;volume=6&amp;issue=5&amp;publication_year=2005&amp;pages=322-7&amp;pmid=15863380&amp;doi=10.1016/S1470-2045(05)70168-6&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="pone.0330492.ref024">
<span class="label">24.</span><cite>Sun Y, Zhang D, Guo X, Li W, Li C, Luo J, et al. MKK3 modulates JNK-dependent cell migration and invasion. Cell Death Dis. 2019;10(3):149. doi: 10.1038/s41419-019-1350-6

</cite> [<a href="https://doi.org/10.1038/s41419-019-1350-6" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC6377636/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/30770795/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Cell%20Death%20Dis&amp;title=MKK3%20modulates%20JNK-dependent%20cell%20migration%20and%20invasion&amp;author=Y%20Sun&amp;author=D%20Zhang&amp;author=X%20Guo&amp;author=W%20Li&amp;author=C%20Li&amp;volume=10&amp;issue=3&amp;publication_year=2019&amp;pages=149&amp;pmid=30770795&amp;doi=10.1038/s41419-019-1350-6&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="pone.0330492.ref025">
<span class="label">25.</span><cite>Pinal N, Calleja M, Morata G. Pro-apoptotic and pro-proliferation functions of the JNK pathway of Drosophila: roles in cell competition, tumorigenesis and regeneration. Open Biol. 2019;9(3):180256. doi: 10.1098/rsob.180256

</cite> [<a href="https://doi.org/10.1098/rsob.180256" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC6451367/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/30836847/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Open%20Biol&amp;title=Pro-apoptotic%20and%20pro-proliferation%20functions%20of%20the%20JNK%20pathway%20of%20Drosophila:%20roles%20in%20cell%20competition,%20tumorigenesis%20and%20regeneration&amp;author=N%20Pinal&amp;author=M%20Calleja&amp;author=G%20Morata&amp;volume=9&amp;issue=3&amp;publication_year=2019&amp;pages=180256&amp;pmid=30836847&amp;doi=10.1098/rsob.180256&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="pone.0330492.ref026">
<span class="label">26.</span><cite>Liu F, Feng XX, Zhu SL, Huang HY, Chen YD, Pan YF, et al. Sonic Hedgehog Signaling Pathway Mediates Proliferation and Migration of Fibroblast-Like Synoviocytes in Rheumatoid Arthritis via MAPK/ERK Signaling Pathway. Front Immunol. 2018;9:2847. doi: 10.3389/fimmu.2018.02847

</cite> [<a href="https://doi.org/10.3389/fimmu.2018.02847" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC6290332/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/30568656/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Front%20Immunol&amp;title=Sonic%20Hedgehog%20Signaling%20Pathway%20Mediates%20Proliferation%20and%20Migration%20of%20Fibroblast-Like%20Synoviocytes%20in%20Rheumatoid%20Arthritis%20via%20MAPK/ERK%20Signaling%20Pathway&amp;author=F%20Liu&amp;author=XX%20Feng&amp;author=SL%20Zhu&amp;author=HY%20Huang&amp;author=YD%20Chen&amp;volume=9&amp;publication_year=2018&amp;pages=2847&amp;pmid=30568656&amp;doi=10.3389/fimmu.2018.02847&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="pone.0330492.ref027">
<span class="label">27.</span><cite>Weber C, Buerger A, Priglinger S, Mercieca K, Liegl R. Influence of a Prostaglandin F2α Analogue on Corneal Hysteresis and Expression of Extracellular Matrix Metalloproteinases 3 and 9. Transl Vis Sci Technol. 2023;12(5):28. doi: 10.1167/tvst.12.5.28

</cite> [<a href="https://doi.org/10.1167/tvst.12.5.28" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC10226607/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/37233995/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Transl%20Vis%20Sci%20Technol&amp;title=Influence%20of%20a%20Prostaglandin%20F2%CE%B1%20Analogue%20on%20Corneal%20Hysteresis%20and%20Expression%20of%20Extracellular%20Matrix%20Metalloproteinases%203%20and%209&amp;author=C%20Weber&amp;author=A%20Buerger&amp;author=S%20Priglinger&amp;author=K%20Mercieca&amp;author=R%20Liegl&amp;volume=12&amp;issue=5&amp;publication_year=2023&amp;pages=28&amp;pmid=37233995&amp;doi=10.1167/tvst.12.5.28&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="pone.0330492.ref028">
<span class="label">28.</span><cite>Younis NS, Mohamed ME. Anethole Pretreatment Modulates Cerebral Ischemia/Reperfusion: The Role of JNK, p38, MMP-2 and MMP-9 Pathways. Pharmaceuticals (Basel). 2023;16(3):442. doi: 10.3390/ph16030442

</cite> [<a href="https://doi.org/10.3390/ph16030442" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC10057436/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/36986541/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Pharmaceuticals%20(Basel)&amp;title=Anethole%20Pretreatment%20Modulates%20Cerebral%20Ischemia/Reperfusion:%20The%20Role%20of%20JNK,%20p38,%20MMP-2%20and%20MMP-9%20Pathways&amp;author=NS%20Younis&amp;author=ME%20Mohamed&amp;volume=16&amp;issue=3&amp;publication_year=2023&amp;pages=442&amp;pmid=36986541&amp;doi=10.3390/ph16030442&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="pone.0330492.ref029">
<span class="label">29.</span><cite>Li S, Stachon T, Liu S, Li Z, Hsu S-L, Kundu S, et al. Increased sensitivity of primary aniridia limbal stromal cells to travoprost, leading to elevated migration and MMP-9 protein levels, in vitro. PLoS One. 2025;20(6):e0326967. doi: 10.1371/journal.pone.0326967

</cite> [<a href="https://doi.org/10.1371/journal.pone.0326967" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC12200743/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/40570009/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=PLoS%20One&amp;title=Increased%20sensitivity%20of%20primary%20aniridia%20limbal%20stromal%20cells%20to%20travoprost,%20leading%20to%20elevated%20migration%20and%20MMP-9%20protein%20levels,%20in%20vitro&amp;author=S%20Li&amp;author=T%20Stachon&amp;author=S%20Liu&amp;author=Z%20Li&amp;author=S-L%20Hsu&amp;volume=20&amp;issue=6&amp;publication_year=2025&amp;pmid=40570009&amp;doi=10.1371/journal.pone.0326967&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="pone.0330492.ref030">
<span class="label">30.</span><cite>Latta L, Nordström K, Stachon T, Langenbucher A, Fries FN, Szentmáry N, et al. Expression of retinoic acid signaling components ADH7 and ALDH1A1 is reduced in aniridia limbal epithelial cells and a siRNA primary cell based aniridia model. Exp Eye Res. 2019;179:8–17. doi: 10.1016/j.exer.2018.10.002

</cite> [<a href="https://doi.org/10.1016/j.exer.2018.10.002" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/30292490/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Exp%20Eye%20Res&amp;title=Expression%20of%20retinoic%20acid%20signaling%20components%20ADH7%20and%20ALDH1A1%20is%20reduced%20in%20aniridia%20limbal%20epithelial%20cells%20and%20a%20siRNA%20primary%20cell%20based%20aniridia%20model&amp;author=L%20Latta&amp;author=K%20Nordstr%C3%B6m&amp;author=T%20Stachon&amp;author=A%20Langenbucher&amp;author=FN%20Fries&amp;volume=179&amp;publication_year=2019&amp;pages=8-17&amp;pmid=30292490&amp;doi=10.1016/j.exer.2018.10.002&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="pone.0330492.ref031">
<span class="label">31.</span><cite>Latta L, Knebel I, Bleil C, Stachon T, Katiyar P, Zussy C, et al. Similarities in DSG1 and KRT3 Downregulation through Retinoic Acid Treatment and PAX6 Knockdown Related Expression Profiles: Does PAX6 Affect RA Signaling in Limbal Epithelial Cells?. Biomolecules. 2021;11(11):1651. doi: 10.3390/biom11111651

</cite> [<a href="https://doi.org/10.3390/biom11111651" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC8615883/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/34827649/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Biomolecules&amp;title=Similarities%20in%20DSG1%20and%20KRT3%20Downregulation%20through%20Retinoic%20Acid%20Treatment%20and%20PAX6%20Knockdown%20Related%20Expression%20Profiles:%20Does%20PAX6%20Affect%20RA%20Signaling%20in%20Limbal%20Epithelial%20Cells?&amp;author=L%20Latta&amp;author=I%20Knebel&amp;author=C%20Bleil&amp;author=T%20Stachon&amp;author=P%20Katiyar&amp;volume=11&amp;issue=11&amp;publication_year=2021&amp;pages=1651&amp;pmid=34827649&amp;doi=10.3390/biom11111651&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="pone.0330492.ref032">
<span class="label">32.</span><cite>Sun X, Kaufman PD. Ki-67: more than a proliferation marker. Chromosoma. 2018;127(2):175–86. doi: 10.1007/s00412-018-0659-8

</cite> [<a href="https://doi.org/10.1007/s00412-018-0659-8" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC5945335/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/29322240/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Chromosoma&amp;title=Ki-67:%20more%20than%20a%20proliferation%20marker&amp;author=X%20Sun&amp;author=PD%20Kaufman&amp;volume=127&amp;issue=2&amp;publication_year=2018&amp;pages=175-86&amp;pmid=29322240&amp;doi=10.1007/s00412-018-0659-8&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="pone.0330492.ref033">
<span class="label">33.</span><cite>Asadi M, Taghizadeh S, Kaviani E, Vakili O, Taheri-Anganeh M, Tahamtan M, et al. Caspase-3: Structure, function, and biotechnological aspects. Biotechnol Appl Biochem. 2022;69(4):1633–45. doi: 10.1002/bab.2233

</cite> [<a href="https://doi.org/10.1002/bab.2233" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/34342377/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Biotechnol%20Appl%20Biochem&amp;title=Caspase-3:%20Structure,%20function,%20and%20biotechnological%20aspects&amp;author=M%20Asadi&amp;author=S%20Taghizadeh&amp;author=E%20Kaviani&amp;author=O%20Vakili&amp;author=M%20Taheri-Anganeh&amp;volume=69&amp;issue=4&amp;publication_year=2022&amp;pages=1633-45&amp;pmid=34342377&amp;doi=10.1002/bab.2233&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="pone.0330492.ref034">
<span class="label">34.</span><cite>Craig VJ, Zhang L, Hagood JS, Owen CA. Matrix metalloproteinases as therapeutic targets for idiopathic pulmonary fibrosis. Am J Respir Cell Mol Biol. 2015;53(5):585–600. doi: 10.1165/rcmb.2015-0020TR

</cite> [<a href="https://doi.org/10.1165/rcmb.2015-0020TR" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC4742954/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/26121236/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Am%20J%20Respir%20Cell%20Mol%20Biol&amp;title=Matrix%20metalloproteinases%20as%20therapeutic%20targets%20for%20idiopathic%20pulmonary%20fibrosis&amp;author=VJ%20Craig&amp;author=L%20Zhang&amp;author=JS%20Hagood&amp;author=CA%20Owen&amp;volume=53&amp;issue=5&amp;publication_year=2015&amp;pages=585-600&amp;pmid=26121236&amp;doi=10.1165/rcmb.2015-0020TR&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="pone.0330492.ref035">
<span class="label">35.</span><cite>Álvarez de Toledo Elizalde J, López García S, Benítez Del Castillo JM, Durán de la Colina J, Gris Castejón O, Celis Sánchez J, et al. Aniridia and the ocular surface: Medical and surgical problems and solutions. Arch Soc Esp Oftalmol (Engl Ed). 2021;96 Suppl 1:15–37. doi: 10.1016/j.oftale.2021.04.003

</cite> [<a href="https://doi.org/10.1016/j.oftale.2021.04.003" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/34836585/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Arch%20Soc%20Esp%20Oftalmol%20(Engl%20Ed)&amp;title=Aniridia%20and%20the%20ocular%20surface:%20Medical%20and%20surgical%20problems%20and%20solutions&amp;author=J%20%C3%81lvarez%20de%20Toledo%20Elizalde&amp;author=S%20L%C3%B3pez%20Garc%C3%ADa&amp;author=JM%20Ben%C3%ADtez%20Del%20Castillo&amp;author=J%20Dur%C3%A1n%20de%20la%20Colina&amp;author=O%20Gris%20Castej%C3%B3n&amp;publication_year=2021&amp;pages=15-37&amp;pmid=34836585&amp;doi=10.1016/j.oftale.2021.04.003&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="pone.0330492.ref036">
<span class="label">36.</span><cite>Ihnatko R, Eden U, Fagerholm P, Lagali N. Congenital Aniridia and the Ocular Surface. Ocul Surf. 2016;14(2):196–206. doi: 10.1016/j.jtos.2015.10.003

</cite> [<a href="https://doi.org/10.1016/j.jtos.2015.10.003" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/26738798/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Ocul%20Surf&amp;title=Congenital%20Aniridia%20and%20the%20Ocular%20Surface&amp;author=R%20Ihnatko&amp;author=U%20Eden&amp;author=P%20Fagerholm&amp;author=N%20Lagali&amp;volume=14&amp;issue=2&amp;publication_year=2016&amp;pages=196-206&amp;pmid=26738798&amp;doi=10.1016/j.jtos.2015.10.003&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="pone.0330492.ref037">
<span class="label">37.</span><cite>Yang H, Xie Y, Yang D, Ren D. Oxidative stress-induced apoptosis in granulosa cells involves JNK, p53 and Puma. Oncotarget. 2017;8(15):25310–22. doi: 10.18632/oncotarget.15813

</cite> [<a href="https://doi.org/10.18632/oncotarget.15813" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC5421932/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/28445976/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Oncotarget&amp;title=Oxidative%20stress-induced%20apoptosis%20in%20granulosa%20cells%20involves%20JNK,%20p53%20and%20Puma&amp;author=H%20Yang&amp;author=Y%20Xie&amp;author=D%20Yang&amp;author=D%20Ren&amp;volume=8&amp;issue=15&amp;publication_year=2017&amp;pages=25310-22&amp;pmid=28445976&amp;doi=10.18632/oncotarget.15813&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="pone.0330492.ref038">
<span class="label">38.</span><cite>Liang H, Baudouin C, Daull P, Garrigue J-S, Brignole-Baudouin F. In Vitro Corneal and Conjunctival Wound-Healing Assays as a Tool for Antiglaucoma Prostaglandin Formulation Characterization. Front Biosci (Landmark Ed). 2022;27(5):147. doi: 10.31083/j.fbl2705147

</cite> [<a href="https://doi.org/10.31083/j.fbl2705147" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/35638414/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Front%20Biosci%20(Landmark%20Ed)&amp;title=In%20Vitro%20Corneal%20and%20Conjunctival%20Wound-Healing%20Assays%20as%20a%20Tool%20for%20Antiglaucoma%20Prostaglandin%20Formulation%20Characterization&amp;author=H%20Liang&amp;author=C%20Baudouin&amp;author=P%20Daull&amp;author=J-S%20Garrigue&amp;author=F%20Brignole-Baudouin&amp;volume=27&amp;issue=5&amp;publication_year=2022&amp;pages=147&amp;pmid=35638414&amp;doi=10.31083/j.fbl2705147&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="pone.0330492.ref039">
<span class="label">39.</span><cite>Li S, Liu Z, Fang X-D, Wang X-Y, Fei B-Y. MicroRNA (miR)-597-5p Inhibits Colon Cancer Cell Migration and Invasion by Targeting FOS-Like Antigen 2 (FOSL2). Front Oncol. 2019;9:495. doi: 10.3389/fonc.2019.00495

</cite> [<a href="https://doi.org/10.3389/fonc.2019.00495" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC6581747/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/31245295/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Front%20Oncol&amp;title=MicroRNA%20(miR)-597-5p%20Inhibits%20Colon%20Cancer%20Cell%20Migration%20and%20Invasion%20by%20Targeting%20FOS-Like%20Antigen%202%20(FOSL2)&amp;author=S%20Li&amp;author=Z%20Liu&amp;author=X-D%20Fang&amp;author=X-Y%20Wang&amp;author=B-Y%20Fei&amp;volume=9&amp;publication_year=2019&amp;pages=495&amp;pmid=31245295&amp;doi=10.3389/fonc.2019.00495&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="pone.0330492.ref040">
<span class="label">40.</span><cite>Sun X, Dai G, Yu L, Hu Q, Chen J, Guo W. miR-143-3p inhibits the proliferation, migration and invasion in osteosarcoma by targeting FOSL2. Sci Rep. 2018;8(1):606. doi: 10.1038/s41598-017-18739-3

</cite> [<a href="https://doi.org/10.1038/s41598-017-18739-3" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC5766605/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/29330462/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Sci%20Rep&amp;title=miR-143-3p%20inhibits%20the%20proliferation,%20migration%20and%20invasion%20in%20osteosarcoma%20by%20targeting%20FOSL2&amp;author=X%20Sun&amp;author=G%20Dai&amp;author=L%20Yu&amp;author=Q%20Hu&amp;author=J%20Chen&amp;volume=8&amp;issue=1&amp;publication_year=2018&amp;pages=606&amp;pmid=29330462&amp;doi=10.1038/s41598-017-18739-3&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="pone.0330492.ref041">
<span class="label">41.</span><cite>He J, Mai J, Li Y, Chen L, Xu H, Zhu X, et al. miR-597 inhibits breast cancer cell proliferation, migration and invasion through FOSL2. Oncol Rep. 2017;37(5):2672–8. doi: 10.3892/or.2017.5558

</cite> [<a href="https://doi.org/10.3892/or.2017.5558" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC5428280/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/28393251/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Oncol%20Rep&amp;title=miR-597%20inhibits%20breast%20cancer%20cell%20proliferation,%20migration%20and%20invasion%20through%20FOSL2&amp;author=J%20He&amp;author=J%20Mai&amp;author=Y%20Li&amp;author=L%20Chen&amp;author=H%20Xu&amp;volume=37&amp;issue=5&amp;publication_year=2017&amp;pages=2672-8&amp;pmid=28393251&amp;doi=10.3892/or.2017.5558&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="pone.0330492.ref042">
<span class="label">42.</span><cite>Guo J, Qiu X, Zhang L, Wei R. Smurf1 regulates macrophage proliferation, apoptosis and migration via JNK and p38 MAPK signaling pathways. Mol Immunol. 2018;97:20–6. doi: 10.1016/j.molimm.2018.03.005

</cite> [<a href="https://doi.org/10.1016/j.molimm.2018.03.005" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/29550577/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Mol%20Immunol&amp;title=Smurf1%20regulates%20macrophage%20proliferation,%20apoptosis%20and%20migration%20via%20JNK%20and%20p38%20MAPK%20signaling%20pathways&amp;author=J%20Guo&amp;author=X%20Qiu&amp;author=L%20Zhang&amp;author=R%20Wei&amp;volume=97&amp;publication_year=2018&amp;pages=20-6&amp;pmid=29550577&amp;doi=10.1016/j.molimm.2018.03.005&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="pone.0330492.ref043">
<span class="label">43.</span><cite>Martínez-Martínez D, Toledo Lobo M-V, Baquero P, Ropero S, Angulo JC, Chiloeches A, et al. Downregulation of Snail by DUSP1 Impairs Cell Migration and Invasion through the Inactivation of JNK and ERK and Is Useful as a Predictive Factor in the Prognosis of Prostate Cancer. Cancers (Basel). 2021;13(5):1158. doi: 10.3390/cancers13051158

</cite> [<a href="https://doi.org/10.3390/cancers13051158" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC7962644/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/33800291/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Cancers%20(Basel)&amp;title=Downregulation%20of%20Snail%20by%20DUSP1%20Impairs%20Cell%20Migration%20and%20Invasion%20through%20the%20Inactivation%20of%20JNK%20and%20ERK%20and%20Is%20Useful%20as%20a%20Predictive%20Factor%20in%20the%20Prognosis%20of%20Prostate%20Cancer&amp;author=D%20Mart%C3%ADnez-Mart%C3%ADnez&amp;author=M-V%20Toledo%20Lobo&amp;author=P%20Baquero&amp;author=S%20Ropero&amp;author=JC%20Angulo&amp;volume=13&amp;issue=5&amp;publication_year=2021&amp;pages=1158&amp;pmid=33800291&amp;doi=10.3390/cancers13051158&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="pone.0330492.ref044">
<span class="label">44.</span><cite>Chen X, Chen Y, Wiggs JL, Pasquale LR, Sun X, Fan BJ. Association of Matrix Metalloproteinase-9 (MMP9) Variants with Primary Angle Closure and Primary Angle Closure Glaucoma. PLoS One. 2016;11(6):e0157093. doi: 10.1371/journal.pone.0157093

</cite> [<a href="https://doi.org/10.1371/journal.pone.0157093" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC4896618/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/27272641/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=PLoS%20One&amp;title=Association%20of%20Matrix%20Metalloproteinase-9%20(MMP9)%20Variants%20with%20Primary%20Angle%20Closure%20and%20Primary%20Angle%20Closure%20Glaucoma&amp;author=X%20Chen&amp;author=Y%20Chen&amp;author=JL%20Wiggs&amp;author=LR%20Pasquale&amp;author=X%20Sun&amp;volume=11&amp;issue=6&amp;publication_year=2016&amp;pmid=27272641&amp;doi=10.1371/journal.pone.0157093&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="pone.0330492.ref045">
<span class="label">45.</span><cite>Xiao B, Chen D, Luo S, Hao W, Jing F, Liu T, et al. Extracellular translationally controlled tumor protein promotes colorectal cancer invasion and metastasis through Cdc42/JNK/ MMP9 signaling. Oncotarget. 2016;7(31):50057–73. doi: 10.18632/oncotarget.10315

</cite> [<a href="https://doi.org/10.18632/oncotarget.10315" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC5226568/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/27367023/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Oncotarget&amp;title=Extracellular%20translationally%20controlled%20tumor%20protein%20promotes%20colorectal%20cancer%20invasion%20and%20metastasis%20through%20Cdc42/JNK/%20MMP9%20signaling&amp;author=B%20Xiao&amp;author=D%20Chen&amp;author=S%20Luo&amp;author=W%20Hao&amp;author=F%20Jing&amp;volume=7&amp;issue=31&amp;publication_year=2016&amp;pages=50057-73&amp;pmid=27367023&amp;doi=10.18632/oncotarget.10315&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="pone.0330492.ref046">
<span class="label">46.</span><cite>Thanh HD, Lee S, Nguyen TT, Huu TN, Ahn E-J, Cho S-H, et al. Temozolomide promotes matrix metalloproteinase 9 expression through p38 MAPK and JNK pathways in glioblastoma cells. Sci Rep. 2024;14(1):14341. doi: 10.1038/s41598-024-65398-2

</cite> [<a href="https://doi.org/10.1038/s41598-024-65398-2" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC11192740/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/38906916/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Sci%20Rep&amp;title=Temozolomide%20promotes%20matrix%20metalloproteinase%209%20expression%20through%20p38%20MAPK%20and%20JNK%20pathways%20in%20glioblastoma%20cells&amp;author=HD%20Thanh&amp;author=S%20Lee&amp;author=TT%20Nguyen&amp;author=TN%20Huu&amp;author=E-J%20Ahn&amp;volume=14&amp;issue=1&amp;publication_year=2024&amp;pages=14341&amp;pmid=38906916&amp;doi=10.1038/s41598-024-65398-2&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="pone.0330492.ref047">
<span class="label">47.</span><cite>Zhu H, Zhang L, Jia H, Xu L, Cao Y, Zhai M, et al. Tetrahydrocurcumin improves lipopolysaccharide-induced myocardial dysfunction by inhibiting oxidative stress and inflammation via JNK/ERK signaling pathway regulation. Phytomedicine. 2022;104:154283. doi: 10.1016/j.phymed.2022.154283

</cite> [<a href="https://doi.org/10.1016/j.phymed.2022.154283" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/35779282/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Phytomedicine&amp;title=Tetrahydrocurcumin%20improves%20lipopolysaccharide-induced%20myocardial%20dysfunction%20by%20inhibiting%20oxidative%20stress%20and%20inflammation%20via%20JNK/ERK%20signaling%20pathway%20regulation&amp;author=H%20Zhu&amp;author=L%20Zhang&amp;author=H%20Jia&amp;author=L%20Xu&amp;author=Y%20Cao&amp;volume=104&amp;publication_year=2022&amp;pages=154283&amp;pmid=35779282&amp;doi=10.1016/j.phymed.2022.154283&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="pone.0330492.ref048">
<span class="label">48.</span><cite>Kim JH, Kim EJ, Kim Y-H, Kim YI, Lee S-H, Jung J-C, et al. In Vivo Effects of Preservative-free and Preserved Prostaglandin Analogs: Mouse Ocular Surface Study. Korean J Ophthalmol. 2015;29(4):270–9. doi: 10.3341/kjo.2015.29.4.270

</cite> [<a href="https://doi.org/10.3341/kjo.2015.29.4.270" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC4520871/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/26240512/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Korean%20J%20Ophthalmol&amp;title=In%20Vivo%20Effects%20of%20Preservative-free%20and%20Preserved%20Prostaglandin%20Analogs:%20Mouse%20Ocular%20Surface%20Study&amp;author=JH%20Kim&amp;author=EJ%20Kim&amp;author=Y-H%20Kim&amp;author=YI%20Kim&amp;author=S-H%20Lee&amp;volume=29&amp;issue=4&amp;publication_year=2015&amp;pages=270-9&amp;pmid=26240512&amp;doi=10.3341/kjo.2015.29.4.270&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="pone.0330492.ref049">
<span class="label">49.</span><cite>Ammar DA, Noecker RJ, Kahook MY. Effects of benzalkonium chloride- and polyquad-preserved combination glaucoma medications on cultured human ocular surface cells. Adv Ther. 2011;28(6):501–10. doi: 10.1007/s12325-011-0029-x

</cite> [<a href="https://doi.org/10.1007/s12325-011-0029-x" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/21603985/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Adv%20Ther&amp;title=Effects%20of%20benzalkonium%20chloride-%20and%20polyquad-preserved%20combination%20glaucoma%20medications%20on%20cultured%20human%20ocular%20surface%20cells&amp;author=DA%20Ammar&amp;author=RJ%20Noecker&amp;author=MY%20Kahook&amp;volume=28&amp;issue=6&amp;publication_year=2011&amp;pages=501-10&amp;pmid=21603985&amp;doi=10.1007/s12325-011-0029-x&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="pone.0330492.ref050">
<span class="label">50.</span><cite>Liang H, Brignole-Baudouin F, Pauly A, Riancho L, Baudouin C. Polyquad-preserved travoprost/timolol, benzalkonium chloride (BAK)-preserved travoprost/timolol, and latanoprost/timolol in fixed combinations: a rabbit ocular surface study. Adv Ther. 2011;28(4):311–25. doi: 10.1007/s12325-011-0003-7

</cite> [<a href="https://doi.org/10.1007/s12325-011-0003-7" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/21424577/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Adv%20Ther&amp;title=Polyquad-preserved%20travoprost/timolol,%20benzalkonium%20chloride%20(BAK)-preserved%20travoprost/timolol,%20and%20latanoprost/timolol%20in%20fixed%20combinations:%20a%20rabbit%20ocular%20surface%20study&amp;author=H%20Liang&amp;author=F%20Brignole-Baudouin&amp;author=A%20Pauly&amp;author=L%20Riancho&amp;author=C%20Baudouin&amp;volume=28&amp;issue=4&amp;publication_year=2011&amp;pages=311-25&amp;pmid=21424577&amp;doi=10.1007/s12325-011-0003-7&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="pone.0330492.ref051">
<span class="label">51.</span><cite>Eskandari E, Eaves CJ. Paradoxical roles of caspase-3 in regulating cell survival, proliferation, and tumorigenesis. J Cell Biol. 2022;221(6):e202201159. doi: 10.1083/jcb.202201159

</cite> [<a href="https://doi.org/10.1083/jcb.202201159" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC9106709/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/35551578/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=J%20Cell%20Biol&amp;title=Paradoxical%20roles%20of%20caspase-3%20in%20regulating%20cell%20survival,%20proliferation,%20and%20tumorigenesis&amp;author=E%20Eskandari&amp;author=CJ%20Eaves&amp;volume=221&amp;issue=6&amp;publication_year=2022&amp;pmid=35551578&amp;doi=10.1083/jcb.202201159&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
</ul></section></section></section><article class="sub-article" id="pone.0330492.r001"><section class="pmc-layout__citation font-secondary font-xs"><div>PLoS One. doi: <a href="https://doi.org/10.1371/journal.pone.0330492.r001" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">10.1371/journal.pone.0330492.r001</a>
</div></section><section class="front-matter"><div class="ameta p font-secondary font-xs">
<hgroup><h1>Decision Letter 0</h1></hgroup><div class="cg p">
<a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Ljubimov%20AV%22%5BAuthor%5D" class="usa-link" aria-describedby="id12"><span class="name western">Alexander V Ljubimov</span></a><div hidden="hidden" id="id12">
<h3><span class="name western">Alexander V Ljubimov</span></h3>
<div>Academic Editor</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Ljubimov%20AV%22%5BAuthor%5D" class="usa-link"><span class="name western">Alexander V Ljubimov</span></a>
</div>
</div>
</div>
<ul class="d-buttons inline-list">
<li><button class="d-button" aria-controls="aip_a.c" aria-expanded="false">Author information</button></li>
<li><button class="d-button" aria-controls="clp_a.c" aria-expanded="false">Copyright and License information</button></li>
</ul>
<div class="d-panels font-secondary-light">
<div id="aip_a.c" class="d-panel p" style="display: none">
<h4 class="font-secondary">Roles</h4>
<div class="p">
<strong class="contrib"><span class="name western">Alexander V Ljubimov</span></strong>: <span class="role">Academic Editor</span>
</div>
</div>
<div id="clp_a.c" class="d-panel p" style="display: none">
<div>© 2025 Alexander V Ljubimov</div>
<p>This is an open access article distributed under the terms of the <a href="https://creativecommons.org/licenses/by/4.0/" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Creative Commons Attribution License</a> , which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.</p>
<div class="p"><a href="/about/copyright/" class="usa-link">PMC Copyright notice</a></div>
</div>
</div>
<div></div>
</div></section><section class="body sub-article-body"><hr class="headless">
<p>
<em>25 Jun 2025</em>
</p>
<p>--&gt;PONE-D-25-21972--&gt;--&gt;The Effect of Travoprost on Primary Human Limbal Epithelial Cells and the siRNA-based Aniridia Limbal Epithelial Cell Model, In Vitro--&gt;--&gt;PLOS ONE</p>
<p>Dear Dr. Li,</p>
<p>Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process.</p>
<p>The manuscript by Li et al. has been reviewed and significant concerns voiced. Please address all issues and pay particular attention to the following points:</p>
<p>1. Please justify the 20 min timepoint selected for travoprost treatment. This seems to be a very short exposure of the drug and does not accurately mimic clinical settings.</p>
<p>2. The authors should discuss why cell viability is decreased even at lower concentrations.</p>
<p>3. The results section needs to be re-written for clarity. The performed experiments need a rationale.</p>
<p>4. Figure 3 images have low resolution. Please increase the resolution when making the tiff file.</p>
<p>5. Please clarify whether travoprost affects cell proliferation in siPAX6 LEC, not just cell migration.</p>
<p>6. Please revisit the Figure 4, 0.313 ug/mL travoprost treatment: resolve the discrepancy between an increase in PAX6 expression and the bar graph.</p>
<p>7. Please provide rationale for measuring the expression of several genes/proteins like FOSL1, ERK1, ERK2, JNK, and MMP-9 that have been shown without any prior mention.</p>
<p>8. In Figures 5 and 6, please comment on why the expression of several markers are changed at the mRNA level but not at the protein level. This could be because the authors have measured the expression of total proteins (e.g., ERK and NF-kB) but not the phosphorylated (activated) forms.</p>
<p>9. There are several pathways that mediate cell proliferation and migration (e.g., Akt or Wnt). The authors have not explained why ERK was selected over other pathways. Please check some other effectors.</p>
<p>10. The Quantitative PCR should be Quantitative RT-PCR.</p>
<p>Please submit your revised manuscript by Aug 09 2025 11:59PM. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at <span>plosone@plos.org</span> . When you're ready to submit your revision, log on to <a href="https://www.editorialmanager.com/pone/" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">https://www.editorialmanager.com/pone/</a> and select the 'Submissions Needing Revision' folder to locate your manuscript file.</p>
<p>Please include the following items when submitting your revised manuscript:--&gt;</p>
<ul class="list" style="list-style-type:disc">
<li><p>A rebuttal letter that responds to each point raised by the academic editor and reviewer(s). You should upload this letter as a separate file labeled 'Response to Reviewers'.</p></li>
<li><p>A marked-up copy of your manuscript that highlights changes made to the original version. You should upload this as a separate file labeled 'Revised Manuscript with Track Changes'.</p></li>
<li><p>An unmarked version of your revised paper without tracked changes. You should upload this as a separate file labeled 'Manuscript'.</p></li>
</ul>
<p>If you would like to make changes to your financial disclosure, please include your updated statement in your cover letter. Guidelines for resubmitting your figure files are available below the reviewer comments at the end of this letter.</p>
<p>If applicable, we recommend that you deposit your laboratory protocols in protocols.io to enhance the reproducibility of your results. Protocols.io assigns your protocol its own identifier (DOI) so that it can be cited independently in the future. For instructions see: <a href="https://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">https://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols</a> . Additionally, PLOS ONE offers an option for publishing peer-reviewed Lab Protocol articles, which describe protocols hosted on protocols.io. Read more information on sharing protocols at <a href="https://plos.org/protocols?utm_medium=editorial-email&amp;utm_source=authorletters&amp;utm_campaign=protocols" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">https://plos.org/protocols?utm_medium=editorial-email&amp;utm_source=authorletters&amp;utm_campaign=protocols</a> .</p>
<p>We look forward to receiving your revised manuscript.</p>
<p>Kind regards,</p>
<p>Alexander V Ljubimov, Ph.D.</p>
<p>Academic Editor</p>
<p>PLOS ONE</p>
<p>Journal Requirements:</p>
<p>When submitting your revision, we need you to address these additional requirements.</p>
<p>1. Please ensure that your manuscript meets PLOS ONE's style requirements, including those for file naming. The PLOS ONE style templates can be found at</p>
<p><a href="https://journals.plos.org/plosone/s/file?id=wjVg/PLOSOne_formatting_sample_main_body.pdf" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">https://journals.plos.org/plosone/s/file?id=wjVg/PLOSOne_formatting_sample_main_body.pdf</a> and</p>
<p>
<a href="https://journals.plos.org/plosone/s/file?id=ba62/PLOSOne_formatting_sample_title_authors_affiliations.pdf" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">https://journals.plos.org/plosone/s/file?id=ba62/PLOSOne_formatting_sample_title_authors_affiliations.pdf</a>
</p>
<p>2. We note that your Data Availability Statement is currently as follows: [All relevant data are within the manuscript and its Supporting Information files.]</p>
<p>Please confirm at this time whether or not your submission contains all raw data required to replicate the results of your study. Authors must share the “minimal data set” for their submission. PLOS defines the minimal data set to consist of the data required to replicate all study findings reported in the article, as well as related metadata and methods (<a href="https://journals.plos.org/plosone/s/data-availability#loc-minimal-data-set-definition" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">https://journals.plos.org/plosone/s/data-availability#loc-minimal-data-set-definition</a>).</p>
<p>For example, authors should submit the following data:</p>
<p>- The values behind the means, standard deviations and other measures reported;</p>
<p>- The values used to build graphs;</p>
<p>- The points extracted from images for analysis.</p>
<p>Authors do not need to submit their entire data set if only a portion of the data was used in the reported study.</p>
<p>If your submission does not contain these data, please either upload them as Supporting Information files or deposit them to a stable, public repository and provide us with the relevant URLs, DOIs, or accession numbers. For a list of recommended repositories, please see <a href="https://journals.plos.org/plosone/s/recommended-repositories" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">https://journals.plos.org/plosone/s/recommended-repositories</a>.</p>
<p>If there are ethical or legal restrictions on sharing a de-identified data set, please explain them in detail (e.g., data contain potentially sensitive information, data are owned by a third-party organization, etc.) and who has imposed them (e.g., an ethics committee). Please also provide contact information for a data access committee, ethics committee, or other institutional body to which data requests may be sent. If data are owned by a third party, please indicate how others may request data access.</p>
<p>3. PLOS ONE now requires that authors provide the original uncropped and unadjusted images underlying all blot or gel results reported in a submission’s figures or Supporting Information files. This policy and the journal’s other requirements for blot/gel reporting and figure preparation are described in detail at <a href="https://journals.plos.org/plosone/s/figures#loc-blot-and-gel-reporting-requirements" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">https://journals.plos.org/plosone/s/figures#loc-blot-and-gel-reporting-requirements</a> and <a href="https://journals.plos.org/plosone/s/figures#loc-preparing-figures-from-image-files" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">https://journals.plos.org/plosone/s/figures#loc-preparing-figures-from-image-files</a>. When you submit your revised manuscript, please ensure that your figures adhere fully to these guidelines and provide the original underlying images for all blot or gel data reported in your submission. See the following link for instructions on providing the original image data: <a href="https://journals.plos.org/plosone/s/figures#loc-original-images-for-blots-and-gels.%C2%A0%C2%A0" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">https://journals.plos.org/plosone/s/figures#loc-original-images-for-blots-and-gels.  </a></p>
<p>In your cover letter, please note whether your blot/gel image data are in Supporting Information or posted at a public data repository, provide the repository URL if relevant, and provide specific details as to which raw blot/gel images, if any, are not available. Email us at plosone@plos.org if you have any questions.</p>
<p>[Note: HTML markup is below. Please do not edit.]</p>
<p>Reviewers' comments:</p>
<p>Reviewer's Responses to Questions</p>
<p>--&gt;<strong>Comments to the Author</strong></p>
<p>1. Is the manuscript technically sound, and do the data support the conclusions?</p>
<p>The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented. --&gt;</p>
<p>Reviewer #1: Partly</p>
<p>**********</p>
<p>--&gt;2. Has the statistical analysis been performed appropriately and rigorously? --&gt;</p>
<p>Reviewer #1: Yes</p>
<p>**********</p>
<p>--&gt;3. Have the authors made all data underlying the findings in their manuscript fully available?</p>
<p>The <a href="http://www.plosone.org/static/policies.action#sharing" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">PLOS Data policy</a> requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified.--&gt;</p>
<p>Reviewer #1: Yes</p>
<p>**********</p>
<p>--&gt;4. Is the manuscript presented in an intelligible fashion and written in standard English?</p>
<p>PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here.--&gt;</p>
<p>Reviewer #1: No</p>
<p>**********</p>
<p>--&gt;5. Review Comments to the Author</p>
<p>Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters)--&gt;</p>
<p>Reviewer #1: The manuscript by Li et al. investigates the in vitro effect of travoprost on primary limbal epithelial cells in an siRNA based aniridia model. The authors have studied an important topic that may be relevant clinically for aniridia treatment. However, there are several concerns that makes it unsuitable for publication in its current form:</p>
<p>1. The authors have not explained how the 20 min timepoint was selected for travoprost treatment. This is a very short exposure of the drug and does not accurately mimic clinical settings.</p>
<p>2. The authors do not discuss why cell viability is decreased even at lower concentrations.</p>
<p>3. The results section needs to be re-written for clarity and flow. The authors have merely stated what experiments are performed without providing a rationale.</p>
<p>4. Figure 3 images are in low resolution. Please provide them in high resolution.</p>
<p>5. It would be beneficial to see if travoprost affects cell proliferation in siPAX6 LEC, and not just on cell migration.</p>
<p>6. In Figure 4, 0.313 ug/mL travoprost treatment seems to increase PAX6 expression, which is not accurately represented by the bar graph.</p>
<p>7. The expression of several genes/proteins like FOSL1, ERK1, ERK2, and JNK have been shown in results without any prior mention. The authors should provide appropriate rationale before the result or mention them within the context of this study in the introduction. Same for MMP9.</p>
<p>8. In Figures 5 and 6, the authors have not explained why the expression of several markers are changed at the mRNA level but not at the protein level. This could be because the authors have measured the expression of total proteins (for eg. ERK and NFkB) and not the phosphorylated (activated) form.</p>
<p>9. There are several pathways that mediate cell proliferation and migration (for eg. Akt or Wnt). The authors have not explained why ERK was selected over other pathways.</p>
<p>**********</p>
<p>--&gt;6. PLOS authors have the option to publish the peer review history of their article (<a href="https://journals.plos.org/plosone/s/editorial-and-peer-review-process#loc-peer-review-history" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">what does this mean?</a> ). If published, this will include your full peer review and any attached files.</p>
<p>If you choose “no”, your identity will remain anonymous but your review may still be made public.</p>
<p><strong>Do you want your identity to be public for this peer review?</strong> For information about this choice, including consent withdrawal, please see our <a href="https://www.plos.org/privacy-policy" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Privacy Policy</a> .--&gt;</p>
<p>Reviewer #1: <strong>Yes: </strong> Ruchi Shah</p>
<p>**********</p>
<p>[NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.]</p>
<p>While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, <a href="https://pacev2.apexcovantage.com/" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">https://pacev2.apexcovantage.com/</a> . PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email PLOS at <span>figures@plos.org</span> . Please note that Supporting Information files do not need this step.</p></section></article><article class="sub-article" id="pone.0330492.r002"><section class="pmc-layout__citation font-secondary font-xs"><div>PLoS One. 2025 Aug 19;20(8):e0330492. doi: <a href="https://doi.org/10.1371/journal.pone.0330492.r002" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">10.1371/journal.pone.0330492.r002</a>
</div></section><section class="front-matter"><div class="ameta p font-secondary font-xs">
<hgroup><h1>Author response to Decision Letter 1</h1></hgroup><ul class="d-buttons inline-list">
<li><button class="d-button" aria-controls="anp_a.d" aria-expanded="false">Article notes</button></li>
<li><button class="d-button" aria-controls="clp_a.d" aria-expanded="false">Copyright and License information</button></li>
</ul>
<div class="d-panels font-secondary-light">
<div id="anp_a.d" class="d-panel p" style="display: none"><div class="notes p"><section id="historyfront-stub2" class="history"><p>Collection date 2025.</p></section></div></div>
<div id="clp_a.d" class="d-panel p" style="display: none"><div class="p"><a href="/about/copyright/" class="usa-link">PMC Copyright notice</a></div></div>
</div>
<div></div>
</div></section><section class="body sub-article-body"><hr class="headless">
<p>
<em>19 Jul 2025</em>
</p>
<p>Reviewer #1:</p>
<p>1. Please justify the 20 min timepoint selected for travoprost treatment. This seems to be a very short exposure of the drug and does not accurately mimic clinical settings.</p>
<p>We thank the reviewer for this insightful comment. In vivo studies in rabbits have shown that plasma concentrations of travoprost peak within 10 to 30 minutes after administration and then decline rapidly (Waugh J, et al. Drugs Aging. 2002;19(6):465–473). In our preliminary experiments, we treated limbal epithelial cells (LECs) with various concentrations of travoprost for 10, 20, and 30 minutes, respectively. These tests revealed that a 10-minute exposure had no discernible effect on LEC viability, whereas a 30-minute exposure resulted in a marked reduction in cell viability, which in turn made it challenging to collect sufficient cells for subsequent Western blot and qPCR analyses.</p>
<p>Taking these observations into account, we selected a 20-minute exposure as a representative short-term in vitro treatment model. This duration aligns with several previous in vitro studies that investigated the effects of prostaglandin analogs on corneal epithelial cells (Paimela T, et al. Mol Vis. 2012;18:1189–1196; Whitson JT, et al. Adv Ther. 2012;29(10):874–888). Additionally, one of our prior studies employed a similar 20-minute travoprost treatment to examine effects on limbal stromal cells (Li S, et al. PLoS One. 2025;20(6):e0326967).</p>
<p>Nonetheless, we fully agree that studies involving chronic exposure are essential to more accurately reflect clinical conditions. We have now acknowledged this limitation in the Discussion section and highlighted the need for future in vivo and long-term exposure studies.</p>
<p>2. The authors should discuss why cell viability is decreased even at lower concentrations.</p>
<p>We appreciate the reviewer’s suggestion. We have incorporated the required information into the Discussion section, as follows:</p>
<p>“At lower concentrations, the reduction in LEC viability induced by travoprost may not result from overt cytotoxicity but rather from the early activation of stress- and apoptosis-related signaling pathways. In PAX6-knockdown LECs, we observed an increase in caspase-3 protein levels following treatment with 0.313 μg/mL travoprost, supporting the hypothesis that travoprost can trigger apoptotic processes even at relatively low concentrations. This early response appears to be more pronounced in PAX6-deficient cells, which exhibit impaired regulatory capacity and heightened sensitivity to external stimuli. Similarly, we found that low-concentration travoprost treatment elevated JNK protein levels in PAX6-knockdown LECs, suggesting that travoprost may also induce mild oxidative stress under these conditions [37].”</p>
<p>3. The results section needs to be re-written for clarity. The performed experiments need a rationale.</p>
<p>Thank you for this valuable feedback. We have restructured the Results section to enhance clarity by introducing a clear rationale at the beginning of each subsection. These revisions are intended to guide the reader more effectively through the experimental design and the interpretation of our findings.</p>
<p>4. Figure 3 images have low resolution. Please increase the resolution when making the tiff file.</p>
<p>Thank you very much. We have replaced Figure 3 with higher-resolution TIFF images to meet publication standards, and these updated images are included in the revised submission.</p>
<p>5. Please clarify whether travoprost affects cell proliferation in siPAX6 LEC, not just cell migration.</p>
<p>Thank you for pointing this out. Performing PAX6 knockdown in 96-well plates presents certain technical challenges, which is why we did not assess the effect of travoprost on the proliferative capacity of PAX6-knockdown LECs in this study.</p>
<p>However, we have now included a comparative analysis of Ki67 mRNA levels following travoprost treatment in the revised Results section (Figure 5). While the primary suppression of proliferation was observed in normal LECs at higher travoprost concentrations, no statistically significant changes in Ki67 mRNA levels were detected in either LECs or PAX6-knockdown LECs treated with 0.156 or 0.313 μg/mL travoprost. This clarification has been incorporated into both the Results and Discussion sections.</p>
<p>“3.4 Ki67 mRNA levels</p>
<p>Ki67 is widely regarded as a marker of cell proliferation [32]. The mRNA levels of Ki67 did not differ significantly between LECs and PAX6-knockdown LECs (p = 0.321). Moreover, treatment with travoprost did not affect Ki67 mRNA expression in either the LEC or PAX6-knockdown subgroups (p ≥ 0.867) (Fig 5).</p>
<p>Fig 5. Ki67 mRNA levels in limbal epithelial cells (LECs) and PAX6-knockdown LECs following a 20-minute treatment with travoprost at concentrations of 0.156 μg/mL and 0.313 μg/mL (n=7). mRNA values are presented on a logarithmic scale (Log₂) and expressed as the geometric mean±geometric standard deviation (SD). Two-way ANOVA was used for statistical analysis, and significant p-values (p&lt;0.05) are indicated in the diagrams.</p>
<p>No significant differences were observed between any of the analyzed groups or subgroups (p≥0.321).”</p>
<p>“We also examined the effects of 0.156 and 0.313 μg/mL travoprost on Ki67 mRNA levels, a marker of cell proliferation [32], in both LECs and PAX6-knockdown LECs. These travoprost concentrations did not affect proliferation in either group, consistent with our BrdU assay results.”</p>
<p>6. Please revisit the Figure 4, 0.313 ug/mL travoprost treatment: resolve the discrepancy between an increase in PAX6 expression and the bar graph.</p>
<p>We thank the reviewer for bringing this to our attention. We found no significant increase in PAX6 expression after treatment with 0.313 μg/mL travoprost in either LECs or PAX6-knockdown LECs. Figure 4 now includes a representative Western blot image for clarity.</p>
<p>7. Please provide rationale for measuring the expression of several genes/proteins like FOSL1, ERK1, ERK2, JNK, and MMP-9 that have been shown without any prior mention.</p>
<p>Thank you very much. We appreciate this suggestion and have now revised the Introduction to more clearly justify our focus on these targets:</p>
<p>“Fos like 2 (FOSL2) is considered a target gene of PAX6 and is closely associated with corneal opacity [21]. It is also thought to play a role in regulating cell migration and proliferation [22]. Mitogen-activated protein kinases (MAPKs) are primarily categorized into three subfamilies: extracellular signal-regulated kinases (ERKs), c-Jun N-terminal kinases (JNKs), and mitogen-activated protein kinase 14 (MAPK14, also known as p38) [23]. Among these, ERKs and JNKs are particularly implicated in controlling cell proliferation, migration, and apoptosis [24–26]. As previously noted, travoprost can elevate MMP levels, thereby contributing to the reduction of IOP [27]. Related studies have also demonstrated that MMP expression is regulated through the JNK pathway [28]. In our earlier investigation of aniridia limbal stromal cells (AN-LSCs), we found that travoprost may influence MMP9 expression via the JNK signaling pathway, subsequently affecting cell migration [29]. Based on these findings, the present study focuses on evaluating the expression of these key genes and proteins.”</p>
<p>8. In Figures 5 and 6, please comment on why the expression of several markers are changed at the mRNA level but not at the protein level. This could be because the authors have measured the expression of total proteins (e.g., ERK and NF-kB) but not the phosphorylated (activated) forms.</p>
<p>Thank you for this important observation. The reviewer correctly noted the discrepancies where certain markers showed differences at the mRNA level but not at the protein level. We acknowledge that for some proteins, such as ERK and NF-κB, we only measured total protein levels and did not assess their phosphorylated (active) forms. Given that we observed no differences between the subgroups treated with varying concentrations of travoprost, we did not extend our analyses in the present study to include phosphorylated protein levels. Nonetheless, we have now added a note in the Discussion section acknowledging this as a limitation of our study, emphasizing that the active (phosphorylated) forms of ERK and NF-κB were not assessed and warrant further investigation:</p>
<p>“In the present study, the limited amount of available material prevented us from measuring the active, phosphorylated forms of ERK and NF-κB, highlighting the need for further investigation.”</p>
<p>9. There are several pathways that mediate cell proliferation and migration (e.g., Akt or Wnt). The authors have not explained why ERK was selected over other pathways. Please check some other effectors.</p>
<p>We thank the reviewer for this valuable suggestion. Our initial focus on ERK and JNK was based on their well-established roles in ocular epithelial wound healing and their reported regulation by prostaglandin analogs. We agree that examining additional pathways would provide a more comprehensive understanding. Nevertheless, working with primary cells provided only limited material, which made it unfeasible to analyze all pathways in this study. Accordingly, we have added a note in the Discussion acknowledging as a limitation of our current study that neither the Akt nor Wnt pathways were analyzed, and we propose investigating these pathways in future research:</p>
<p>“For the same reason, we were also unable to analyze the Akt and Wnt pathways, which we propose to investigate in future studies.”</p>
<p>10. The Quantitative PCR should be Quantitative RT-PCR.</p>
<p>Thank you for pointing this out. We have corrected all instances of "Quantitative PCR" to "Quantitative RT-PCR" throughout the manuscript.</p>
<section class="sm xbox font-sm" id="pone.0330492.s002"><div class="caption p">
<span>Attachment</span><p>Submitted filename: <em>Response to Reviewers.docx</em></p>
</div>
<div class="media p"><div class="caption">
<a href="/articles/instance/12364336/bin/pone.0330492.s002.docx" data-ga-action="click_feat_suppl" class="usa-link">pone.0330492.s002.docx</a><sup> (38.2KB, docx) </sup>
</div></div></section></section></article><article class="sub-article" id="pone.0330492.r003"><section class="pmc-layout__citation font-secondary font-xs"><div>PLoS One. doi: <a href="https://doi.org/10.1371/journal.pone.0330492.r003" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">10.1371/journal.pone.0330492.r003</a>
</div></section><section class="front-matter"><div class="ameta p font-secondary font-xs">
<hgroup><h1>Decision Letter 1</h1></hgroup><div class="cg p">
<a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Ljubimov%20AV%22%5BAuthor%5D" class="usa-link" aria-describedby="id13"><span class="name western">Alexander V Ljubimov</span></a><div hidden="hidden" id="id13">
<h3><span class="name western">Alexander V Ljubimov</span></h3>
<div>Academic Editor</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Ljubimov%20AV%22%5BAuthor%5D" class="usa-link"><span class="name western">Alexander V Ljubimov</span></a>
</div>
</div>
</div>
<ul class="d-buttons inline-list">
<li><button class="d-button" aria-controls="aip_a.e" aria-expanded="false">Author information</button></li>
<li><button class="d-button" aria-controls="clp_a.e" aria-expanded="false">Copyright and License information</button></li>
</ul>
<div class="d-panels font-secondary-light">
<div id="aip_a.e" class="d-panel p" style="display: none">
<h4 class="font-secondary">Roles</h4>
<div class="p">
<strong class="contrib"><span class="name western">Alexander V Ljubimov</span></strong>: <span class="role">Academic Editor</span>
</div>
</div>
<div id="clp_a.e" class="d-panel p" style="display: none">
<div>© 2025 Alexander V Ljubimov</div>
<p>This is an open access article distributed under the terms of the <a href="https://creativecommons.org/licenses/by/4.0/" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Creative Commons Attribution License</a> , which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.</p>
<div class="p"><a href="/about/copyright/" class="usa-link">PMC Copyright notice</a></div>
</div>
</div>
<div></div>
</div></section><section class="body sub-article-body"><hr class="headless">
<p>
<em>4 Aug 2025</em>
</p>
<p>The Effect of Travoprost on Primary Human Limbal Epithelial Cells and the siRNA-based Aniridia Limbal Epithelial Cell Model, In Vitro</p>
<p>PONE-D-25-21972R1</p>
<p>Dear Dr. Li,</p>
<p>We’re pleased to inform you that your manuscript has been judged scientifically suitable for publication and will be formally accepted for publication once it meets all outstanding technical requirements.</p>
<p>Within one week, you’ll receive an e-mail detailing the required amendments. When these have been addressed, you’ll receive a formal acceptance letter and your manuscript will be scheduled for publication.</p>
<p>An invoice will be generated when your article is formally accepted. Please note, if your institution has a publishing partnership with PLOS and your article meets the relevant criteria, all or part of your publication costs will be covered. Please make sure your user information is up-to-date by logging into Editorial Manager at <a href="https://www.editorialmanager.com/pone/" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Editorial Manager®</a>  and clicking the ‘Update My Information' link at the top of the page. For questions related to billing, please contact <a href="https://plos.my.site.com/s/" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">billing support</a> .</p>
<p>If your institution or institutions have a press office, please notify them about your upcoming paper to help maximize its impact. If they’ll be preparing press materials, please inform our press team as soon as possible -- no later than 48 hours after receiving the formal acceptance. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact onepress@plos.org.</p>
<p>Kind regards,</p>
<p>Alexander V Ljubimov, Ph.D.</p>
<p>Academic Editor</p>
<p>PLOS ONE</p>
<p>Additional Editor Comments (optional):</p>
<p>No further concerns.</p>
<p>Reviewers' comments:</p>
<p>Reviewer's Responses to Questions</p>
<p>--&gt;<strong>Comments to the Author</strong></p>
<p>1. If the authors have adequately addressed your comments raised in a previous round of review and you feel that this manuscript is now acceptable for publication, you may indicate that here to bypass the “Comments to the Author” section, enter your conflict of interest statement in the “Confidential to Editor” section, and submit your "Accept" recommendation.--&gt;</p>
<p>Reviewer #1: All comments have been addressed</p>
<p>**********</p>
<p>--&gt;2. Is the manuscript technically sound, and do the data support the conclusions?</p>
<p>The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented. --&gt;</p>
<p>Reviewer #1: Yes</p>
<p>**********</p>
<p>--&gt;3. Has the statistical analysis been performed appropriately and rigorously? --&gt;</p>
<p>Reviewer #1: Yes</p>
<p>**********</p>
<p>--&gt;4. Have the authors made all data underlying the findings in their manuscript fully available?</p>
<p>The <a href="http://www.plosone.org/static/policies.action#sharing" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">PLOS Data policy</a> requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified.--&gt;</p>
<p>Reviewer #1: Yes</p>
<p>**********</p>
<p>--&gt;5. Is the manuscript presented in an intelligible fashion and written in standard English?</p>
<p>PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here.--&gt;</p>
<p>Reviewer #1: Yes</p>
<p>**********</p>
<p>--&gt;6. Review Comments to the Author</p>
<p>Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters)--&gt;</p>
<p>Reviewer #1: The authors have adequately addressed all concerns. The revised manuscript reads much more clearly than before. No further comments.</p>
<p>**********</p>
<p>--&gt;7. PLOS authors have the option to publish the peer review history of their article (<a href="https://journals.plos.org/plosone/s/editorial-and-peer-review-process#loc-peer-review-history" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">what does this mean?</a> ). If published, this will include your full peer review and any attached files.</p>
<p>If you choose “no”, your identity will remain anonymous but your review may still be made public.</p>
<p><strong>Do you want your identity to be public for this peer review?</strong> For information about this choice, including consent withdrawal, please see our <a href="https://www.plos.org/privacy-policy" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Privacy Policy</a> .--&gt;</p>
<p>Reviewer #1: <strong>Yes: </strong> Ruchi Shah</p>
<p>**********</p></section></article><article class="sub-article" id="pone.0330492.r004"><section class="pmc-layout__citation font-secondary font-xs"><div>PLoS One. doi: <a href="https://doi.org/10.1371/journal.pone.0330492.r004" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">10.1371/journal.pone.0330492.r004</a>
</div></section><section class="front-matter"><div class="ameta p font-secondary font-xs">
<hgroup><h1>Acceptance letter</h1></hgroup><div class="cg p">
<a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Ljubimov%20AV%22%5BAuthor%5D" class="usa-link" aria-describedby="id14"><span class="name western">Alexander V Ljubimov</span></a><div hidden="hidden" id="id14">
<h3><span class="name western">Alexander V Ljubimov</span></h3>
<div>Academic Editor</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Ljubimov%20AV%22%5BAuthor%5D" class="usa-link"><span class="name western">Alexander V Ljubimov</span></a>
</div>
</div>
</div>
<ul class="d-buttons inline-list">
<li><button class="d-button" aria-controls="aip_a.f" aria-expanded="false">Author information</button></li>
<li><button class="d-button" aria-controls="clp_a.f" aria-expanded="false">Copyright and License information</button></li>
</ul>
<div class="d-panels font-secondary-light">
<div id="aip_a.f" class="d-panel p" style="display: none">
<h4 class="font-secondary">Roles</h4>
<div class="p">
<strong class="contrib"><span class="name western">Alexander V Ljubimov</span></strong>: <span class="role">Academic Editor</span>
</div>
</div>
<div id="clp_a.f" class="d-panel p" style="display: none">
<div>© 2025 Alexander V Ljubimov</div>
<p>This is an open access article distributed under the terms of the <a href="https://creativecommons.org/licenses/by/4.0/" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Creative Commons Attribution License</a> , which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.</p>
<div class="p"><a href="/about/copyright/" class="usa-link">PMC Copyright notice</a></div>
</div>
</div>
<div></div>
</div></section><section class="body sub-article-body"><hr class="headless">
<p>PONE-D-25-21972R1</p>
<p>PLOS ONE</p>
<p>Dear Dr. Li,</p>
<p>I'm pleased to inform you that your manuscript has been deemed suitable for publication in PLOS ONE. Congratulations! Your manuscript is now being handed over to our production team.</p>
<p>At this stage, our production department will prepare your paper for publication. This includes ensuring the following:</p>
<p>* All references, tables, and figures are properly cited</p>
<p>* All relevant supporting information is included in the manuscript submission,</p>
<p>* There are no issues that prevent the paper from being properly typeset</p>
<p>You will receive further instructions from the production team, including instructions on how to review your proof when it is ready. Please keep in mind that we are working through a large volume of accepted articles, so please give us a few days to review your paper and let you know the next and final steps.</p>
<p>Lastly, if your institution or institutions have a press office, please let them know about your upcoming paper now to help maximize its impact. If they'll be preparing press materials, please inform our press team within the next 48 hours. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact onepress@plos.org.</p>
<p>You will receive an invoice from PLOS for your publication fee after your manuscript has reached the completed accept phase. If you receive an email requesting payment before acceptance or for any other service, this may be a phishing scheme. Learn how to identify phishing emails and protect your accounts at <a href="https://explore.plos.org/phishing" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">https://explore.plos.org/phishing</a>.</p>
<p>If we can help with anything else, please email us at customercare@plos.org.</p>
<p>Thank you for submitting your work to PLOS ONE and supporting open access.</p>
<p>Kind regards,</p>
<p>PLOS ONE Editorial Office Staff</p>
<p>on behalf of</p>
<p>Dr. Alexander V Ljubimov</p>
<p>Academic Editor</p>
<p>PLOS ONE</p></section></article><article class="sub-article" id="_ad93_"><section class="pmc-layout__citation font-secondary font-xs"><div></div></section><section class="front-matter"><div class="ameta p font-secondary font-xs">
<hgroup><h1>Associated Data</h1></hgroup><ul class="d-buttons inline-list"></ul>
<div class="d-panels font-secondary-light"></div>
<div></div>
<p class="font-secondary"><em>This section collects any data citations, data availability statements, or supplementary materials included in this article.</em></p>
</div></section><section class="body sub-article-body"><section id="_adsm93_" lang="en" class="supplementary-materials"><h2 class="pmc_sec_title">Supplementary Materials</h2>
<section class="sm xbox font-sm" id="db_ds_supplementary-material1_reqid_"><div class="caption p">
<span>Attachment</span><p>Submitted filename: <em>Response to Reviewers.docx</em></p>
</div>
<div class="media p"><div class="caption">
<a href="/articles/instance/12364336/bin/pone.0330492.s002.docx" data-ga-action="click_feat_suppl" class="usa-link">pone.0330492.s002.docx</a><sup> (38.2KB, docx) </sup>
</div></div></section></section><section id="_adda93_" lang="en" class="data-availability-statement"><h2 class="pmc_sec_title">Data Availability Statement</h2>
<p>All relevant data are within the manuscript and its Supporting information files.</p></section></section></article><footer class="p courtesy-note font-secondary font-sm text-center"><hr class="headless">
<p>Articles from PLOS One are provided here courtesy of <strong>PLOS</strong></p></footer></section></article>

                      

                    </main>
                </div>
            </div>
        </div>

        



<!-- Secondary navigation placeholder -->
<div class="pmc-sidenav desktop:grid-col-4 display-flex">
    <section class="pmc-sidenav__container" aria-label="Article resources and navigation">
        <button type="button" class="usa-button pmc-sidenav__container__close usa-button--unstyled">
            <img src="/static/img/usa-icons/close.svg" role="img" alt="Close" />
        </button>
    <div class="display-none desktop:display-block">
       <section class="margin-top-4 desktop:margin-top-0">
              <h2 class="margin-top-0">ACTIONS</h2>
           <ul class="usa-list usa-list--unstyled usa-list--actions">
               
               <li>
                     <a
                             href="https://doi.org/10.1371/journal.pone.0330492"
                             class="usa-button usa-button--outline width-24 font-xs display-inline-flex flex-align-center flex-justify-start padding-left-1"
                             target="_blank"
                             rel="noreferrer noopener"
                             data-ga-category="actions"
                             data-ga-action="click"
                             data-ga-label="publisher_link_desktop"
                     >
                         <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img" hidden>
                            <use xlink:href="/static/img/sprite.svg#launch"></use>
                         </svg>
                         <span class="display-inline-flex flex-justify-center flex-1 padding-right-2">View on publisher site</span>
                     </a>
               </li>
               
               
               <li>
                    <a
                            href="pdf/pone.0330492.pdf"
                            class="usa-button usa-button--outline width-24 display-inline-flex flex-align-center flex-justify-start padding-left-1"
                            data-ga-category="actions"
                            data-ga-action="click"
                            data-ga-label="pdf_download_desktop"
                    >
                         <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img" hidden>
                            <use xlink:href="/static/img/sprite.svg#file_download"></use>
                        </svg>
                        <span class="display-inline-flex flex-justify-center flex-1">PDF (1.7 MB)</span>
                    </a>
               </li>
               
                
               <li>
                   <button role="button" class="usa-button width-24 citation-dialog-trigger display-inline-flex flex-align-center flex-justify-start padding-left-1"
                        aria-label="Open dialog with citation text in different styles"
                        data-ga-category="actions"
                        data-ga-action="open"
                        data-ga-label="cite_desktop"
                        data-all-citations-url="/resources/citations/12364336/"
                        data-citation-style="nlm"
                        data-download-format-link="/resources/citations/12364336/export/"
                    >
                        <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img" hidden>
                            <use xlink:href="/static/img/sprite.svg#format_quote"></use>
                        </svg>
                       <span class="display-inline-flex flex-justify-center flex-1 button-label">Cite</span>
                    </button>
               </li>
                
               <li>

                        <button class="usa-button width-24 collections-dialog-trigger collections-button display-inline-flex flex-align-center flex-justify-start padding-left-1 collections-button-empty"
                              aria-label="Save article in MyNCBI collections."
                              data-ga-category="actions"
                              data-ga-action="click"
                              data-ga-label="collections_button_desktop"
                              data-collections-open-dialog-enabled="false"
                              data-collections-open-dialog-url="https://account.ncbi.nlm.nih.gov/?back_url=https%3A%2F%2Fpmc.ncbi.nlm.nih.gov%2Farticles%2FPMC12364336%2F%3Freport%3Dclassic%23open-collections-dialog"
                              data-in-collections="false">
                            <svg class="usa-icon width-3 height-3 usa-icon--bookmark-full" aria-hidden="true" focusable="false" role="img" hidden>
                                <use xlink:href="/static/img/action-bookmark-full.svg#icon"></use>
                            </svg>
                            <svg class="usa-icon width-3 height-3 usa-icon--bookmark-empty" aria-hidden="true" focusable="false" role="img" hidden>
                                <use xlink:href="/static/img/action-bookmark-empty.svg#icon"></use>
                            </svg>
                            <span class="display-inline-flex flex-justify-center flex-1">Collections</span>
                       </button>
               </li>
               <li class="pmc-permalink">
                    <button
                            type="button"
                            class="usa-button width-24 display-inline-flex flex-align-center flex-justify padding-left-1 shadow-none"
                            aria-label="Show article permalink"
                            aria-expanded="false"
                            aria-haspopup="true"
                            data-ga-category="actions"
                            data-ga-action="open"
                            data-ga-label="permalink_desktop"
                    >
                         <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img" hidden>
                            <use xlink:href="/static/img/sprite.svg#share"></use>
                        </svg>
                        <span class="display-inline-flex flex-justify-center flex-1 button-label">Permalink</span>
                    </button>
                   

<div class="pmc-permalink__dropdown" hidden>
    <div class="pmc-permalink__dropdown__container">
          <h2 class="usa-modal__heading margin-top-0 margin-bottom-2 text-uppercase font-sans-xs">PERMALINK</h2>
          <div class="pmc-permalink__dropdown__content">
              <input type="text" class="usa-input" value="https://pmc.ncbi.nlm.nih.gov/articles/PMC12364336/" aria-label="Article permalink">
              <button class="usa-button display-inline-flex pmc-permalink__dropdown__copy__btn margin-right-0" title="Copy article permalink" data-ga-category="save_share" data-ga-action="link" data-ga-label="copy_link">
                  <svg class="usa-icon" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#content_copy"></use>
                  </svg>
                  <span class="margin-left-1">Copy</span>
              </button>
          </div>
    </div>
</div>
               </li>
           </ul>
       </section>
     </div>

        <section class="pmc-resources margin-top-6 desktop:margin-top-4" data-page-path="/articles/PMC12364336/">
            <h2 class="margin-top-0">RESOURCES</h2>
            
                <div class="usa-accordion usa-accordion--multiselectable" data-allow-multiple>
                    <h3 class="usa-accordion__heading">
                        <button
                        type="button"
                        class="usa-accordion__button"
                        aria-expanded="false"
                        aria-controls="resources-similar-articles"
                        data-ga-category="resources_accordion"
                        data-ga-action="open_similar_articles"
                        data-ga-label="/articles/PMC12364336/"
                        data-action-open="open_similar_articles"
                        data-action-close="close_similar_articles"
                        >
                            Similar articles
                        </button>
                    </h3>
                    <div
                            id="resources-similar-articles"
                            class="usa-accordion__content usa-prose"
                            
                                data-source-url="/resources/similar-article-links/40828815/"
                            
                    >
                        
                    </div>
                    <h3 class="usa-accordion__heading">
                        <button
                        type="button"
                        class="usa-accordion__button"
                        aria-expanded="false"
                        aria-controls="resources-cited-by-other-articles"
                        data-ga-category="resources_accordion"
                        data-ga-action="open_cited_by"
                        data-ga-label="/articles/PMC12364336/"
                        data-action-open="open_cited_by"
                        data-action-close="close_cited_by"
                        >
                             Cited by other articles
                        </button>
                    </h3>
                    <div
                            id="resources-cited-by-other-articles"
                            class="usa-accordion__content usa-prose"
                            
                                data-source-url="/resources/cited-by-links/40828815/"
                            
                    >
                          
                    </div>
                    
                        <h3 class="usa-accordion__heading">
                            <button
                            type="button"
                            class="usa-accordion__button"
                            aria-expanded="false"
                            aria-controls="resources-links-to-ncbi-databases"
                            data-ga-category="resources_accordion"
                            data-ga-action="open_NCBI_links"
                            data-ga-label="/articles/PMC12364336/"
                            data-action-open="open_NCBI_links"
                            data-action-close="close_NCBI_link"
                            >
                                 Links to NCBI Databases
                            </button>
                        </h3>
                        <div
                                id="resources-links-to-ncbi-databases"
                                class="usa-accordion__content usa-prose"
                                data-source-url="/resources/db-links/12364336/"
                        >
                        </div>
                    
                    
                </div>
            
        </section>


        <section
        class="usa-in-page-nav usa-in-page-nav--wide margin-top-6 desktop:margin-top-4"
        data-title-text="On this page"
        data-title-heading-level="h2"
        data-scroll-offset="0"
        data-root-margin="-10% 0px -80% 0px"
        data-main-content-selector="main"
        data-threshold="1"
        hidden
        ></section>
    </section>
</div>


        

<div class="overlay" role="dialog" aria-label="Citation Dialog" hidden>
    <div class="dialog citation-dialog" aria-hidden="true">
        <div class="display-inline-flex flex-align-center flex-justify width-full margin-bottom-2">
            <h2 class="usa-modal__heading margin-0">Cite</h2>
             <button type="button" class="usa-button usa-button--unstyled close-overlay text-black width-auto"  tabindex="1">
                <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#close"></use>
                </svg>
             </button>
        </div>

        

<div class="citation-text-block">
  <div class="citation-text margin-bottom-2"></div>
  <ul class="usa-list usa-list--unstyled display-inline-flex flex-justify width-full flex-align-center">
      <li>
        <button
          class="usa-button usa-button--unstyled text-no-underline display-flex flex-align-center copy-button dialog-focus"
          data-ga-category="save_share"
          data-ga-action="cite"
          data-ga-label="copy"
          tabindex="2">
            <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img">
                <use xlink:href="/static/img/sprite.svg#content_copy"></use>
            </svg>
            <span>Copy</span>
        </button>
      </li>
      <li>
          <a
              href="#"
              role="button"
              class="usa-button usa-button--unstyled text-no-underline display-flex flex-align-center export-button"
              data-ga-category="save_share"
              data-ga-action="cite"
              data-ga-label="download"
              title="Download a file for external citation management software"
              tabindex="3">
                <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#file_download"></use>
                </svg>
                <span class="display-none mobile-lg:display-inline">Download .nbib</span>
                <span class="display-inline mobile-lg:display-none">.nbib</span>
            </a>
      </li>
      <li>
          

<div class="display-inline-flex flex-align-center">
  <label class="usa-label margin-top-0">Format:</label>
  <select aria-label="Format" class="usa-select citation-style-selector padding-1 margin-top-0 border-0 padding-right-4" tabindex="4" >
    
      <option data-style-url-name="ama"
              value="AMA"
              >
        AMA
      </option>
    
      <option data-style-url-name="apa"
              value="APA"
              >
        APA
      </option>
    
      <option data-style-url-name="mla"
              value="MLA"
              >
        MLA
      </option>
    
      <option data-style-url-name="nlm"
              value="NLM"
              selected="selected">
        NLM
      </option>
    
  </select>
</div>
      </li>
  </ul>
</div>
    </div>
</div>

        <div class="overlay" role="dialog" hidden>
  <div id="collections-action-dialog" class="dialog collections-dialog" aria-hidden="true">
   <div class="display-inline-flex flex-align-center flex-justify width-full margin-bottom-2">
        <h2 class="usa-modal__heading margin-0">Add to Collections</h2>
    </div>
    <div class="collections-action-panel action-panel">
      


<form id="collections-action-dialog-form"
      class="usa-form maxw-full collections-action-panel-form action-panel-content action-form action-panel-smaller-selectors"
      data-existing-collections-url="/list-existing-collections/"
      data-add-to-existing-collection-url="/add-to-existing-collection/"
      data-create-and-add-to-new-collection-url="/create-and-add-to-new-collection/"
      data-myncbi-max-collection-name-length="100"
      data-collections-root-url="https://www.ncbi.nlm.nih.gov/myncbi/collections/">

    <input type="hidden" name="csrfmiddlewaretoken" value="inMOZn4TGxBPsaIjU9ab3uinW9VOeQ68DDmcrPcE4QMnDKWlkmTgDccRgVvRa9td">

    <fieldset class="usa-fieldset margin-bottom-2">
        <div class="usa-radio">
            <input type="radio"
            id="collections-action-dialog-new"
            class="usa-radio__input usa-radio__input--tile collections-new  margin-top-0"
            name="collections"
            value="new"
            data-ga-category="collections_button"
            data-ga-action="click"
            data-ga-label="collections_radio_new" />
            <label class="usa-radio__label" for="collections-action-dialog-new">Create a new collection</label>
        </div>
        <div class="usa-radio">
            <input type="radio"
            id="collections-action-dialog-existing"
            class="usa-radio__input usa-radio__input--tile collections-existing"
            name="collections"
            value="existing"
            checked="true"
            data-ga-category="collections_button"
            data-ga-action="click"
            data-ga-label="collections_radio_existing" />
            <label class="usa-radio__label" for="collections-action-dialog-existing">Add to an existing collection</label>
        </div>
    </fieldset>

    <fieldset class="usa-fieldset margin-bottom-2">
        <div class="action-panel-control-wrap new-collections-controls">
           <label for="collections-action-dialog-add-to-new" class="usa-label margin-top-0">
                Name your collection
               <abbr title="required" class="usa-hint usa-hint--required text-no-underline">*</abbr>
          </label>
          <input
            type="text"
            name="add-to-new-collection"
            id="collections-action-dialog-add-to-new"
            class="usa-input collections-action-add-to-new"
            pattern="[^&quot;&amp;=&lt;&gt;/]*" title="The following characters are not allowed in the Name field: &quot;&amp;=&lt;&gt;/"
            maxlength=""
            data-ga-category="collections_button"
            data-ga-action="create_collection"
            data-ga-label="non_favorties_collection"
            required
          />
        </div>
        <div class="action-panel-control-wrap existing-collections-controls">
             <label for="collections-action-dialog-add-to-existing" class="usa-label margin-top-0">
                Choose a collection
              </label>
              <select id="collections-action-dialog-add-to-existing"
                      class="usa-select collections-action-add-to-existing"
                      data-ga-category="collections_button"
                      data-ga-action="select_collection"
                      data-ga-label="($('.collections-action-add-to-existing').val() === 'Favorites') ? 'Favorites' : 'non_favorites_collection'">
              </select>
              <div class="collections-retry-load-on-error usa-input-error-message selection-validation-message">
                Unable to load your collection due to an error<br>
                <a href="#">Please try again</a>
              </div>
        </div>
    </fieldset>

    <div class="display-inline-flex">
        <button class="usa-button margin-top-0 action-panel-submit"
            type="submit"
            data-loading-label="Adding..."
            data-pinger-ignore
            data-ga-category="collections_button"
            data-ga-action="click"
            data-ga-label="add">
          Add
        </button>
        <button class="usa-button usa-button--outline margin-top-0 action-panel-cancel"
                aria-label="Close 'Add to Collections' panel"
                ref="linksrc=close_collections_panel"
                data-ga-category="collections_button"
                data-ga-action="click"
                data-ga-label="cancel">
          Cancel
        </button>
    </div>
</form>
    </div>
  </div>
</div>

        

      </div>
    </div>
  </div>



        
    
    

<footer class="ncbi-footer ncbi-dark-background " >
    
        <div class="ncbi-footer__icon-section">
            <div class="ncbi-footer__social-header">
                Follow NCBI
            </div>

            <div class="grid-container ncbi-footer__ncbi-social-icons-container">
                
                    <a href="https://twitter.com/ncbi"
                       class="ncbi-footer__social-icon ncbi-footer__social-icon--gray"
                       target="_blank"
                       rel="noreferrer noopener">
                        <svg width="40"
                             height="40"
                             viewBox="0 0 40 40"
                             fill="none"
                             xmlns="http://www.w3.org/2000/svg"
                             focusable="false"
                             aria-hidden="true">
                            <path d="m6.067 8 10.81 13.9L6 33.2h4.2l8.4-9.1 7.068 9.1H34L22.8 18.5 31.9 8h-3.5l-7.7 8.4L14.401 8H6.067Zm3.6 1.734h3.266l16.8 21.732H26.57L9.668 9.734Z">
                            </path>
                        </svg>
                        <span class="usa-sr-only">NCBI on X (formerly known as Twitter)</span>
                    </a>
                

                
                    <a href="https://www.facebook.com/ncbi.nlm"
                       class="ncbi-footer__social-icon ncbi-footer__social-icon--gray"
                       target="_blank"
                       rel="noreferrer noopener">
                        <svg width="16"
                             height="29"
                             focusable="false"
                             aria-hidden="true"
                             viewBox="0 0 16 29"
                             fill="none"
                             xmlns="http://www.w3.org/2000/svg">
                            <path d="M3.8809 21.4002C3.8809 19.0932 3.8809 16.7876 3.8809 14.478C3.8809 14.2117 3.80103 14.1452 3.54278 14.1492C2.53372 14.1638 1.52334 14.1492 0.514288 14.1598C0.302626 14.1598 0.248047 14.0972 0.248047 13.8936C0.256034 12.4585 0.256034 11.0239 0.248047 9.58978C0.248047 9.37013 0.302626 9.30224 0.528931 9.3049C1.53798 9.31688 2.54837 9.3049 3.55742 9.31555C3.80103 9.31555 3.8809 9.26097 3.87957 9.00272C3.87158 8.00565 3.85428 7.00592 3.90753 6.00884C3.97142 4.83339 4.31487 3.73115 5.04437 2.78467C5.93095 1.63318 7.15699 1.09005 8.56141 0.967577C10.5582 0.79319 12.555 0.982221 14.5518 0.927641C14.7102 0.927641 14.7462 0.99287 14.7449 1.13664C14.7449 2.581 14.7449 4.02668 14.7449 5.47104C14.7449 5.67604 14.6517 5.68669 14.4946 5.68669C13.4523 5.68669 12.4113 5.68669 11.3703 5.68669C10.3506 5.68669 9.92057 6.10868 9.90593 7.13904C9.89661 7.7647 9.91525 8.39303 9.89794 9.01869C9.88995 9.26364 9.96583 9.31822 10.2015 9.31688C11.7204 9.30623 13.2393 9.31688 14.7595 9.3049C15.0257 9.3049 15.0723 9.3728 15.0444 9.62439C14.89 10.9849 14.7515 12.3467 14.6144 13.7085C14.5691 14.1571 14.5785 14.1585 14.1458 14.1585C12.8386 14.1585 11.5313 14.1665 10.2254 14.1518C9.95119 14.1518 9.89794 14.2317 9.89794 14.4899C9.90593 19.0799 9.89794 23.6752 9.91125 28.2612C9.91125 28.5674 9.8407 28.646 9.53186 28.6433C7.77866 28.6273 6.02414 28.6366 4.27094 28.634C3.82499 28.634 3.87158 28.6992 3.87158 28.22C3.87602 25.9472 3.87913 23.6739 3.8809 21.4002Z">
                            </path>
                        </svg>
                        <span class="usa-sr-only">NCBI on Facebook</span>
                    </a>
                

                
                    <a href="https://www.linkedin.com/company/ncbinlm"
                       class="ncbi-footer__social-icon ncbi-footer__social-icon--gray"
                       target="_blank"
                       rel="noreferrer noopener">
                        <svg width="25"
                             height="23"
                             viewBox="0 0 26 24"
                             fill="none"
                             xmlns="http://www.w3.org/2000/svg"
                             focusable="false"
                             aria-hidden="true">
                            <path d="M14.6983 9.98423C15.6302 9.24808 16.5926 8.74754 17.6762 8.51991C19.673 8.09126 21.554 8.30824 23.1262 9.7526C24.2351 10.7723 24.7529 12.1115 25.0165 13.5612C25.1486 14.3363 25.2105 15.1218 25.2015 15.9081C25.2015 18.3043 25.2015 20.6898 25.2082 23.0806C25.2082 23.3468 25.1549 23.444 24.8621 23.4414C23.1297 23.4272 21.3992 23.4272 19.6704 23.4414C19.4041 23.4414 19.3429 23.3588 19.3442 23.1019C19.3535 20.5194 19.3442 17.9368 19.3442 15.3543C19.3442 14.0005 18.3258 12.9448 17.0266 12.9488C15.7273 12.9528 14.6983 14.0071 14.6983 15.361C14.6983 17.9328 14.6917 20.5047 14.6983 23.0753C14.6983 23.3708 14.6198 23.444 14.3296 23.4427C12.6185 23.4294 10.9079 23.4294 9.19779 23.4427C8.93155 23.4427 8.86099 23.3735 8.86232 23.1086C8.8783 19.7619 8.88628 16.4144 8.88628 13.066C8.88628 11.5688 8.87874 10.0708 8.86365 8.57182C8.86365 8.3575 8.90758 8.27896 9.14054 8.28029C10.9048 8.29094 12.6687 8.29094 14.4321 8.28029C14.6464 8.28029 14.6983 8.34818 14.6983 8.54653C14.6903 9.00047 14.6983 9.45441 14.6983 9.98423Z">
                            </path>
                            <path d="M6.55316 15.8443C6.55316 18.2564 6.55316 20.6699 6.55316 23.082C6.55316 23.3629 6.48127 23.4388 6.19906 23.4374C4.47737 23.4241 2.75568 23.4241 1.03399 23.4374C0.767751 23.4374 0.69986 23.3629 0.701191 23.1006C0.709178 18.2648 0.709178 13.4281 0.701191 8.59053C0.701191 8.34026 0.765089 8.27237 1.01669 8.2737C2.74991 8.28435 4.48048 8.28435 6.20838 8.2737C6.47462 8.2737 6.5465 8.33627 6.54517 8.6065C6.54783 11.0186 6.55316 13.4308 6.55316 15.8443Z">
                            </path>
                            <path d="M3.65878 0.243898C5.36804 0.243898 6.58743 1.45529 6.58743 3.1406C6.58743 4.75801 5.32145 5.95742 3.60819 5.96807C3.22177 5.97614 2.83768 5.90639 2.47877 5.76299C2.11985 5.61959 1.79344 5.40546 1.51897 5.13334C1.24449 4.86123 1.02755 4.53668 0.881058 4.17902C0.734563 3.82136 0.661505 3.43788 0.666231 3.05141C0.67555 1.42601 1.9362 0.242566 3.65878 0.243898Z">
                            </path>
                        </svg>
                        <span class="usa-sr-only">NCBI on LinkedIn</span>
                    </a>
                

                
                    <a href="https://github.com/ncbi"
                       class="ncbi-footer__social-icon ncbi-footer__social-icon--gray"
                       target="_blank"
                       rel="noreferrer noopener">
                        <svg width="28"
                             height="27"
                             viewBox="0 0 28 28"
                             fill="none"
                             xmlns="http://www.w3.org/2000/svg"
                             focusable="false"
                             aria-hidden="true">
                            <path d="M16.7228 20.6334C17.5057 20.5527 18.2786 20.3944 19.0301 20.1608C21.3108 19.4193 22.5822 17.8259 22.963 15.4909C23.1228 14.5112 23.1814 13.5287 22.9883 12.5437C22.8106 11.6423 22.4013 10.8028 21.8007 10.1076C21.7526 10.0605 21.7197 10 21.7064 9.934C21.6931 9.86799 21.7 9.79952 21.7262 9.73748C22.0856 8.6206 21.9711 7.51969 21.601 6.42677C21.582 6.3497 21.5345 6.2827 21.468 6.23923C21.4016 6.19577 21.3211 6.17906 21.2429 6.19248C20.7329 6.21649 20.2313 6.33051 19.7611 6.52928C19.1103 6.7908 18.4899 7.12198 17.9104 7.51703C17.84 7.56996 17.7581 7.60551 17.6713 7.62078C17.5846 7.63605 17.4954 7.6306 17.4112 7.60489C15.2596 7.05882 13.0054 7.06203 10.8554 7.61421C10.7806 7.63586 10.7018 7.63967 10.6253 7.62534C10.5487 7.611 10.4766 7.57892 10.4148 7.53167C9.64788 7.03247 8.85171 6.58918 7.96368 6.33359C7.65781 6.24338 7.34123 6.19458 7.02239 6.18849C6.94879 6.17986 6.87462 6.19893 6.81432 6.242C6.75402 6.28507 6.71191 6.34904 6.69621 6.42145C6.32342 7.51437 6.2209 8.61527 6.56307 9.73348C6.59635 9.84264 6.64694 9.93316 6.54177 10.0516C5.47666 11.2604 5.09988 12.6834 5.19574 14.2676C5.2663 15.4244 5.46201 16.5466 6.01454 17.5769C6.84399 19.1171 8.21664 19.9119 9.85158 20.3352C10.3938 20.4706 10.9444 20.5698 11.4998 20.632C11.5384 20.7492 11.4506 20.7798 11.408 20.8291C11.1734 21.1179 10.9894 21.4441 10.8634 21.7942C10.7622 22.0458 10.8315 22.4039 10.6065 22.5516C10.263 22.7766 9.83827 22.8485 9.42421 22.8871C8.17936 23.0056 7.26471 22.4877 6.6283 21.4348C6.25552 20.8184 5.76956 20.3325 5.08523 20.0663C4.76981 19.9325 4.42139 19.8967 4.08537 19.9638C3.7898 20.029 3.73788 20.1901 3.93891 20.4111C4.03639 20.5234 4.14989 20.6207 4.27575 20.6999C4.9796 21.1318 5.51717 21.7884 5.80152 22.5636C6.37002 23.9973 7.48039 24.5697 8.93825 24.6323C9.43741 24.6575 9.93768 24.615 10.4254 24.5058C10.5892 24.4672 10.6531 24.4872 10.6517 24.6762C10.6451 25.4936 10.6637 26.3123 10.6517 27.131C10.6517 27.6635 10.1684 27.9297 9.58663 27.7393C8.17396 27.2671 6.84977 26.5631 5.66838 25.656C2.59555 23.2891 0.720966 20.1861 0.217704 16.3376C-0.357453 11.9127 0.911353 8.00824 3.98551 4.73881C6.11909 2.42656 8.99932 0.939975 12.1203 0.540191C16.5351 -0.0601815 20.4347 1.14323 23.7232 4.16373C26.2449 6.47869 27.724 9.37672 28.1048 12.7726C28.5828 17.0325 27.3686 20.7945 24.4768 23.9827C22.9762 25.6323 21.0956 26.8908 18.9982 27.6488C18.8783 27.6927 18.7585 27.738 18.636 27.7726C18.0356 27.9404 17.6189 27.6395 17.6189 27.0098C17.6189 25.7452 17.6308 24.4806 17.6295 23.2159C17.6329 22.9506 17.6128 22.6856 17.5696 22.4238C17.4325 21.6664 17.3419 21.484 16.7228 20.6334Z">
                            </path>
                        </svg>
                        <span class="usa-sr-only">NCBI on GitHub</span>
                    </a>
                

                
                    <a href="https://ncbiinsights.ncbi.nlm.nih.gov/"
                       class="ncbi-footer__social-icon ncbi-footer__social-icon--gray"
                       target="_blank"
                       rel="noreferrer noopener">
                        <svg width="26"
                             height="26"
                             viewBox="0 0 27 27"
                             fill="none"
                             xmlns="http://www.w3.org/2000/svg"
                             focusable="false"
                             aria-hidden="true">
                            <path d="M23.7778 26.4574C23.1354 26.3913 22.0856 26.8024 21.636 26.3087C21.212 25.8444 21.4359 24.8111 21.324 24.0347C19.9933 14.8323 14.8727 8.80132 6.09057 5.85008C4.37689 5.28406 2.58381 4.99533 0.779072 4.99481C0.202773 4.99481 -0.0229751 4.83146 0.00455514 4.21479C0.0660406 3.08627 0.0660406 1.95525 0.00455514 0.826734C-0.0413285 0.0815827 0.259669 -0.0193618 0.896534 0.00266238C6.96236 0.222904 12.3693 2.24179 16.9889 6.16209C22.9794 11.2478 26.1271 17.7688 26.4372 25.648C26.4629 26.294 26.3179 26.5271 25.6609 26.4684C25.0827 26.417 24.4991 26.4574 23.7778 26.4574Z">
                            </path>
                            <path d="M14.8265 26.441C14.0924 26.441 13.2371 26.6795 12.6626 26.3786C12.0092 26.0372 12.3781 25.0644 12.246 24.378C11.1154 18.5324 6.6849 14.5497 0.74755 14.1001C0.217135 14.0615 -0.0104482 13.9422 0.0134113 13.3659C0.0519536 12.1454 0.0482829 10.9213 0.0134113 9.69524C-0.00127145 9.14464 0.196946 9.03268 0.703502 9.04736C9.21217 9.27128 16.5994 16.2511 17.2804 24.7231C17.418 26.4446 17.418 26.4446 15.6579 26.4446H14.832L14.8265 26.441Z">
                            </path>
                            <path d="M3.58928 26.4555C2.64447 26.4618 1.73584 26.0925 1.06329 25.4289C0.39073 24.7653 0.00933763 23.8617 0.0030097 22.9169C-0.00331824 21.9721 0.365937 21.0635 1.02954 20.3909C1.69315 19.7184 2.59675 19.337 3.54156 19.3306C4.48637 19.3243 5.39499 19.6936 6.06755 20.3572C6.7401 21.0208 7.1215 21.9244 7.12782 22.8692C7.13415 23.814 6.7649 24.7226 6.10129 25.3952C5.43768 26.0677 4.53409 26.4491 3.58928 26.4555Z">
                            </path>
                        </svg>
                        <span class="usa-sr-only">NCBI RSS feed</span>
                    </a>
                
            </div>
        </div>
    

    <div data-testid="gridContainer"
         class="grid-container ncbi-footer__container">
        <div class="grid-row ncbi-footer__main-content-container"
             data-testid="grid">
            
                <div class="ncbi-footer__column">
                    
                        <p class="ncbi-footer__circled-icons-heading">
                            Connect with NLM
                        </p>
                    

                    <div class="ncbi-footer__circled-icons-list">
                        
                            <a href=https://twitter.com/nlm_nih class="ncbi-footer__social-icon ncbi-footer__social-icon--circled" target="_blank" rel="noreferrer noopener">
                                <svg width="32"
                                     height="32"
                                     viewBox="0 0 40 40"
                                     fill="none"
                                     xmlns="http://www.w3.org/2000/svg"
                                     focusable="false"
                                     aria-hidden="true">
                                    <path d="m6.067 8 10.81 13.9L6 33.2h4.2l8.4-9.1 7.068 9.1H34L22.8 18.5 31.9 8h-3.5l-7.7 8.4L14.401 8H6.067Zm3.6 1.734h3.266l16.8 21.732H26.57L9.668 9.734Z">
                                    </path>
                                </svg>
                                <span class="usa-sr-only">NLM on X (formerly known as Twitter)</span>
                            </a>
                        

                        
                            <a href=https://www.facebook.com/nationallibraryofmedicine class="ncbi-footer__social-icon ncbi-footer__social-icon--circled" target="_blank" rel="noreferrer noopener">
                                <svg width="13"
                                     height="24"
                                     viewBox="0 0 13 24"
                                     fill="none"
                                     xmlns="http://www.w3.org/2000/svg"
                                     focusable="false"
                                     aria-hidden="true">
                                    <path d="M4.11371 23.1369C4.11371 23.082 4.11371 23.0294 4.11371 22.9745V12.9411H0.817305C0.6709 12.9411 0.670898 12.9411 0.670898 12.8016C0.670898 11.564 0.670898 10.3287 0.670898 9.09341C0.670898 8.97903 0.705213 8.95158 0.815017 8.95158C1.8673 8.95158 2.91959 8.95158 3.97417 8.95158H4.12057V8.83263C4.12057 7.8055 4.12057 6.7738 4.12057 5.74897C4.1264 4.92595 4.31387 4.11437 4.66959 3.37217C5.12916 2.38246 5.94651 1.60353 6.95717 1.1921C7.64827 0.905008 8.3913 0.764035 9.13953 0.778051C10.0019 0.791777 10.8644 0.830666 11.7268 0.860404C11.8869 0.860404 12.047 0.894717 12.2072 0.90158C12.2964 0.90158 12.3261 0.940469 12.3261 1.02968C12.3261 1.5421 12.3261 2.05452 12.3261 2.56465C12.3261 3.16857 12.3261 3.7725 12.3261 4.37642C12.3261 4.48165 12.2964 4.51367 12.1912 4.51138C11.5369 4.51138 10.8804 4.51138 10.2261 4.51138C9.92772 4.51814 9.63058 4.5526 9.33855 4.61433C9.08125 4.6617 8.84537 4.78881 8.66431 4.97766C8.48326 5.16652 8.3662 5.40755 8.32972 5.66661C8.28476 5.89271 8.26027 6.1224 8.25652 6.35289C8.25652 7.19014 8.25652 8.02969 8.25652 8.86923C8.25652 8.89439 8.25652 8.91955 8.25652 8.95615H12.0219C12.1797 8.95615 12.182 8.95616 12.1614 9.10714C12.0768 9.76596 11.9876 10.4248 11.9029 11.0813C11.8312 11.6319 11.7626 12.1824 11.697 12.733C11.6719 12.9434 11.6787 12.9434 11.4683 12.9434H8.26338V22.899C8.26338 22.979 8.26338 23.0591 8.26338 23.1392L4.11371 23.1369Z">
                                    </path>
                                </svg>
                                <span class="usa-sr-only">NLM on Facebook</span>
                            </a>
                        

                        
                            <a href=https://www.youtube.com/user/NLMNIH class="ncbi-footer__social-icon ncbi-footer__social-icon--circled" target="_blank" rel="noreferrer noopener">
                                <svg width="21"
                                     height="15"
                                     viewBox="0 0 21 15"
                                     fill="none"
                                     xmlns="http://www.w3.org/2000/svg"
                                     focusable="false"
                                     aria-hidden="true">
                                    <path d="M19.2561 1.47914C18.9016 1.15888 18.5699 0.957569 17.2271 0.834039C15.5503 0.678484 13.2787 0.655608 11.563 0.65332H9.43556C7.71987 0.65332 5.4483 0.678484 3.77151 0.834039C2.43098 0.957569 2.097 1.15888 1.74242 1.47914C0.813665 2.32097 0.619221 4.62685 0.598633 6.89384C0.598633 7.31781 0.598633 7.74101 0.598633 8.16345C0.626084 10.4121 0.827391 12.686 1.74242 13.521C2.097 13.8412 2.4287 14.0425 3.77151 14.1661C5.4483 14.3216 7.71987 14.3445 9.43556 14.3468H11.563C13.2787 14.3468 15.5503 14.3216 17.2271 14.1661C18.5676 14.0425 18.9016 13.8412 19.2561 13.521C20.1712 12.6929 20.3725 10.451 20.3999 8.22064C20.3999 7.74025 20.3999 7.25986 20.3999 6.77946C20.3725 4.54907 20.1689 2.30724 19.2561 1.47914ZM8.55942 10.5311V4.65201L13.5601 7.50005L8.55942 10.5311Z"
                                          fill="white" />
                                </svg>
                                <span class="usa-sr-only">NLM on YouTube</span>
                            </a>
                        
                    </div>
                </div>
            

            
                <address class="ncbi-footer__address ncbi-footer__column">
                    
        <p>
            <a class="usa-link usa-link--external"
            href="https://www.google.com/maps/place/8600+Rockville+Pike,+Bethesda,+MD+20894/%4038.9959508,
            -77.101021,17z/data%3D!3m1!4b1!4m5!3m4!1s0x89b7c95e25765ddb%3A0x19156f88b27635b8!8m2!3d38.9959508!
            4d-77.0988323"
            rel="noopener noreferrer" target="_blank">National Library of Medicine
            <br/> 8600 Rockville Pike<br/> Bethesda, MD 20894</a>
        </p>
    
                </address>
            

            
                <ul class="usa-list usa-list--unstyled ncbi-footer__vertical-list ncbi-footer__column">
                    
                        <li class="ncbi-footer__vertical-list-item">
                            









    <a href="https://www.nlm.nih.gov/web_policies.html" class="usa-link  usa-link--alt ncbi-footer__link"  >
        

        
            Web Policies
        

        
    </a>


                        </li>
                    
                        <li class="ncbi-footer__vertical-list-item">
                            









    <a href="https://www.nih.gov/institutes-nih/nih-office-director/office-communications-public-liaison/freedom-information-act-office" class="usa-link  usa-link--alt ncbi-footer__link"  >
        

        
            FOIA
        

        
    </a>


                        </li>
                    
                        <li class="ncbi-footer__vertical-list-item">
                            









    <a href="https://www.hhs.gov/vulnerability-disclosure-policy/index.html" class="usa-link usa-link--external usa-link--alt ncbi-footer__link" rel="noreferrer noopener" target='_blank' >
        

        
            HHS Vulnerability Disclosure
        

        
    </a>


                        </li>
                    
                </ul>
            

            
                <ul class="usa-list usa-list--unstyled ncbi-footer__vertical-list ncbi-footer__column">
                    
                        <li class="ncbi-footer__vertical-list-item">
                            









    <a href="https://support.nlm.nih.gov/" class="usa-link  usa-link--alt ncbi-footer__link"  >
        

        
            Help
        

        
    </a>


                        </li>
                    
                        <li class="ncbi-footer__vertical-list-item">
                            









    <a href="https://www.nlm.nih.gov/accessibility.html" class="usa-link  usa-link--alt ncbi-footer__link"  >
        

        
            Accessibility
        

        
    </a>


                        </li>
                    
                        <li class="ncbi-footer__vertical-list-item">
                            









    <a href="https://www.nlm.nih.gov/careers/careers.html" class="usa-link  usa-link--alt ncbi-footer__link"  >
        

        
            Careers
        

        
    </a>


                        </li>
                    
                </ul>
            
        </div>

        
            <div class="grid-row grid-col-12" data-testid="grid">
                <ul class="ncbi-footer__bottom-links-list">
                    
                        <li class="ncbi-footer__bottom-list-item">
                            









    <a href="https://www.nlm.nih.gov/" class="usa-link  usa-link--alt ncbi-footer__link"  >
        

        
            NLM
        

        
    </a>


                        </li>
                    
                        <li class="ncbi-footer__bottom-list-item">
                            









    <a href="https://www.nih.gov/" class="usa-link  usa-link--alt ncbi-footer__link"  >
        

        
            NIH
        

        
    </a>


                        </li>
                    
                        <li class="ncbi-footer__bottom-list-item">
                            









    <a href="https://www.hhs.gov/" class="usa-link usa-link--external usa-link--alt ncbi-footer__link" rel="noreferrer noopener" target='_blank' >
        

        
            HHS
        

        
    </a>


                        </li>
                    
                        <li class="ncbi-footer__bottom-list-item">
                            









    <a href="https://www.usa.gov/" class="usa-link usa-link--external usa-link--alt ncbi-footer__link" rel="noreferrer noopener" target='_blank' >
        

        
            USA.gov
        

        
    </a>


                        </li>
                    
                </ul>
            </div>
        
    </div>
</footer>

    


        
        
    
  <script  type="text/javascript" src="https://cdn.ncbi.nlm.nih.gov/core/pinger/pinger.js"> </script>


    
        

<button class="back-to-top" data-ga-category="pagination" data-ga-action="back_to_top">
    <label>Back to Top</label>
    <svg class="usa-icon order-0" aria-hidden="true" focusable="false" role="img">
        <use xlink:href="/static/img/sprite.svg#arrow_upward"></use>
    </svg>
</button>
    


        
    
    
    
        
    <script type="application/javascript">
    window.ncbi = window.ncbi || {};
    window.ncbi.pmc = window.ncbi.pmc || {};
    window.ncbi.pmc.options = {
        logLevel: 'INFO',
        
        staticEndpoint: '/static/',
        
        citeCookieName: 'pmc-cf',
    };
</script>
    <script type="module" crossorigin="" src="/static/assets/base-133c6271.js"></script>
    
    <script type="text/javascript" src="https://cdn.ncbi.nlm.nih.gov/core/jquery/jquery-3.6.0.min.js">&#xA0;</script>
    <script type="text/javascript">
        jQuery.getScript("https://cdn.ncbi.nlm.nih.gov/core/alerts/alerts.js", function () {
            galert(['div.nav_and_browser', 'div.header', '#universal_header', '.usa-banner', 'body > *:nth-child(1)'])
        });
    </script>


    <script type="text/javascript">var exports = {};</script>
     <script src="/static/CACHE/js/output.13b077bc3ffd.js"></script>

    <script type="module" crossorigin="" src="/static/assets/article-44d04358.js"></script>
    
        <script type="module" crossorigin="" src="/static/assets/math-574fdcc6.js"></script>
    
    

    </body>
</html>
